<SEC-DOCUMENT>0001213900-25-061546.txt : 20250703
<SEC-HEADER>0001213900-25-061546.hdr.sgml : 20250703
<ACCEPTANCE-DATETIME>20250703170037
ACCESSION NUMBER:		0001213900-25-061546
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250703
FILED AS OF DATE:		20250703
DATE AS OF CHANGE:		20250703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LiveOne, Inc.
		CENTRAL INDEX KEY:			0001491419
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-EATING PLACES [5812]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				980657263
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38249
		FILM NUMBER:		251106221

	BUSINESS ADDRESS:	
		STREET 1:		269 SOUTH BEVERLY DRIVE
		STREET 2:		SUITE 1450
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90212
		BUSINESS PHONE:		(310) 601-2505

	MAIL ADDRESS:	
		STREET 1:		269 SOUTH BEVERLY DRIVE
		STREET 2:		SUITE 1450
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90212

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LiveXLive Media, Inc.
		DATE OF NAME CHANGE:	20170808

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LOTON, CORP
		DATE OF NAME CHANGE:	20100507
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>ea0248124-pre14a_liveone.htm
<DESCRIPTION>PRELIMINARY PROXY STATEMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Jul 03 20:00:41 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lvo="http://www.liveone.com/20250908" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-types="http://xbrl.us/us-types/2009-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font: 1pt Times New Roman, Times, Serif; border-top: Black 2pt solid; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED
STATES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington,
D.C. 20549</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin: 0pt auto; width: 25%"><div style="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Schedule&#160;<span style="-sec-ix-hidden: hidden-fact-0">14A</span></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin: 0pt auto; width: 25%"><div style="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxy
Statement Pursuant to Section&#160;14(a)&#160;of</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the
Securities Exchange&#160;Act&#160;of&#160;1934</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amendment
No.&#160;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    by the Registrant</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    by a party other than the Registrant</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Check
the appropriate box:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</span></td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential,
    for Use of the Commission Only (as permitted by Rule&#160;14a-6(e)(2))</span></td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</span></td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</span></td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material under &#167; 240.14a-12</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-154"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LIVEONE,
INC.</b></span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Name
of Registrant as Specified In Its Charter)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin: 0pt auto; width: 50%"><div style="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Name
of Person(s)&#160;Filing Proxy Statement, if other than the Registrant)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payment
of Filing Fee (Check all boxes that apply):</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required</span></td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials</span></td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table in exhibit required by Item&#160;25(b)&#160;per Exchange&#160;Act Rules 14a-6(i)(1)&#160;and&#160;0-11</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font: 1pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-bottom: Black 2pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRELIMNARY
PROXY STATEMENT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="image_001.jpg"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>269
South Beverly Drive, Suite 1450</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beverly
Hills, CA&#160;90212</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTICE
    OF ANNUAL MEETING OF STOCKHOLDERS<br/>
    TO BE HELD ON SEPTEMBER 8, 2025</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Stockholders of LiveOne, Inc.:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are pleased to invite you to attend the 2025 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) of LiveOne, Inc., a Delaware
corporation (the &#8220;Company&#8221;), which will be held on Thursday, September 8, 2025, at 10:00&#160;a.m. local time at the principal
executive offices of PodcastOne located at 335 North Maple Drive, Suite 295, Beverly Hills, CA 90210, for the following purposes, as
more fully described in the accompanying proxy statement (the &#8220;Proxy Statement&#8221;):</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            elect the seven director nominees identified in the Proxy Statement to hold office until
                                            the 2026 Annual Meeting of Stockholders;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            approve an amendment to the Company&#8217;s Certificate of Incorporation to effect a reverse
                                            stock split of its issued and outstanding shares of common stock, $0.001 par value per share,
                                            at a ratio to be determined in the discretion of the Company&#8217;s Board of Directors within
                                            a range of no less than one-for-three through one-for-ten (without reducing the authorized
                                            number of shares of common stock) (the &#8220;Reverse Split&#8221;) and with the Company&#8217;s
                                            Board of Directors able to elect to abandon such proposed amendment and not affect the Reverse
                                            Split authorized by the Company&#8217;s stockholders in its sole discretion;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            ratify the appointment of Macias Gini&#160;&amp; O&#8217;Connell LLP as the Company&#8217;s
                                            independent registered public accounting firm for the fiscal year ending March 31, 2026;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            approve an adjournment of the Annual Meeting to a later date or time, if necessary, to permit
                                            further solicitation and vote of proxies if there are not sufficient votes at the time of
                                            the Annual Meeting to approve any of the proposals presented for a vote at the Annual Meeting;
                                            and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            transact such other business as may properly come before the Annual Meeting or any adjournment
                                            or postponement thereof.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Company&#8217;s Bylaws, the Company&#8217;s board of directors has fixed the close of business on July 14, 2025 (the &#8220;Record
Date&#8221;) as the record date for the determination of stockholders entitled to notice of and to vote at the Annual Meeting or at any
adjournment or postponement thereof. Holders of the Company&#8217;s common stock are entitled to vote at the Annual Meeting.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you for your ongoing support and continued interest in the Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Robert S.&#160;Ellin</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    S.&#160;Ellin</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beverly
    Hills, CA</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    [&#9679;], 2025</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>YOUR
VOTE IS IMPORTANT!</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
STOCKHOLDER MEETING TO BE HELD ON SEPTEMBER 8, 2025:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Proxy Statement is attached. The Notice of Annual Meeting of Stockholders, Proxy Statement, Proxy Card and 2025 Annual Report may be
accessed over the internet free of charge at <i>https://ts.vstocktransfer.com/irhlogin/LIVEONEINC</i>.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are using U.S.&#160;Securities and Exchange Commission rules that allow us to make our Proxy Statement and related materials available
on the internet. Accordingly, we are sending a &#8220;Notice of Internet Availability of Proxy Materials,&#8221; or Notice of Availability,
to our stockholders of record instead of a paper Proxy Statement and annual report containing financial statements, unless paper copies
have previously been requested. The rules provide us the opportunity to save money on the printing and mailing of our proxy materials
and to reduce the impact of our Annual Meeting on the environment. We hope that you will view our Annual Meeting materials over the internet
if possible and convenient for you. Instructions on how to access the proxy materials over the internet or to request a paper or email
copy of our proxy materials can also be found in the notice you received.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Whether
or not you expect to attend the Annual Meeting, please make sure you vote so that your shares will be represented at the Annual Meeting.
</b>Our stockholders can vote over the internet or by telephone as specified in the accompanying voting instructions or by completing
and returning a proxy card. This will ensure the presence of a quorum at the Annual Meeting and save the expense and extra work of additional
solicitation. Sending your proxy card will not prevent you from attending the Annual Meeting, revoking your proxy and voting your stock
in person.</span></p><div>






</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 3 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRELIMNARY
PROXY STATEMENT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; font-weight: bold; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Page</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; width: 88%; text-align: left"><a href="#l_001"><span style="font-family: Times New Roman, Times, Serif">QUESTIONS
    AND ANSWERS ABOUT THE PROXY MATERIALS AND THE ANNUAL MEETING</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; width: 1%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: center">1</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#l_002"><span style="font-family: Times New Roman, Times, Serif">CORPORATE
    GOVERNANCE</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">7</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#l_003"><span style="font-family: Times New Roman, Times, Serif">PROPOSAL
    NO. 1&#160;&#8212;&#160;ELECTION OF DIRECTORS</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">11</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#l_004"><span style="font-family: Times New Roman, Times, Serif">DIRECTOR
    COMPENSATION</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">18</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#l_005"><span style="font-family: Times New Roman, Times, Serif">SECURITY
    OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">19</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#l_006"><span style="font-family: Times New Roman, Times, Serif">EXECUTIVE
    OFFICERS AND DIRECTORS</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">22</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#l_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPOSAL
    NO. 2&#160;&#8212;&#160;APPROVAL OF AN AMENDMENT TO THE COMPANY&#8217;S CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK
    SPLIT</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">25</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#l_008"><span style="font-family: Times New Roman, Times, Serif">PROPOSAL
    NO. 3&#160;&#8212;&#160;RATIFICATION OF THE APPOINTMENT OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">31</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#l_009"><span style="font-family: Times New Roman, Times, Serif">PROPOSAL
    NO. 4.&#160;&#8212;&#160;APPROVAL OF AN ADJOURMENT OF THE ANNUAL MEETING TO A LATER DATE OR TIME IF THERE ARE INSUFFICIENT VOTES
    AT THE TIME OF THE ANNUAL MEETING</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">32</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#l_010"><span style="font-family: Times New Roman, Times, Serif">REPORT
    OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">33</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#l_011"><span style="font-family: Times New Roman, Times, Serif">EXECUTIVE
    COMPENSATION</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">34</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#l_012"><span style="font-family: Times New Roman, Times, Serif">CERTAIN
    RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">45</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: left"><a href="#l_013"><span style="font-family: Times New Roman, Times, Serif">OTHER
    INFORMATION</span></a></td><td style="font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">48</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img alt="" src="image_001.jpg"/></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>269
South Beverly Drive, Suite 1450<br/>
Beverly Hills, CA&#160;90212</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROXY
    STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS <br/>
    TO BE HELD ON SEPTEMBER 8, 2025</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors of LiveOne, Inc., a Delaware corporation (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; LiveOne,&#8221; the
&#8220;Company&#8221; or &#8220;our Company&#8221;) solicits the enclosed proxy for the Annual Meeting of Stockholders (the &#8220;Annual
Meeting&#8221;) to be held on Thursday, September 8, 2025, at 10:00&#160;a.m. local time at the principal executive offices of PodcastOne
located at 335 North Maple Drive, Suite 295, Beverly Hills, CA 90210, and for any adjournment or postponement thereof. This proxy statement
(this &#8220;Proxy Statement&#8221;) is being made available to stockholders on or about July [&#9679;], 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="l_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QUESTIONS
AND ANSWERS ABOUT THE PROXY MATERIALS AND THE ANNUAL MEETING</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td>
    <td style="text-align: justify; font-family: Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
                                            did&#160;I receive a notice regarding the availability of proxy materials on the internet?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Instead
                                            of mailing paper proxy materials, we sent a &#8220;Notice of Internet Availability of Proxy
                                            Materials&#8221; to our stockholders of record. We refer to that notice as the Notice of
                                            Availability. The Notice of Availability provides instructions on how to view our proxy materials
                                            over the internet, how to vote and how to request a paper or email copy of our proxy materials.
                                            This method of providing proxy materials is permitted under rules adopted by the U.S.&#160;Securities
                                            and Exchange Commission (the &#8220;SEC&#8221;). We hope that following this procedure will
                                            allow us to save money on the printing and mailing of those materials and to reduce the impact
                                            that our Annual Meeting has on the environment.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            intend to mail the Notice of Availability on or about July [&#9679;], 2025 to all of our
                                            stockholders of record entitled to vote at the Annual Meeting.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                           <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            is the purpose of the Annual Meeting?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                            the Annual Meeting, our stockholders will act upon the matters outlined in this Proxy Statement,
                                            including:</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.7in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">election
                                            of the seven members of our board of directors, the director nominees being Robert S.&#160;Ellin,
                                            Jay Krigsman, Ramin Arani, Patrick Wachsberger, Kenneth Solomon, Bridget Baker and Kristopher
                                            Wright (Proposal&#160;No. 1);</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.7in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval
                                            of an amendment to our Certificate of Incorporation to effect a reverse stock split of our
                                            issued and outstanding shares of common stock, $0.001 par value per share (the &#8220;common
                                            stock&#8221;), at a ratio to be determined in the discretion of our Board of Directors within
                                            a range of no less than one-for-three through one-for-ten (without reducing the authorized
                                            number of shares of our common stock) (the &#8220;Reverse Split&#8221;) and with our Board
                                            of Directors able to elect to abandon such proposed amendment and not affect the Reverse
                                            Split authorized by our stockholders in its sole discretion (Proposal No. 2);</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.7in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ratification
                                            of Macias Gini&#160;&amp; O&#8217;Connell LLP as our independent registered public accounting
                                            firm for the fiscal year ending March 31, 2026 (Proposal&#160;No. 3); and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.7in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval
                                            of the adjournment of the Annual Meeting, if necessary, if a quorum is present, to solicit
                                            additional proxies if there are not sufficient votes at the time of the Annual Meeting to
                                            approve any of the proposals presented for a vote at the Annual Meeting (Proposal&#160;No.
                                            4).</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management, certain members of our board of directors and representatives of Macias Gini&#160;&amp; O&#8217;Connell LLP, our independent
registered public accounting firm, will be present at the Annual Meeting or at any adjournment or postponement thereof to respond to
appropriate questions from stockholders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.05in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.05in; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.05in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                           <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
                                            is entitled to vote at the Annual Meeting?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
                                            common stockholders as of the close of business on July 14, 2025 (the &#8220;Record Date&#8221;)
                                            are entitled to notice of and to vote at the Meeting. As of the Record Date, there were issued
                                            and outstanding and entitled to vote [&#9679;] shares of our common stock.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                     <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            are the voting rights of the holders of our common stock?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            outstanding share of our common stock will be entitled to one vote on each of the proposals
                                            presented at the Annual Meeting, or at any adjournment or postponement thereof.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                     <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Which
                                            of my shares may&#160;I vote?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            shares owned by you as of the close of business on the Record Date may be voted by you. These
                                            shares include shares that are (i)&#160;held directly in your name as the stockholder of
                                            record and (ii)&#160;held for you as the beneficial owner through a broker, bank or other
                                            nominee.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                     <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
                                            can attend the Annual Meeting?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            of our stockholders as of the Record Date may attend the Annual Meeting, or at any adjournment
                                            or postponement thereof. Even if your shares are held in &#8220;street name,&#8221; as the
                                            beneficial owner of shares, you are invited to attend the Annual Meeting. However, if you
                                            wish to attend the Annual Meeting, please bring to the Annual Meeting your bank or brokerage
                                            statement or a letter from your nominee evidencing your beneficial ownership of our stock
                                            and a form of personal identification. We reserve the right to deny admission to anyone who
                                            cannot show valid identification or sufficient proof of share ownership as of the Record
                                            Date.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7in; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
contact us at (310)&#160;601-2505 or tenia@liveone.com for directions to the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                     <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can&#160;I
                                            find out who the stockholders are?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            list of stockholders as of the Record Date will be available for examination by any stockholder,
                                            for any purpose germane to the Annual Meeting, during ordinary business&#160;hours for ten&#160;days
                                            prior to the Annual Meeting at the office of the Office Manager of the Company at the above
                                            address, and at the time and place of the Annual Meeting, or at any adjournment or postponement
                                            thereof.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                     <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            constitutes a quorum?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Presence
                                            at the Annual Meeting, or at any adjournment or postponement thereof, in person or by proxy,
                                            of the holders of a majority of our common stock outstanding on the Record Date will constitute
                                            a quorum, permitting the Annual Meeting to proceed and business to be conducted. Abstentions
                                            and broker non-votes are included in the calculation of the number of shares considered to
                                            be present at the Annual Meeting. At the close of business on the Record Date, we had [&#9679;]
                                            shares of our common stock issued and outstanding and entitled to vote.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -48pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                     <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What&#160;is&#160;the&#160;difference&#160;between&#160;holding&#160;shares&#160;as&#160;a&#160;&#8220;record&#160;holder&#8221;&#160;versus&#160;a&#160;&#8220;beneficial&#160;owner&#8221;?</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
                                            of our stockholders hold their shares through a broker, bank or other nominee rather than
                                            directly in their own name. As summarized below, there are some distinctions between shares
                                            held of record and those owned beneficially:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Record
holders&#160;</i>&#8212;&#160;If your shares are registered directly in your name with our transfer agent, VStock Transfer, LLC, you
are, with respect to those shares, the stockholder of record or &#8220;record holder.&#8221; As the record holder, you have the right
to grant your voting proxy directly to us or to vote in person at the Annual Meeting, or at any adjournment or postponement thereof.
We have enclosed or sent a proxy card for you to use. You may also vote by mail, over the internet or by telephone, as described below
under the heading &#8220;Voting&#160;&#8212;&#160;How do&#160;I vote?&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"></p></div><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Beneficial
owners&#160;</i>&#8212;&#160;If your shares are held in a brokerage account or bank or by another nominee, you are, with respect to those
shares, the &#8220;beneficial owner&#8221; of shares held in &#8220;street name.&#8221; As the beneficial owner, you have the right to
direct your nominee on how to vote or to vote in person at the Annual Meeting, or at any adjournment or postponement thereof.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
since you are not a record holder, you may not vote these shares in person at the Annual Meeting, or at any adjournment or postponement
thereof, unless you obtain a &#8220;legal proxy&#8221; from your nominee (who is the record holder), giving you the right to vote the
shares. If you do not wish to vote in person, you may vote by mail, over the internet or by telephone, as described below under the heading
&#8220;Voting&#160;&#8212;&#160;How can&#160;I vote?&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            do&#160;I vote?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
                                            you are a registered stockholder of common stock on the Record Date, </i></b>meaning that
                                            you hold your shares in certificate form or through an account with our transfer agent, VStock
                                            Transfer, LLC (&#8220;VStock Transfer&#8221;), and you wish to vote prior to the Annual Meeting,
                                            or at any adjournment or postponement thereof, you may vote over the Internet, by mail or
                                            in person at the Annual Meeting:</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.7in"/><td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Over
                                            the Internet.&#160;</i></b>Go to the website of our tabulator, VStock Transfer, at <i>https://ts.vstocktransfer.com/pxlogin.
                                            </i>Have your proxy card in hand when you access the website and follow the instructions
                                            to vote your shares. You must submit your Internet proxy before 11:59&#160;p.m., Eastern
                                            Time, on September 7, 2025, the&#160;day prior to the Annual Meeting, for your proxy to be
                                            valid and your vote to count.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.7in"/><td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>By
                                            Mail.&#160;</i></b>Complete and sign your proxy card and mail it to VStock Transfer, LLC,
                                            18 Lafayette Place, Woodmere, NY&#160;11598, in the postage prepaid envelope we provided.
                                            VStock must receive the proxy card not later than September 7, 2025, the&#160;day before
                                            the Annual Meeting, for your proxy to be valid and your vote to count.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.7in"/><td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>In
                                            Person at the Meeting.&#160;</i></b>You can vote in person by attending the Annual Meeting,
                                            or at any adjournment or postponement thereof, and delivering your completed proxy card in
                                            person or by completing a ballot, which we will provide to you at the meeting.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
on the Record Date your shares are held in street name</i>, </b>the proxy materials are being forwarded to you by or on behalf of your
bank, broker or other nominee. If you received the proxy materials directly from Broadridge, follow the instructions above for stockholders
of record. If you received the proxy materials from your bank, broker or other nominee, follow the instructions provided by your bank,
broker or other nominee explaining how you can vote. If you would like to vote in person at the Annual Meeting, or at any adjournment
or postponement thereof, contact your bank, broker or other nominee who holds your shares to obtain a broker&#8217;s proxy card and bring
it with you to the Annual Meeting, along with a bank or brokerage statement or a letter from your nominee evidencing your beneficial
ownership of our stock and a form of personal identification. A broker&#8217;s proxy is not the form of proxy enclosed with this Proxy
Statement. <b>You will not be able to vote shares you hold in street name in person at the Annual Meeting unless you have a proxy from
your bank, broker or other nominee issued in your name giving you the right to vote your shares.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            if&#160;I do not specify how my shares are to be voted?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you are the stockholder of record and you submit a proxy but do not provide any voting instructions,
                                            your shares will be voted in accordance with the recommendations of our board of directors.
                                            If you hold your shares in street name and do not instruct your bank or broker how to vote,
                                            it will nevertheless be entitled to vote your shares of common stock with respect to &#8220;routine&#8221;
                                            items but not with respect to &#8220;non-routine&#8221; items.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
                                            note that at the Annual Meeting, or at any adjournment or postponement thereof, we believe
                                            that only the approval of an amendment to our Certificate of Incorporation to effect the
                                            Reverse Split (Proposal No. 2),&#160;ratification of the appointment of our independent registered
                                            public accounting firm (Proposal&#160;No. 3) and the approval of an adjournment of the Annual
                                            Meeting, if necessary (Proposal&#160;No. 4), will each be considered a &#8220;routine&#8221;
                                            matter. Under applicable rules, banks and brokers are permitted to vote the shares held in
                                            their name for the account of a beneficial holder for &#8220;routine&#8221; matters, even
                                            if such bank or broker does not receive instructions from the beneficial holder. We will
                                            refer to these votes cast by banks and brokers without instruction from the relevant beneficial
                                            holder as &#8220;Broker Discretionary Votes.&#8221; We believe that based on the policies
                                            of most banks and brokers, the majority of Broker Discretionary Votes will be cast in accordance
                                            with the recommendations of our board of directors, and therefore &#8220;<b><span style="text-decoration:underline">FOR</span></b>&#8221;
                                            Proposal No. 2,&#160; &#8220;<b><span style="text-decoration:underline">FOR</span></b>&#8221; Proposal&#160;No. 3 and &#8220;<b><span style="text-decoration:underline">FOR</span></b>&#8221;
                                            Proposal&#160;No. 4. We believe that the other proposals (Proposals No. 1 and No. 2) will
                                            be considered a &#8220;non-routine&#8221; item, and your broker will not have discretion
                                            to vote on this proposal. We will refer to these shares not voted by banks and brokers in
                                            absence of instructions from the relevant beneficial holder as &#8220;broker non-votes.&#8221;
                                            Please also see below Question 15. Vote Requirement &#8212; How many votes are required to
                                            approve each item?</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is therefore important that you provide instructions to your bank or broker so that your shares are voted accordingly.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            is a broker non-vote?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
                                            a broker non-vote occurs when shares held by a nominee for a beneficial owner are not voted
                                            with respect to a particular proposal because (i)&#160;the nominee has not received voting
                                            instructions from the beneficial owner with respect to such proposal (despite voting on at
                                            least one other proposal for which it does have discretionary authority or for which it has
                                            received instructions) and (ii)&#160;the nominee lacks discretionary voting power to vote
                                            such shares. Under the rules of The Nasdaq Capital Market, a nominee does not have discretionary
                                            voting power with respect to &#8220;non-routine&#8221; matters or the election of directors.
                                            The approval of an amendment to our Certificate of Incorporation to effect the Reverse Split
                                            (Proposal No. 2), the ratification of the appointment of our independent registered public
                                            accounting firm (Proposal&#160;No. 3) and the approval of an adjournment of the Annual Meeting,
                                            if necessary (Proposal&#160;No. 4), are each a routine matter and the other proposals are
                                            non-routine matters.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are the beneficial owner of our common stock, your nominee will send you directions on how you can instruct them to vote.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>May&#160;I
                                            change my vote after&#160;I return my proxy?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
                                            You may revoke your proxy and change your vote at any time before the proxy is exercised.
                                            Record holders may change their vote by:</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: -17.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.7in"/><td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            timely, valid, later-dated proxy;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: -17.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.7in"/><td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            timely written notice of revocation submitted to our Office Manager at our principal executive
                                            offices at 269 South Beverly Drive, Suite 1450, Beverly Hills, CA&#160;90212; or</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: -17.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.7in"/><td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">attending
                                            the Annual Meeting, or at any adjournment or postponement thereof, and voting in person.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
owners may change their vote by complying with the instructions on their voting instruction cards.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should be aware that simply attending the Annual Meeting will not in and of itself constitute a revocation of your proxy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
                                            does our board of directors recommend that&#160;I vote?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            board of directors recommends that you vote your shares:</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.7in"/><td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration:underline">FOR</span></i></b>
                                            the election of each of the director nominees named in this Proxy Statement (Proposal&#160;No.
                                            1);</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.7in"/><td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration:underline">FOR</span></i></b>&#160;the
                                            approval of an amendment to our Certificate of Incorporation to effect the Reverse Split
                                            (Proposal No. 2);</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.7in"/><td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration:underline">FOR</span></i></b>
                                            the ratification of Macias Gini&#160;&amp; O&#8217;Connell LLP as our independent registered
                                            public accounting firm for the fiscal year ending March 31, 2026 (Proposal&#160;No. 3); and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.7in"/><td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration:underline">FOR</span></i></b>
                                            the approval of an adjournment of the Annual Meeting, if necessary (Proposal&#160;No. 4).</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
                                            Requirement&#160;&#8212;&#160;How many votes are required to approve each item?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Election
                                            of directors</span> (Proposal&#160;No. 1)&#160;</i>&#8212;&#160;If a quorum is present, a plurality
                                            of the votes cast shall be sufficient to elect directors (that is the nominees for our directors
                                            who receive the most votes will be elected). For purposes of electing directors, not voting
                                            or withholding your vote by voting &#8220;abstain&#8221; (or a direction to your broker,
                                            bank or other nominee to withhold your vote, called a &#8220;broker non-vote&#8221;) is not
                                            counted as a vote cast, and therefore will have no effect on the outcome of the election
                                            of directors.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Approval
of an amendment to our Certificate of Incorporation to effect the Reverse Split</span>&#160;(Proposal No. 2)&#160;</i>&#8212; If a quorum
is present, for this proposal to be approved, the number of votes cast &#8220;FOR&#8221; the proposal must exceed the number of votes
cast &#8220;AGAINST&#8221; this proposal; provided that our common stock is listed on The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
immediately before the Reverse Split becomes effective and meets the listing requirements of Nasdaq relating to the minimum number of
holders immediately after the Reverse Split becomes effective (the &#8220;Listing Condition&#8221;), in which case, abstentions and any
broker non-votes with respect to this proposal will not be considered &#8220;votes cast&#8221; and will have no effect on this proposal.
If the Listing Condition is not met, this proposal must receive the affirmative vote of the holders of a majority of our issued and outstanding
shares of common stock as of the Record Date and abstentions and any broker non-votes with respect to this proposal would have the same
effect as a vote against this proposal. Brokerage firms will have discretionary authority to vote their customers&#8217; unvoted shares
held by the firms in street name on this proposal, and we do not anticipate receiving any broker non-votes on this proposal.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">All
other proposals</span> (Proposals No. 3 and No. 4 and any other items properly brought before the Annual Meeting)&#160;</i>&#8212;&#160;If
a quorum is present, approval of each of these proposals and any other item properly brought before the Annual Meeting requires that
the votes cast in favor of such action exceed the votes cast opposing such action. For purposes of these votes, abstentions or not voting
on a matter will not be counted as either votes cast for or against this proposal and therefore will not count in determining the approval
of these proposals. Broker non-votes will have no effect on the outcome of these proposals.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12pt; text-align: justify; text-indent: 0.7in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of Proposals No. 3 and 4 are not binding on our board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            happens if a nominee is unable to stand for election?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a nominee is unable to stand for election, the board of directors may either reduce the number
                                            of directors to be elected or select a substitute nominee. If a substitute nominee is selected,
                                            the proxy holders will vote your shares for the substitute nominee, unless you have voted
                                            &#8220;Withhold&#8221; with respect to the original nominee.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
                                            Count&#160;&#8212;&#160;How are votes counted?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Votes
                                            will be counted by the inspector of election appointed for the Annual Meeting, who will separately
                                            count, for each proposal votes &#8220;For,&#8221; &#8220;Against,&#8221; abstentions and
                                            broker non-votes.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                      <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
                                            Results&#160;&#8212;&#160;Where can&#160;I find the voting results of the Annual Meeting?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            will publish the final voting results of the Annual Meeting, or at any adjournment or postponement
                                            thereof, in a Current Report on Form&#160;8-K filed with the SEC within four&#160;business&#160;days
                                            after the Annual Meeting.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                      <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            should&#160;I do if&#160;I receive more than one set of voting materials?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            may receive more than one set of voting materials, including multiple copies of the Notice
                                            of Availability, this Proxy Statement and multiple proxy cards or voting instruction cards.
                                            For example, if you hold your shares in more than one brokerage account, you may receive
                                            a separate voting instruction card for each brokerage account. If you are a record holder
                                            and your shares are registered in more than one name, you will receive more than one Notice
                                            of Availability or proxy card. If you receive multiple sets of voting materials, please vote
                                            each Notice of Availability, proxy card and voting instruction card that you receive.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
                                            will pay the costs of soliciting these proxies?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxies
                                            will be solicited initially by mail. Further solicitation may be made in person or by telephone,
                                            email or facsimile by members of our management. We will bear the expense of preparing, printing
                                            and mailing this Proxy Statement and accompanying materials to our stockholders. Upon request,
                                            we will reimburse brokers, banks or similar entities acting as nominees for reasonable expenses
                                            incurred in forwarding copies of the proxy materials relating to the Annual Meeting to the
                                            beneficial owners of our common stock.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>21.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
                                            happens if additional matters are presented at the Annual Meeting?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            than the four proposals described in this Proxy Statement, we are not aware of any other
                                            business to be acted upon at the Annual Meeting, or at any adjournment or postponement thereof.
                                            If you grant a proxy, the persons named as proxy holders, Robert S.&#160;Ellin, our Chairman
                                            and Chief Executive Officer, and Ryan Carhart, our Chief Financial Officer, will have the
                                            discretion to vote your shares on any additional matters properly presented for a vote at
                                            the Annual Meeting.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>22.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Q:</b></span></td>
                                                                                                                                                                                                                                                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
                                            can help answer my questions?</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you have any questions about our proxy materials or the Annual Meeting, you can contact our
                                            Office Manager at:</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LiveOne,
Inc.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">269
South Beverly Drive, Suite 1450</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beverly
Hills, CA&#160;90212</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Office Manager</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(310)&#160;601-2505</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>****</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="l_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CORPORATE
GOVERNANCE</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a Code of Ethics for our directors, officers and employees, which, in conjunction with our Certificate of Incorporation,
Bylaws and board of directors&#8217; committee charters, form our framework for governance. All of these documents are publicly available
on our investor relations/corporate governance website at <i>http://ir.livexlive.com/ir-home </i>or may be obtained upon written request
to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LiveOne,
Inc.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">269
South Beverly Drive, Suite 1450</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beverly
Hills, CA&#160;90212</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Office Manager</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governance
Highlights</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are committed to maintaining high standards of business conduct and corporate governance, which we believe are essential to running our
business efficiently, serving our stockholders well and maintaining our integrity in the marketplace. Some of the highlights of our corporate
governance include:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
We Do:</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6
                                            of 7 directors are independent</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                            election of all members of our board of directors (see Proposal&#160;No. 1)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                            advisory vote to ratify independent auditor (see Proposal&#160;No. 3)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restrictive
                                            stock ownership and insider trading guidelines</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regular
                                            board of directors self-assessments at both individual and committee levels</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
                                            of directors committee members are all independent</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>What
We <span style="text-decoration:underline">Don&#8217;t</span> Do:</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            repricing of underwater stock options without stockholder approval</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            hedging of Company securities per Company policy</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            pledging of Company securities without preapproval per Company policy</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors currently consists of seven directors, seven of whom are independent (as determined by our board of directors), one
of whom serves as our Chairman and Chief Executive Officer. Our board of directors has reviewed the independence of our directors and
has determined that each of Messrs. Krigsman, Arani, Wachsberger, Solomon and Wright and Ms. Baker qualify as an independent director
pursuant to Rule&#160;5605(a)(2)&#160;of Nasdaq and applicable SEC rules and regulations. In making this determination, our board of
directors considered the relationships that each of these non-employee directors has with us and all other facts and circumstances our
board of directors deemed relevant in determining their independence.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Composition and Director Qualifications</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating Committee periodically assesses the appropriate size and composition of our board of directors, taking into account our specific
needs. The committee utilizes various methods for identifying and evaluating candidates for director. Candidates may come to the attention
of the committee through recommendations of directors, management, stockholders and professional search firms. Generally, the committee
seeks members with diverse backgrounds, viewpoints and life and professional experiences, which contribute to the board of directors&#8217;
broad spectrum of experience and expertise, and who have a reputation of integrity, provided such individuals should all have a high
level of management and/or financial experience.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we have no formal diversity policy that applies to the consideration of director candidates, the Nominating Committee has determined
that diversity should be an important consideration in the selection of candidates, and that the board should be comprised of members
who reflect diversity not only in race and gender, but also in viewpoints, experiences, backgrounds, skills and other qualities and attributes.
The board and the Nominating Committee recognize the value of gender, race, ethnicity and age diversity and are focused on expanding
the board to continue to diversify its makeup. Consistent with this commitment, the board appointed its first female member during the
fiscal year ended March&#160;31, 2020, appointed Mr.&#160;Wright during the fiscal year ended March&#160;31, 2022 and continues to search
for other suitable diverse candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rather
than being bound by one-size-fits-all policies regarding the composition of our board of directors, the Nominating Committee instead
seeks to make individual, facts-specific determinations. We believe that our Company requires specialized experience and expertise in
its leaders due to the uniqueness of its business and industry. Commencing with our 2020 fiscal year, the Nominating Committee annually
assesses the appropriateness of the size of our board of directors, the skill set mix of each director, and the performance of each director
when reviewing the annual board self-assessments, where each director has the opportunity to provide comprehensive feedback on himself/herself,
his/her peers and the board as a whole. Two of the current members of our board of directors have been our directors since 2011 and 2012
respectively, and the other five members of our board of directors joined us in 2019 and 2021, reflecting our evolving and expanding
business and leadership needs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating Committee does not mandate an age or length of service at which a director must resign, and instead focuses on whether each
director continues to provide value to the company and its stockholders. The Nominating Committee has committed itself to carefully considering
diversity when evaluating future director candidates, giving strong consideration to candidates that would contribute to the board&#8217;s
gender, ethnic and other diversity.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
a minimum, directors should:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                            experience in positions with a high degree of responsibility;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">demonstrate
                                            strong leadership skills;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                            the time, energy, interest and willingness to serve as a director; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">contribute
                                            to the mix of skills, core competencies and qualifications of the board of directors and
                                            management.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our board of directors reconstituted our board committees in February&#160;2021 and our Nominating Committee in October&#160;2022
to reflect the committees&#8217; composition more closely with the skills and experience of our board members.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to recommendations from directors, management and professional search firms, the Nominating Committee will consider director
candidates properly submitted by our stockholders. Stockholder recommendations should be sent to the Office Manager at our principal
executive offices. The Nominating Committee will review all potential director nominees in the same manner, regardless of the source
of the recommendation, in accordance with its charter.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating Committee currently consists of Messrs. Krigsman and Wright. We have not yet appointed a new chairman to chair our Nominating
Committee to replace the vacancy created by Mr. Foster&#8217;s resignation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Leadership Structure</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
the office of Chairman of our board of directors and Chief Executive Officer are held by Robert S.&#160;Ellin. Due to our size and early
stage of operations, we believe it is currently most effective to have the Chairman of the board of directors and Chief Executive Officer
positions be held by the same individual. Under our Bylaws, the Chairman of the board of directors is responsible for coordinating the
board of directors&#8217; activities, including the scheduling of meetings and the determination of relevant agenda items.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
Oversight and Compensation Risk Assessment</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors oversees a company-wide approach to risk management. Our board of directors determines the appropriate risk level
for us generally, assesses the specific risks faced by us and reviews the steps taken by our management to manage those risks. While
our board of directors has ultimate oversight responsibility for the risk management process, its committees oversee risk in certain
specified areas.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specifically,
our Compensation Committee is responsible for overseeing the management of risks relating to our executive compensation plans and arrangements,
and the incentives created by the compensation awards it administers. Our Audit Committee oversees management of enterprise risks and
financial risks, as well as potential conflicts of interests. Our board of directors is responsible for overseeing the management of
risks associated with the independence of our board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management also reviews and reports on potential areas of risk at the request of the Audit Committee or other members of the board of
directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our compensation policies and practices do not create inappropriate or unintended significant risk to our Company as a whole.
We also believe that our incentive compensation arrangements provide incentives that do not encourage risk-taking beyond our ability
to effectively identify and manage significant risks, are compatible with effective internal controls and our risk management practices
and are supported by the oversight and administration of the Compensation Committee with regard to executive compensation programs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a Code of Ethics applicable to all of our directors, officers and employees, including our Chief Executive Officer, Chief
Financial Officer and Controller, which is a &#8220;code of ethics&#8221; as defined by applicable SEC rules. The purpose and role of
this code is to, among other things, focus our directors, officers and employees on areas of ethical risk, provide guidance to help them
recognize and deal with ethical issues, provide mechanisms to report unethical or unlawful conduct and to help enhance and formalize
our culture of integrity, honesty and accountability. If we make any amendments to this code, other than technical, administrative or
other non-substantive amendments, or grant any waivers, including implicit waivers, from any provision of this code that applies to our
Chief Executive Officer, Chief Financial Officer or Controller, or persons performing similar functions, and that relates to an element
of the SEC&#8217;s &#8220;code of ethics&#8221; definition, then we will disclose the nature of the amendment or waiver in the &#8220;Corporate
Governance&#8221; section of our investor relations/corporate governance website <i>http://ir.livexlive.com/ir-home</i>.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Insider
Trading Policy </b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="ixv-8498">adopted</ix:nonNumeric> an Insider Trading Policy that governs the purchase, sale, and/or other transactions of our securities by our directors,
officers and employees that we believe is reasonably designed to promote compliance with applicable insider trading laws, rules and regulations
and Nasdaq listing standards. A copy of our Insider Trading Policy is filed as Exhibit 19.1 to our Annual Report on Form 10-K for the
fiscal year ended March 31, 2025. In addition, with regard to our trading in its own securities, it is our policy to comply with the
federal securities laws and the applicable exchange listing requirements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January&#160;8, 2024, our board of directors, by a unanimous vote, including by all of its disinterested members, approved the request
made by Mr.&#160;Robert Ellin, our Chief Executive Officer, Chairman, director and principal stockholder, for a one-time exception to
our Insider Trading Policy which prohibits, among other things, purchases and sales of our securities in the public markets during the
&#8220;closed trading window&#8221; that followed the end of our third fiscal quarter ended December&#160;31, 2023. The exception granted
on a one-time basis the ability for any officer, director, employee or consultant of our Company to engage in such purchases and sales
of our securities in the public market, if such person desires, until the earlier of (i)&#160;such time as such person utilizing this
waiver is in possession of any material, non-public information and (ii)&#160;January&#160;31, 2024, subject to such person confirming
to us before any purchase or sale of our securities that such person is not aware of any material, non-public information. Subsequent
to receipt of the exception, Mr.&#160;Ellin did not execute any trades during such exception period. In addition, during such exception
period, we settled a small amount of restricted stock units issued to our employees that vested during such period and an applicable
portion of the underlying shares was sold in the public market to cover applicable federal and state taxes.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant
Practices Specific to Stock Options</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not generally grant stock options as part of our equity compensation programs. If stock options were to be <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ecd:AwardTmgPredtrmndFlag" id="ixv-8499">granted&#160;in the future</ix:nonNumeric>,
we would not grant such options in anticipation of the release of material nonpublic information&#160;that is likely to result in changes
to the price of our common stock. In addition, we generally do not grant stock options (i)&#160;during trading blackout periods established
under our Insider Trading Policy, or (ii) at any time during the four business days&#160;prior to or the one business day following the
filing of our periodic reports or the filing or furnishing of a Current Report on Form 8-K that&#160;disclose material nonpublic information.
These restrictions do not apply to restricted stock units, performance stock units, or other types of equity awards that&#160;do not
include an exercise price related to the market price of our common stock on the date of grant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.7in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2025, (i) none of our Named Executive Officers (as defined below) were awarded stock options, and (ii) we <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="ecd:MnpiDiscTimedForCompValFlag" id="ixv-8500">did not time</ix:nonNumeric> the&#160;disclosure
of <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="ecd:AwardTmgMnpiCnsdrdFlag" id="ixv-8501">material nonpublic information</ix:nonNumeric> for the purpose of affecting the value of executive compensation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policy
Regarding Attendance at Annual Meetings of Stockholders</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have a policy with regard to board members&#8217; attendance at annual meetings. We expect that our Chairman and one or more of
the other directors will attend our Annual Meeting, or at any adjournment or postponement thereof.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholder
Communications</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
and other interested parties may communicate with the board of directors, any committee thereof, the independent or non-management directors
as a group or any individual director in writing. All such written communications must identify the recipient and be forwarded by mail
to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LiveOne,
Inc.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">269
South Beverly Drive, Suite 1450</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beverly
Hills, CA&#160;90212</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Office Manager</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Office Manager will act as agent for the directors in facilitating such communications. In that capacity, the Office Manager may review,
sort and summarize the communications.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complaints
about accounting, internal accounting controls or auditing matters may be made by utilizing our Business Integrity web-reporting tool,
which we are in the process of implementing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="l_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
NO. 1 &#8212;&#160;ELECTION OF DIRECTORS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Nominees</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors is soliciting approval of the following director nominees:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Robert
                                            S.&#160;Ellin</i></span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Jay
                                            Krigsman</i></span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ramin
                                            Arani</i></span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Patrick
                                            Wachsberger</i></span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Kenneth
                                            Solomon</i></span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bridget
                                            Baker</i></span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Kristopher
                                            Wright</i></span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we elect all members of our board of directors annually, the seven nominees will serve for a one-year term expiring on the date of our
2026 Annual Meeting of Stockholders or until their successors are elected or their earlier resignation or removal. All of the director
nominees are current members of the board of directors and are standing for re-election.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the director nominees has indicated a willingness to serve, or continue to serve, as a director if elected. If any director nominee
becomes unable to serve, the board of directors may designate a substitute nominee, in which case the designated proxy holders, Mr.&#160;Ellin
and Mr.&#160;Carhart, will vote for such substitute nominee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
plurality of votes cast will be required to elect each director nominee (that is the nominees for our directors who receive the most
votes will be elected). For purposes of electing directors, not voting, withholding your vote by voting &#8220;abstain&#8221; or a broker
non-vote is not counted as a vote cast, and therefore will have no effect on the outcome of the election of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board of Directors Unanimously Recommends a Vote <span style="text-decoration:underline">FOR</span><br/>
Each Named Director Nominee.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General
Information About the Board of Directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws provide that our business and affairs will be managed by, or under the direction of, our board of directors. Set forth below is
biographical information for the director nominees as of the date of this Proxy Statement, and the qualifications that led our board
of directors to conclude that each should serve as a director.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Robert
S.&#160;Ellin</i></b><i>, Age: 60</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
                                            Background: </i>Mr.&#160;Ellin has served as our Chairman (or Executive Chairman prior to
                                            September&#160;1, 2017) of our board of directors since September&#160;2011 and as our Chief
                                            Executive Officer (or President prior to September&#160;1, 2017) since September&#160;2011.
                                            On September&#160;2, 2017, our board of directors changed Mr.&#160;Ellin&#8217;s title from
                                            President to Chief Executive Officer. Mr.&#160;Ellin formerly served as our Chief Executive
                                            Officer from September&#160;9, 2011 to April&#160;30, 2014 and as our Chief Financial Officer
                                            from April&#160;26, 2012 until September&#160;30, 2013. Mr.&#160;Ellin has also served as
                                            the Executive Chairman of PodcastOne, Inc.&#8217;s, our majority owned subsidiary and a Nasdaq
                                            listed company (&#8220;PodcastOne&#8221;), board of directors since December&#160;14, 2022
                                            and as a director of PodcastOne since July&#160;1, 2020. Mr.&#160;Ellin has more than 20&#160;years
                                            of investment and turnaround experience. He is Managing Director and Portfolio Manager of
                                            Trinad Capital Master Fund Ltd. (&#8220;Trinad Capital&#8221;). Trinad Capital is our principal
                                            stockholder and a hedge fund dedicated to investing in micro-cap public companies. Mr.&#160;Ellin
                                            was a founder and served as a member of the board of directors from February&#160;2005 to
                                            September&#160;2013, and as Executive Chairman of the board of directors, of Mandalay Digital
                                            Group, Inc. (MNDL) from December&#160;2011 to April&#160;2013. He has also served on the
                                            Board of Governors at Cedars-Sinai Hospital in Los Angeles, California since March&#160;2007.
                                            Prior to joining Trinad Capital, Mr.&#160;Ellin was the founder and President of Atlantis
                                            Equities, Inc. (&#8220;Atlantis&#8221;), a private investment company. Founded in 1990, Atlantis
                                            actively managed an investment portfolio of small capitalization public companies as well
                                            as select private company investments. Mr.&#160;Ellin played an active role in Atlantis investee
                                            companies including board representation, management selection, corporate finance and other
                                            advisory services. Through Atlantis and related companies, he spearheaded investments into
                                            THQ, Inc., Grand Toys, Forward Industries, Inc. (FORD), Majesco Entertainment (COOL) and
                                            iWon.com. Mr.&#160;Ellin also completed a leveraged buyout of S&amp;S Industries, Inc. where
                                            he served as President from 1996 to 1998. S&amp;S Industries was one of the largest manufacturers
                                            in the world of underwires which had strong partnerships with leading companies including
                                            Bally&#8217;s, Maidenform, and Sara Lee. Prior to founding Atlantis Equities, Mr.&#160;Ellin
                                            worked in Institutional Sales at LF Rothschild and was Manager of Retail Operations at Lombard
                                            Securities. Mr.&#160;Ellin received his BBA degree from Pace University.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
                                            Membership Qualifications: </i>Our board of directors has concluded that Mr.&#160;Ellin is
                                            well-qualified to serve on our board of directors and has the requisite qualifications, skills
                                            and perspectives based on, among other factors, him being the Managing Director and Portfolio
                                            Manager of Trinad Capital, our controlling stockholder, and his extensive business, investment,
                                            finance and public company experience, particularly in investing in micro-cap public companies.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Jay
Krigsman</i></b><i>, Age: 60</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
                                            Background: </i>Mr.&#160;Krigsman has served as a director of our Company since April&#160;26,
                                            2012. Mr.&#160;Krigsman has been the Executive Vice President and Asset Manager of The Krausz
                                            Companies since 1992, where he assists in property acquisitions, oversees the company&#8217;s
                                            property management team and is responsible for developing and implementing strategic leasing
                                            programs. Prior to joining The Krausz Companies, Mr.&#160;Krigsman had the senior leasing
                                            responsibilities for Birtcher Development Co. Mr.&#160;Krigsman holds a Certified Commercial
                                            Investment Member designation from the CCIM Institute, a Sr. Certified Leasing Specialist
                                            designation from the International Council of Shopping Centers and holds a California Real
                                            Estate Broker&#8217;s License. Mr.&#160;Krigsman currently serves on the board of directors
                                            of Trinad Capital, our principal stockholder. Mr.&#160;Krigsman received a BA in Business
                                            Administration from the University of Maryland.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
                                            Membership Qualifications: </i>Our board of directors has concluded that Mr.&#160;Krigsman
                                            is well-qualified to serve on our board of directors and has the requisite qualifications,
                                            skills and perspectives based on, among other factors, his professional background and experience
                                            in acquisitions and management and him being the Executive Vice President and Asset Manager
                                            of The Krausz Companies for over 20&#160;years.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ramin
Arani</i></b><i>, Age: 55</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
                                            Background: </i>Mr.&#160;Arani has been serving as a member of our board of directors since
                                            January&#160;14, 2019. Mr.&#160;Arani currently serves as an advisor to LionTree, LLC, a
                                            global investment banking firm headquartered in New&#160;York City, a role he has held since
                                            April&#160;2023, and as a partner at&#160;&amp;vest Capital since February&#160;2022. Mr.&#160;Arani
                                            also currently serves on the boards of directors of Brunello Cucinelli SpA, an Italy-based
                                            company engaged in the fashion industry which is listed on the Milan Stock Exchange, and
                                            FAST Acquisition Corp&#160;II, a NYSE listed special purpose acquisition company. Most recently
                                            Mr.&#160;Arani served as the Chief Financial Officer of Vice Media Group from November&#160;2019
                                            until December&#160;2021. Prior to that Mr.&#160;Arani was a Portfolio Manager at Fidelity
                                            Management&#160;&amp; Research Company (&#8220;FMR Co&#8221;), the investment adviser for
                                            Fidelity&#8217;s family of mutual funds, until his retirement at the end of 2018. Most recently
                                            Ramin was Fund Manager of the Fidelity Puritan Fund from February&#160;2008 through September&#160;2018
                                            where the fund achieved top 5% performance relative to Lipper and Morningstar Balanced Fund
                                            Peers over all key performance time periods. The Fund was a 5 star rated&#160;&amp; Silver
                                            designated Fund according to Morningstar, under his management. FMR Co is a wholly owned
                                            subsidiary of FMR LLC, which is a greater than 5% stockholder of our Company and acquired
                                            its position as part of our public offering completed in December&#160;2017. Fidelity Investments
                                            is a leading provider of investment management, retirement planning, portfolio guidance,
                                            brokerage, benefits outsourcing, and other financial products and services to more than 20&#160;million
                                            individuals, institutions and financial intermediaries. Prior to the Puritan Fund, Mr.&#160;Arani
                                            managed the Fidelity Trend Fund for 7&#160;years, the Health Care Sector Fund in the late
                                            90&#8217;s and the Retail Select Fund in the mid-late &#8216;90&#8217;s. As a Fidelity research
                                            analyst from&#160;1992-2000 Mr.&#160;Arani covered the Aerospace&#160;&amp; Defense, REIT,
                                            Retail, and Pharmaceutical industries. As an investor in private companies for the past 13&#160;years,
                                            Ramin has served on several company boards of directors, such as Legendary Pictures, Vice,
                                            Moda Operandi, Rent the Runway, Goop, and Emotion Network. Mr.&#160;Arani has also personally
                                            been a founding partner and/or board member of Rumble Boxing, ED by Ellen Degeneres and Girlgaze.
                                            Among his philanthropic efforts, Mr.&#160;Arani has served on the boards of directors of
                                            The College Foundation of the University of Virginia, The Nichols School, the Institute for
                                            Global Leadership at Tufts University, Opportunity Network, Devereux Cleo Wallace and national
                                            dog rescue Danny&#160;&amp; Ron&#8217;s Rescue. Mr.&#160;Arani earned his Bachelor of Arts
                                            degree in international relations from Tufts University. He also received the 1994, 1996
                                            and 1998 Institutional Investor &#8220;Best of the Buyside&#8221; awards for his research
                                            work.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
                                            Membership Qualifications: </i>Our board of directors has concluded that Mr.&#160;Arani is
                                            well-qualified to serve on our board of directors and has the requisite qualifications, skills
                                            and perspectives based on, among other factors, his experience in the investment industry
                                            for over 25&#160;years, including deep understanding of the capital markets.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Patrick
Wachsberger</i></b><i>, Age: 73</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
                                            Background: </i>Mr.&#160;Wachsberger has been serving as a member of our board of directors
                                            since January&#160;25, 2019. Mr.&#160;Wachsberger currently serves as the founder and manager
                                            of Picture Perfect Entertainment LLC, a film and television production and distribution studio
                                            he founded in 2018. Prior to that, Mr.&#160;Wachsberger was serving as Co-Chairman of Lionsgate
                                            Films (Lionsgate Motion Picture Group), an American film production and film distribution
                                            studio (&#8220;Lionsgate&#8221;), joining in January&#160;2012 when Lionsgate acquired Summit
                                            Entertainment, which he helped launch in 1993. Mr.&#160;Wachsberger has risen to become one
                                            of the leading international film executives in the world during his 30-year motion picture
                                            industry career. As Co-Chairman at Lionsgate, Mr.&#160;Wachsberger oversaw all aspects of
                                            Lionsgate&#8217;s feature film acquisition, production and distribution and was responsible
                                            for leading its motion picture business around the world. During his tenure, Lionsgate&#8217;s
                                            feature film slate generated nearly $10&#160;billion at the global box office over the past
                                            five&#160;years, led by the critically-acclaimed breakout sensation Wonder, the global box
                                            office phenomenon La Land, winner of six Academy Awards&#174;, double Oscar&#174; winner Hacksaw
                                            Ridge, and the blockbuster Hunger Games, John Wick, and Now You See Me franchises. Other
                                            recent hits include The Hitman&#8217;s Bodyguard, The Big Sick (in partnership with Amazon
                                            Studios) and The Shack. Under Mr.&#160;Wachsberger&#8217;s leadership, Lionsgate built a
                                            global distribution infrastructure encompassing nearly 20 output deals in major territories,
                                            including the successful 50/50 joint venture of International Distribution Company in Latin
                                            America and Lionsgate&#8217;s successful self-distribution operations in the U.K.&#160;Lionsgate,
                                            while also continuing to grow its film business in China and India. Mr.&#160;Wachsberger
                                            was awarded in 2017 the prestigious honor of Chevalier des Arts et des Lettres (Knight in
                                            the Order of Arts and Letters), received CineEurope&#8217;s International Distributor of
                                            the Year award in 2018 and was named as a &#8220;Game Changer&#8221; at the 2016 Zurich Film
                                            Festival.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
                                            Membership Qualifications: </i>Our board of directors has concluded that Mr.&#160;Wachsberger
                                            is well-qualified to serve on the board of directors and has the requisite qualifications,
                                            skills and perspectives based on, among other factors, his extensive experience and leadership
                                            in the media and entertainment industry, including with respect to the acquisition, production,
                                            growth and distribution of various entertainment assets.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Kenneth
Solomon</b><i>, Age: 62</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
                                            Background: </i>Mr.&#160;Solomon has been serving as a member of our board of directors since
                                            May&#160;24, 2019. Mr.&#160;Solomon currently serves as the Chairman of the Board and Chief
                                            Executive Officer of The Tennis Channel, Inc., which operates a professional sports and tennis
                                            lifestyle-based television channel. Mr.&#160;Solomon is also a Partner of Arcadia Investment
                                            Partners, a private investment firm, serves as the Chairman of Ovation TV, Inc., and since
                                            2008 has been serving as a director of World Golf Tour, Inc. Previously Mr.&#160;Solomon
                                            served as Founding President of Fine Living Network, LLC (also known as Fine Living TV Network)
                                            (formerly Fine Living Cable Network). He led the network from concept through launch in just
                                            over three&#160;years and ultimately to 25,000,000 subscribers and agreements with distributors
                                            representing 73% of the cable and satellite universe. Prior to launching Fine Living, he
                                            served as founding president of iBlast. Mr.&#160;Solomon was responsible for building the
                                            nation&#8217;s largest and farthest-reaching digital distribution network, with 18 major
                                            broadcast groups comprising 246 individual television stations, covering 93% of U.S.&#160;television
                                            households. He served as President of Universal Studios Television (also&#160;Studios USA
                                            Television) where he oversaw worldwide program and asset development and distribution activities
                                            for primetime network, cable, syndication, and made-for-television movies. Mr.&#160;Solomon
                                            also served as Co-head of DreamWorks Television, where he worked with the new studio&#8217;s
                                            legendary founders to help create and develop its worldwide television operations. He also
                                            has held senior positions at News Corp., including Executive Vice President of network distribution
                                            of Fox Broadcasting through its transitional ascending period where he was responsible for
                                            all network affiliate relations, as well as leading the network&#8217;s successful conversion
                                            of dozens of CBS, ABC and NBC affiliates to Fox, and launching the NFL and NHL franchises.
                                            He also served as Executive Vice President and General Sales Manager of Twentieth Century
                                            Fox Domestic Television. Mr.&#160;Solomon was integrally involved in the formative development,
                                            sale and launch of FX cable network, News Corp.&#8217;s first venture into basic cable. He
                                            held key leadership positions at a number of preeminent media and television companies. Mr.&#160;Solomon
                                            has more than 20&#160;years of experience in cable, new media, TV production, distribution,
                                            and advertising through top posts at Universal Television, DreamWorks, News Corp. and Scripps.
                                            Mr.&#160;Solomon captured the Emmy award for best drama with &#8220;Law&#160;&amp; Order&#8221;
                                            and pioneered the licensing of an original series across multiple network platforms with
                                            &#8220;Law&#160;&amp; Order: Special Victims Unit&#8221; to NBC and USA Network. Mr.&#160;Solomon
                                            received his Bachelor of Arts degree in Sociology from UCLA.&#160;Mr.&#160;Solomon has been
                                            honored as &#8220;Humanitarian of the Year&#8221; by H.E.L.P.&#160;Group.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
                                            Membership Qualifications: </i>Our board of directors has concluded that Mr.&#160;Solomon
                                            is well-qualified to serve on the board of directors and has the requisite qualifications,
                                            skills and perspectives based on, among other factors, his extensive experience and leadership
                                            in the media and entertainment industry, including entertainment asset development and distribution.</span></td></tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bridget
Baker</b><i>, Age: 63</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
                                            Background: </i>Ms. Baker has been serving as a member of our board of directors since October&#160;20,
                                            2019. As Chief Executive Officer of Baker Media Inc., Ms. Baker advises and represents major
                                            media and technology companies. Prior to establishing Baker Media in 2013, Ms. Baker had
                                            a distinguished 22-year career at NBCUniversal as a cofounder of CNBC and ultimately, from
                                            2006 to 2013, the company&#8217;s first President of TV Networks Distribution, overseeing
                                            its $5&#160;billion content distribution business. In this role, she was a member of the
                                            company&#8217;s Management Committee, the top 1% senior executives, and at the forefront
                                            of a wide range of strategic initiatives, from expanding coverage of the Olympic Games to
                                            creating Hulu. She was a key player in over $50&#160;billion of corporate mergers and acquisitions,
                                            including Universal Studios, Bravo and Telemundo. She established the first ever women&#8217;s
                                            affinity group at NBCUniversal, the award-winning Women&#8217;s Network, and served as chair
                                            from&#160;2005-2009. Additionally, she served on the boards of the Sundance Channel, the
                                            NBC Peacock Foundation and Women in Cable&#160;&amp; Telecommunications. From 2013 to 2018,
                                            Ms. Baker served as a member of the board of directors of General Communication, Inc., the
                                            largest Alaska-based communications provider offering a full range of wireless, data, video,
                                            and managed services to residential customers, businesses, governmental entities, and educational
                                            and medical institutions. Ms. Baker received her Bachelor of Arts degree in Political Studies
                                            from Pitzer College where she is an 18-year Trustee and was honored in 2010 as a Distinguished
                                            Alumni.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
                                            Membership Qualifications:&#160;</i>Our board of directors has concluded that Ms. Baker is
                                            well-qualified to serve on the board of directors and has the requisite qualifications, skills
                                            and perspectives based on, among other factors, her extensive experience and leadership in
                                            the media, tech and entertainment industry, including content distribution and strategy,
                                            as well bringing diversity in viewpoints, experiences, backgrounds, skills and other qualities
                                            and attributes to the board of directors.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Kristopher
Wright</b><i>, Age: 50</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
                                            Background: </i>Mr.&#160;Wright has been serving as a member of our board of directors since
                                            May&#160;21, 2021. Mr.&#160;Wright is a senior leader in the Consumer Products Industry with
                                            more than 20&#160;years of innovative, growth oriented, results-driven leadership experience.
                                            Mr.&#160;Wright has spent the past 10&#160;years at Nike and is currently Vice President
                                            of Nike Global Men&#8217;s Footwear Lifestyle Product. Prior to joining Nike, Mr.&#160;Wright
                                            held senior management roles at Converse, Jordan, and Reebok. In October&#160;2020, Mr.&#160;Wright
                                            was recognized by Business Insider as one of 28 Outstanding People of Color in the Sneaker
                                            Industry. Prior to joining Nike, Mr.&#160;Wright founded the luxury lifestyle footwear brand
                                            Jhung Yuro, where as Chief Executive Officer, he led the company&#8217;s Far East factory/supplier
                                            sourcing and negotiations, developed marketing initiatives, established distribution and
                                            merchandising strategies for a wide variety of retail partners. In 2008 Headgear purchased
                                            a 50% stake in Jhung Yuro to launch a joint venture partnership which provided infrastructure
                                            and resources to grow the brand. Additionally, Mr.&#160;Wright is an appointed member of
                                            the Executive Leadership Council, a national organization of Black CEOs and senior executives
                                            in Fortune 1000 and Global 500 companies. Mr.&#160;Wright also serves on the Advisory Board
                                            of Directors for the Southwestern Athletic Conference (SWAC). Mr.&#160;Wright earned his
                                            Bachelor of Arts degree in marketing and business administration from Clark Atlanta University.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
                                            Membership Qualifications: </i>Our board of directors has concluded that Mr.&#160;Wright
                                            is well-qualified to serve on the board of directors and has the requisite qualifications,
                                            skills and perspectives based on, among other factors, his extensive experience and leadership
                                            in the marketing industry, including brand awareness and distribution strategies, as well
                                            bringing diversity in viewpoints, experiences, backgrounds, skills and other qualities and
                                            attributes to the board of directors.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Meetings</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.35in">Our board of directors both met in person and/or via telephone/video
conference and acted by unanimous written consent during our fiscal year ended March 31, 2025. Our board of directors met twice in person
and/or via telephone/video conference during the 2025 fiscal year, with all of the incumbent directors attending more than 75% of the
aggregate of the meetings of the board of directors and of board committees on which they served, except for Mr. Solomon who attended
at least two-thirds of the aggregate of the meetings of the board of directors and of board committees on which he served. Our board of
directors and our board committees also acted numerous times by unanimous written consent during the 2025 fiscal year. We intend to adopt
a formal policy on director attendance at annual meetings of stockholders, which will state that each director is strongly encouraged
to attend such meetings, whether by phone or in person, unless attendance is precluded by health or other significant personal matters.
We held our 2024 annual meeting of stockholders on September 12, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors has informally designated Mr.&#160;Krigsman to preside over executive sessions of the non-management directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Committees</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors has three standing committees: the Audit Committee, the Nominating Committee and the Compensation Committee, each
of which is described below. Each committee operates under a written charter adopted by the board of directors. All of the committee
charters are publicly available in the &#8220;Corporate Governance&#8221; section of our investor relations/corporate governance website
at <i>http://ir.livexlive.com/ir-home</i> or may be obtained upon written request to our Office Manager at our principal executive offices.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Committee
members are elected by our board of directors, upon the Nominating Committee&#8217;s recommendations, and serve until their successors
are elected or their earlier resignation or removal.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current composition of the board of directors&#8217; committees is as follows:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
                                            <br/> Committee</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating
                                            <br/> Committee</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
                                            <br/> Committee</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    S.&#160;Ellin</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay
    Krigsman</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;
                                                                                                                                                                       (Chair)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick
    Wachsberger</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ramin
    Arani</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kenneth
    Solomon</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridget
    Baker</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kristopher
    Wright</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the end of our fiscal year ended March 31, 2025, the Audit Committee consisted of and currently consists of Messrs. Solomon and Arani.
The Audit Committee currently consists of the same members. We have not yet appointed a new chairman to chair the Audit Committee to
replace the vacancy created by Mr. Foster&#8217;s resignation. We anticipate that one or more existing independent members of our board
of directors will be appointed to the Audit Committee, and we have also began to conduct a search to find a well-qualified candidate
to serve on our board of directors and/or the Audit Committee that has the applicable experience and the necessary qualifications, skills
and perspective. Our board of directors has determined that all of the current members of the Audit Committee are independent, pursuant
to Rule 5605(a)(2) of Nasdaq and Rule 10A-3 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).
Our board of directors has also determined that each Audit Committee member is financially literate and that Mr. Arani qualifies
as an &#8220;audit committee financial expert,&#8221; as such term is defined in Item 407(d)(5) of Regulation S-K. The
Audit Committee met four times in person and/or via telephone/video conference during our 2025 fiscal year.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
set forth in more detail in the Audit Committee Charter, the Audit Committee&#8217;s purpose is to assist the board of directors in its
general oversight of the quality and integrity of our accounting, auditing and financial reporting and internal control practices. The
specific responsibilities of the Audit Committee include:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing,
                                            compensating, retaining, evaluating, terminating, and overseeing our independent registered
                                            public accounting firm;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing
                                            with our independent registered public accounting firm the independence of its members from
                                            its management;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            with our independent registered public accounting firm the scope and results of their audit;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving
                                            all audit and permissible non-audit services to be performed by our independent registered
                                            public accounting firm;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
                                            the financial reporting process and discussing with management and our independent registered
                                            public accounting firm the interim and annual financial statements that we file with the
                                            SEC;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and monitoring our accounting principles, accounting policies, financial and accounting controls,
                                            and compliance with legal and regulatory requirements;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">coordinating
                                            the oversight by our board of directors of our code of business conduct and our disclosure
                                            controls and procedures;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
                                            procedures for the confidential and/or anonymous submission of concerns regarding accounting,
                                            internal controls or auditing matters; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving related-person transactions.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
Committee meetings are attended by our Chief Executive Officer and/or Chief Financial Officer, from time to time, and other members of
management, as requested by the committee. For additional information concerning the Audit Committee, see &#8220;Report of the Audit
Committee of the Board of Directors&#8221; included in this Proxy Statement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating
Committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the end of our fiscal year ended March 31, 2025, the Nominating Committee consisted of and currently consists of Messrs. Krigsman
and Wright. We have not yet appointed a new chairman to chair the Nominating Committee to replace the vacancy created by Mr. Foster&#8217;s
resignation. We anticipate that one or more existing independent members of our board of directors will be appointed to the Nominating
Committee, and we have also began to conduct a search to find a well-qualified candidate to serve on our board of directors and/or the
Nominating Committee that has the applicable experience and the necessary qualifications, skills and perspective. Our board of directors
has determined that all members of the Nominating Committee are independent pursuant to Rule&#160;5605(a)(2)&#160;of Nasdaq. During our
2025 fiscal year, our Nominating Committee acted solely by unanimous written consent. The specific responsibilities of the Nominating
Committee include: </span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying,
                                            screening and recruiting qualified individuals to become board members;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">proposing
                                            nominations for the board of directors and board committee membership;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assessing
                                            the composition of the board of directors and board committees;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
                                            the performance of the board of directors; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">complying
                                            with all other responsibilities and duties set forth in the Nominating Committee Charter.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the end of our fiscal year ended March 31, 2025, the Compensation Committee consisted of and currently consists of Messrs. Krigsman
and Wachsberger and Ms. Baker, with Mr.&#160;Krigsman serving as the Chairman of the Compensation Committee. Our board of directors has
determined that all members of the Compensation Committee are independent pursuant to Rule&#160;5605(a)(2)&#160;of Nasdaq. The Compensation
Committee met twice in person and/or via telephone/video conference during our 2025 fiscal year. The specific responsibilities of the
Compensation Committee include:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            key employee compensation goals, policies, plans and programs;</span></td></tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving the compensation of our directors and executive officers;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving employment agreements and other similar arrangements between us and our executive
                                            officers; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing
                                            and overseeing any compensation consultants or advisors.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
Committee meetings are attended by our Chief Executive Officer and/or Chief Financial Officer, from time to time, and other members of
management, as requested by the committee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="l_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIRECTOR
COMPENSATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
our independent board members receive compensation for their services as a director. Current director compensation consists of an annual
grant of between $90,000 and $130,000 worth of restricted stock units (or pro-rata for service less than one year) to each director,
consisting of an annual grant of $90,000 worth of restricted stock units to each independent board member and (i)&#160;$10,000 worth
of restricted stock units to each member of our Audit Committee and an additional $15,000 worth of restricted stock units to the chairman
of our Audit Committee, and (ii)&#160;$5,000 worth of restricted stock units to each member of our Compensation Committee and an additional
$10,000 worth of restricted stock units to the chairman of our Compensation Committee, with the number of restricted stock units calculated
based on the fair market value of our stock on the date of the grant approval date. Members of our Nominating Committee do not receive
any additional compensation for their service on such committee. On September 10, 2024, our Compensation Committee awarded director compensation
for the period from October 1, 2023 to September 30, 2024, which vested on October 31, 2024, provided that such director continued to
serve as our director and if applicable, a member of the respective committee, on the vesting date. As of March 31, 2025, our Compensation
Committee had not yet determined or awarded director compensation for the period from October&#160;1, 2024 through September&#160;30,
2025 or for any future period. At the direction of the Compensation Committee of our board of directors, we intend to undertake a process
to formerly review, on a periodic basis, our board of directors&#8217; compensation, including but not limited to pay for (x)&#160;each
of our non-employee directors in cash, (y)&#160;each member of the Audit Committee, Compensation Committee and Nominating Committee additional
annual cash amounts, and (z)&#160;the Chairpersons of the Audit Committee, Compensation Committee and Nominating Committee additional
cash amounts. We anticipate retaining an expert compensation consulting firm to benchmark director compensation and provide recommendations
around near and long-term compensation for our board. We expect to conclude this board of director compensation review during our 2026
fiscal year. Currently, no additional per-meeting fees apply under the plan. Subject to such compensation review, we may also grant to
each non-employee director restricted stock units, shares of our common stock and/or stock options to purchase shares of our common stock
(A)&#160;upon such non-employee director&#8217;s appointment to the board of directors (prorated for the period from the director&#8217;s
appointment through the anticipated date of our next annual meeting of stockholders), and (B)&#160;on an annual basis thereafter. We
may also grant additional discretionary stock-based awards to our non-employee directors, and subject to our director compensation review
and board&#8217;s approval, these directors may have the option of electing to receive their cash fees in the form of shares of our common
stock. Only non-employee directors are currently eligible to receive compensation for their services as a director. Accordingly, Mr.&#160;Ellin,
our Chief Executive Officer and Chairman did not and will not receive any separate director compensation during the 2025 fiscal year.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025
Director Compensation Table</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows compensation paid to the members of our board of directors for the fiscal year ended March 31, 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees earned&#160;or paid in cash <br/>
($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock awards<br/>
($)<sup>(1)</sup></b></span></td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option awards<br/>
($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-equity incentive&#160;plan compensation<br/>
($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nonqualified deferred compensation earnings <br/>
($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All&#160;other compensation<br/>
($)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total <br/>
($)</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay Krigsman</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,636</span></td>
    <td style="white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,636</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Craig Foster<sup>(4)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,744</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,744</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Ellin</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(3)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ramin Arani</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,082</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,082</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick Wachsberger</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,530</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,530</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kenneth Solomon</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,082</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,082</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridget Baker</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,530</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,530</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kristopher Wright</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,974</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,974</span></td>
    <td>&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            the aggregate grant date fair value computed in accordance with FASB ASC Topic&#160;718.
                                            The assumptions used in calculating the amounts are discussed in Note&#160;2 &#8212;&#160;Summary
                                            of Significant Accounting Policies&#160;&#8212;&#160;&#8220;Stock-Based Compensation&#8221;
                                            of our financial statements for the year ended March 31, 2025 included elsewhere in our Annual
                                            Report on Form&#160;10-K for the fiscal year ended March 31, 2025.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
                                            our board of directors nor our Compensation Committee has yet awarded director compensation
                                            for the period from October&#160;1, 2024 through September&#160;30, 2025, provided that on
                                            September 10, 2024, our Compensation Committee awarded director compensation for the period
                                            from October 1, 2023 to September 30, 2024 (which vested on October 31, 2024), which compensates
                                            our independent directors for their service through a portion of our fiscal year ended March
                                            31, 2025 (through September 30, 2024). We anticipate that our board of directors or our Compensation
                                            Committee will award restricted stock units as compensation to our independent board members
                                            for such remaining period of our fiscal year ended March&#160;31, 2025 (from October 1, 2024
                                            to March 31, 2025), which shall vest as of such vesting date as determined by our board of
                                            directors (anticipated to be October&#160;31, 2025), provided that such director continues
                                            to serve as our director and if applicable, a member of the respective committee, on such
                                            vesting date. Accordingly, the 2024 Director Compensation Table above reflects the equity
                                            grants that were made to our independent directors during the fiscal year ended March&#160;31,
                                            2025 (as discussed herein). On September 10, 2024, our board of directors approved a plan
                                            to compensate our non-employee&#160;directors with restricted stock units in lieu of cash
                                            director fees for the period from October&#160;1, 2023 to September&#160;30, 2024, based
                                            upon a price of $1.57 per restricted stock unit, which was calculated based on a trailing
                                            volume weighted average closing price as of the date determined by the Compensation Committee.
                                            All restricted stock units vested on October&#160;31, 2024. Each restricted stock unit represents
                                            a contingent right to receive one share of our common stock or the cash value thereof. Each
                                            director had the right to delay the vesting of such restricted stock units to a later date
                                            for tax purposes. Accordingly, Messrs. Krigsman, Foster, Arani, Wachsberger, Solomon and
                                            Wright, and Ms. Baker received on such date their grants of our restricted stock units with
                                            the following grant date fair value attributable to a portion of our fiscal year ended March&#160;31,
                                            2025: $47,818, $52,372, $45,541, $43,265, $45,541, $43,265 and $40,987, respectively.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
                                            directors do not receive any additional compensation for their services on our board of directors.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                            Foster resigned from our board of directors effective as of October 4, 2024.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="l_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding beneficial ownership of our capital stock by:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            person, or group of affiliated persons, known by us to beneficially own more than 5% of our
                                            common stock;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            of our directors;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            of our Named Executive Officers;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            other executive officers; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            of our current executive officers and directors as a group.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares and percentages of beneficial ownership are based on [&#9679;] shares of our common stock outstanding as of the Record
Date.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table is based upon information supplied by to us by our officers, directors and certain principal stockholders. We have determined
beneficial ownership in accordance with the rules of the SEC.&#160;These rules generally attribute beneficial ownership of securities
to persons who possess sole or shared voting power or investment power with respect to those securities. In addition, the rules include
shares of common stock that the person has the right to acquire beneficial ownership within 60&#160;days, including common stock issuable
pursuant to the exercise of stock options or warrants and settlement of restricted stock units that are either immediately exercisable
or issuable or exercisable or issuable on or before September&#160;12, 2025, which is within 60&#160;days of the Record Date. These shares
are deemed to be outstanding and beneficially owned by the person holding those options, warrants or restricted stock units for the purpose
of computing the percentage ownership of that person, but they are not treated as outstanding for the purpose of computing the percentage
ownership of any other person. Unless otherwise indicated, the persons or entities identified in this table have sole voting and investment
power with respect to all shares shown as beneficially owned by them, subject to applicable community property laws.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise noted below, the address for each person or entity listed in the table is c/o LiveOne, Inc., 269&#160;South Beverly Drive,
Suite 1450, Beverly Hills, CA&#160;90212.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and address of beneficial owner</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
    of Common Stock Beneficially Owned and Nature of Beneficial Ownership<sup>(1)</sup></b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentage
    of Class</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5%
    or greater stockholders</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    S.&#160;Ellin and his affiliates<sup>(1)</sup></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,127,649</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">[&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">]<span style="font-size: 10pt">%</span></span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FMR
    LLC<sup>(2)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,997,721</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">]%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245
    Summer Street, Boston, MA&#160;02210</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
    and Executive Officers</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    S.&#160;Ellin<sup>(1)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,127,649</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">]%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ryan
    Carhart<sup>(3)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,041</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay
    Krigsman<sup>(4)(5)(6)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,297,186</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">]%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ramin
    Arani<sup>(5)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">257,601</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick
    Wachsberger<sup>(5)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">257,527</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kenneth
    Solomon<sup>(5)(7)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,262</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridget
    Baker<sup>(5)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">247,531</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kristopher
    Wright<sup>(5)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">155,050</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    current directors and executive officers as a group (8 persons)<sup>(8)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,737,847</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">]%</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            beneficial ownership of less than one percent.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            (i)&#160;2,089,666 shares of common stock owned directly by Mr.&#160;Ellin; (ii)&#160;9,156,608
                                            shares of our common stock directly owned by Trinad Capital, as Mr.&#160;Ellin, the Managing
                                            Director and Portfolio Manager of Trinad Capital, is deemed to have sole voting and dispositive
                                            power over such shares, (iii)&#160;warrants to purchase 535,399 shares of our common stock
                                            issued to Trinad Capital exercisable at a price of $2.10 per share, (iv)&#160;716,216 shares
                                            of our common stock directly owned by Trinad Capital Management LLC (&#8220;Trinad LLC&#8221;),
                                            as Mr.&#160;Ellin, the Managing Member of Trinad LLC, is deemed to have sole voting and dispositive
                                            power over such shares; (v)&#160;6,817,810 shares of our common stock directly owned by JJAT
                                            Corp. (&#8220;JJAT&#8221;), an entity owned by Mr.&#160;Ellin, as Mr.&#160;Ellin is deemed
                                            to have sole voting and dispositive power over such shares; (vi)&#160;2,056,623 shares of
                                            our common stock issuable as of July 14, 2025 upon conversion of the Series&#160;A Preferred
                                            Stock held by Trinad Capital (including the dividend to be paid in kind and accrued as of
                                            such date), which Trinad Capital has the right to convert at the conversion price of $2.10
                                            per share; (vii)&#160;666,667 stock options (as more fully discussed below); (viii)&#160;25,168
                                            restricted stock units granted to Mr.&#160;Ellin in lieu of reduced base salary for the period
                                            from April&#160;1, 2021 to July&#160;31, 2021, which would vest as of September&#160;20,
                                            2025; and (ix)&#160;63,492 restricted stock units granted to Mr.&#160;Ellin in lieu of 50%
                                            of his monthly cash base salary for the period from August&#160;1, 2020 to August&#160;15,
                                            2020, and in lieu of 100% of his monthly cash base salary for the period from August&#160;16,
                                            2020 to December&#160;31, 2020, that Mr.&#160;Ellin agreed to receive in such equity of our
                                            Company, which would vest as of September&#160;20, 2025. Accordingly, securities owned by
                                            these entities may be regarded as being beneficially owned by Mr.&#160;Ellin. Mr.&#160;Ellin
                                            disclaims beneficial ownership in the shares held by Trinad LLC, Trinad Capital and JJAT.&#160;Does
                                            not include (x)&#160;shares of our common stock held by a family trust and family foundation
                                            as to which Mr.&#160;Ellin does not exercise voting or dispositive power, and (y)&#160;shares
                                            of our common stock and/or our restricted stock units that are expected to be granted to
                                            Mr.&#160;Ellin by our board of directors in lieu of 100% of his monthly cash base salary
                                            for the period from January&#160;1, 2022 to December&#160;31, 2022, that Mr.&#160;Ellin agreed
                                            to receive in such equity of our Company, subject to Mr.&#160;Ellin&#8217;s continued employment
                                            with us through the applicable vesting date. See &#8220;Executive Compensation &#11834; 2025
                                            Summary Compensation Table&#8221; for additional information.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            reported on Schedule&#160;13G, Amendment No. 7, filed with the SEC on May 12, 2025 by FMR
                                            LLC and Abigail P.&#160;Johnson. Ms. Johnson is a Director, Chairman and Chief Executive
                                            Officer of FMR LLC.&#160;Members of the Johnson family, including Abigail P.&#160;Johnson,
                                            are the predominant owners, directly or through trusts, of Series&#160;B voting common shares
                                            of FMR LLC, representing 49% of the voting power of FMR LLC.&#160;The Johnson family group
                                            and all other Series&#160;B shareholders have entered into a shareholders&#8217; voting agreement
                                            under which all Series&#160;B voting common shares will be voted in accordance with the majority
                                            vote of Series&#160;B voting common shares. Accordingly, through their ownership of voting
                                            common shares and the execution of the shareholders&#8217; voting agreement, members of the
                                            Johnson family may be deemed, under the Investment Company Act&#160;of&#160;1940, to form
                                            a controlling group with respect to FMR LLC.&#160;Neither FMR LLC nor Abigail P.&#160;Johnson
                                            has the sole power to vote or direct the voting of the shares owned directly by the various
                                            investment companies registered under the Investment Company Act (&#8220;Fidelity Funds&#8221;)
                                            advised by Fidelity Management&#160;&amp; Research Company, a wholly owned subsidiary of
                                            FMR LLC, which power resides with the Fidelity Funds&#8217; Boards of Trustees. Fidelity
                                            Management&#160;&amp; Research Company carries out the voting of the shares under written
                                            guidelines established by the Fidelity Funds&#8217; Boards of Trustees.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes
                                            50,000 restricted stock units granted to Mr.&#160;Carhart pursuant to his employment offer
                                            letter, which would not vest as of September&#160;12, 2025, as more fully described below
                                            under &#8220;Executive Compensation &#8212; Named Executive Officer Employment Agreements&#8221;.
                                            In the event of a Company Change of Control, a PodcastOne Change of Control and/or Slacker
                                            Change of Control (each as defined in Mr.&#160;Carhart&#8217;s employment agreement), 50%
                                            of the unvested portion of the restricted stock units of our Company granted to Mr.&#160;Carhart
                                            will vest effective immediately prior to such event.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            25,000 vested stock options for each director.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            66,879, 55,113, 60,510, 63,694, 57,325 and 60,510 vested restricted stock units granted to
                                            Messrs. Krigsman, Arani, Wachsberger, Solomon and Wright and Ms. Baker in 2024, respectively.
                                            Mr.&#160;Krigsman has determined to defer the settlement of all of his restricted stock units
                                            to a future date for tax purposes.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            890,186 shares of our common stock held by the Krigsman Family Trust, as Mr.&#160;Krigsman,
                                            a trustee of the trust, holds shared voting and dispositive power over such shares. Mr. Krigsman
                                            disclaims beneficial ownership in such shares held by the trust, except for his pecuniary
                                            interest therein. Excludes certain shares that were formerly held in custodial accounts for
                                            the benefit of Mr.&#160;Krigsman&#8217;s daughters under the Uniform Transfers to Minors
                                            Act (&#8220;UTMA&#8221;) and for which Mr.&#160;Krigsman was the custodian. Mr.&#160;Krigsman
                                            no longer has control or voting or dispositive power over such shares as a result of the
                                            transfer from such UTMA accounts to Mr.&#160;Krigsman&#8217;s daughters&#8217; individual
                                            accounts.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            5,170 shares of our common stock held by Wachsberger Family Trust, as Mr. Wachsberger, a
                                            trustee of the trust, holds shared voting and dispositive power over such shares. Mr. Wachsberger
                                            disclaims beneficial ownership in such shares held by the trust, except for his pecuniary
                                            interest therein.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            shares of our common stock held by Trinad Capital, Trinad LLC and JJAT and the shares of
                                            our common stock issuable upon conversion of our Series&#160;A Preferred Stock owned by Trinad
                                            Capital, which are deemed to be beneficially owned by Mr.&#160;Ellin, are counted only once
                                            in this total.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="l_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXECUTIVE
OFFICERS AND DIRECTORS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding our current executive officers and directors as of the Record Date:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Age</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Position</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; font-style: italic; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Executive
    Officers</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 29%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Robert
    S.&#160;Ellin</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">60</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Chief
    Executive Officer, Chairman of the Board and Director</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Ryan
    Carhart</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">45</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chief
    Financial Officer, Executive Vice President, Corporate Secretary and Treasurer</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; font-style: italic; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Non-Executive
    Directors</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Jay
    Krigsman</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">60</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Director</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Ramin
    Arani</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">55</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Director</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Patrick
    Wachsberger</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">73</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Director</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Kenneth
    Solomon</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">62</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Director</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Bridget
    Baker</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">63</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Director</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Kristopher
    Wright</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">50</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Director</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Executive
Officers</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Robert
S.&#160;Ellin.&#160;</i></b>Please see above under &#8220;Proposal&#160;No. 1 &#8212;&#160;Election of Directors&#160;&#8212;&#160;General
Information About the Board of Directors.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ryan
Carhart.&#160;</i></b> Mr. Carhart has served as our and PodcastOne&#8217;s Chief Financial Officer, Corporate Secretary and Treasurer
since February 2025 and has served as the Vice President of our Company and PodcastOne since September 2023. Mr. Carhart also previously
served as the Controller of our Company and PodcastOne from September 2023 to April 2025. Mr. Carhart is a seasoned financial professional
with extensive experience in overseeing operations, corporate strategy and development, financial reporting, mergers and acquisitions,
establishing and overseeing operational excellence initiatives in growing organizations and public company compliance. Prior to his appointment
as our and PodcastOne&#8217;s Vice President and Controller, Mr. Carhart served as the Chief Financial Officer at AUDIENCEX, an AI-powered
digital ad partner, optimizing programmatic, social, and search campaigns with data-driven strategy and creative solutions, and as the
Principal Financial Officer and Principal Accounting Officer of Vado Corp (&#8220;Vado&#8221;), since May, 2019, where he guided AUDIENCEX
through its acquisition by Vado, while overseeing operations and corporate strategy and development. Prior to that, Mr. Carhart served
as the Senior Director of Finance and Controller at MNTN, a builder of advertising software for brands to drive measurable conversions,
revenue, site visits and more through the power of television. Mr. Carhart previously worked at PricewaterhouseCoopers, a global public
accounting firm, with a specialization in the technology and communications industries. Mr. Carhart holds a Master of Science in Accounting
and a Master of Business Administration (MSA/MBA) from Northeastern University, along with a PhD from Claremont Graduate University,
and is a Certified Public Accountant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Non-Employee
Directors</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Jay
Krigsman.&#160;</i></b>Please see bio above under &#8220;Proposal&#160;No. 1 &#8212;&#160;Election of Directors&#160;&#8212;&#160;General
Information About the Board of Directors&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ramin
Arani.&#160;</i></b>Please see bio above under &#8220;Proposal&#160;No. 1 &#8212;&#160;Election of Directors&#160;&#8212;&#160;General
Information About the Board of Directors&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Patrick
Wachsberger.&#160;</i></b>Please see bio above under &#8220;Proposal&#160;No. 1 &#8212;&#160;Election of Directors&#160;&#8212;&#160;General
Information About the Board of Directors&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Kenneth
Solomon.&#160;</i></b>Please see bio above under &#8220;Proposal&#160;No. 1 &#8212;&#160;Election of Directors&#160;&#8212;&#160;General
Information About the Board of Directors&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Bridget
Baker.&#160;</i></b>Please see bio above under &#8220;Proposal&#160;No. 1 &#8212;&#160;Election of Directors&#160;&#8212;&#160;General
Information About the Board of Directors&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Kristopher
Wright.&#160;</i></b>Please see bio above under &#8220;Proposal&#160;No. 1 &#8212;&#160;Election of Directors&#160;&#8212;&#160;General
Information About the Board of Directors&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Terms
of Office</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors are appointed for a one-year term to hold office until the next annual general meeting of our stockholders or until removed
from office in accordance with our Bylaws and the provisions of the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;).
Our directors hold office after the expiration of his or her term until his or her successor is elected and qualified, or until his or
her resignation, death or removal in accordance with our Bylaws or the DGCL.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
officers are appointed by our board of directors and hold office until removed by our board of directors at any time for any reason.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Family
Relationships</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships between or among any of our directors or executive officers or persons nominated or chosen by us to become
directors or executive officers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
see bio above under &#8220;Corporate Governance&#160;&#8212;&#160;Director Independence&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Committees</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
see bio above under &#8220;Proposal&#160;No. 1 &#8212;&#160;Election of Directors&#160;&#8212;&#160;Board Committees&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Leadership Structure</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
see bio above under &#8220;Corporate Governance&#160;&#8212;&#160;Board Leadership Structure&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
Oversight</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
see bio above under &#8220;Corporate Governance&#160;&#8212;&#160;Risk Oversight and Compensation Risk Assessment&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
see bio above under &#8220;Corporate Governance&#160;&#8212;&#160;Code of Ethics&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Insider
Trading Policy</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
see bio above under &#8220;Corporate Governance&#160;&#8212;&#160;Insider Trading Policy&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee Interlocks and Insider Participation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
member of the Compensation Committee was at any time during the 2025 fiscal year, or at any other time, an officer or employee of our
Company, and no member had any relationship requiring disclosure under Item&#160;404 of Regulation&#160;S-K promulgated by the SEC.&#160;None
of our executive officers (i)&#160;serves as a member of the compensation committee of any other company of which any member of the Compensation
Committee or our board of directors is an executive officer, or (ii)&#160;serves as a member of the board of directors of any other company
of which any member of the Compensation Committee is an executive officer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delinquent
Section&#160;16(a)&#160;Reports</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&#160;16(a)&#160;of
the Exchange&#160;Act requires our directors, executive officers, and persons who own more than 10% of our common stock to file initial
reports of ownership and changes in ownership of our common stock and other equity securities with the SEC.&#160;These individuals are
required by the regulations of the SEC to furnish us with copies of all Section&#160;16(a)&#160;forms they file. Based solely on a review
of the copies of the forms furnished to us, and written representations from reporting persons that no Forms 5 were required to report
delinquent filings, we believe that all filing requirements applicable to our current officers, directors and 10% beneficial owners were
complied with during the fiscal&#160;years ended March 31, 2025 and 2024, except that Mr. Krigsman&#8217;s and Mr. Solomon&#8217;s Form
4s filed with the SEC on September 23, 2024 and September 24, 2024, respectively, were inadvertently filed late.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominations
to the Board of Directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General&#160;</i>&#8212;&#160;Our
directors take a critical role in guiding our strategic direction and oversee the management of the Company. Our board of directors&#8217;
candidates are considered based upon various criteria, such as their broad-based business and professional skills and experiences, a
global business and social perspective, concern for the long-term interests of the shareholders, diversity, and personal integrity and
judgment. In addition, directors must have time available to devote to our board of directors activities and to enhance their knowledge
of our business. Accordingly, we seek to attract and retain highly qualified directors who have sufficient time to attend to their substantial
duties and responsibilities to our Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating Committee assists our board of directors in identifying qualified individuals to become board members, in determining the
composition of the board and in monitoring the process to assess board effectiveness.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Changes
to the Procedures by Which Security Holders May Recommend Nominees to Our Board of Directors</i>&#160;&#8212;&#160;During the year ended
March 31, 2025, there were no material changes to the procedures by which our security holders may recommend nominees to our board of
directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="l_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
NO. 2 &#8212; APPROVAL OF AN AMENDMENT TO THE COMPANY&#8217;S CERTIFICATE OF<br/>
INCORPORATION TO EFFECT A REVERSE STOCK SPLIT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has adopted and submitted for stockholder approval an amendment to our Certificate of Incorporation, as amended (the
&#8220;Certificate of Incorporation&#8221;), to effect a reverse stock split of all outstanding shares of our common stock, if our board
of directors deems that it is in our Company&#8217;s and our stockholders&#8217; best interests, at a ratio to be determined by our board
of directors in the range (the &#8220;Split Range&#8221;) of one-for-three (1-for-3) through one-for-ten (1-for-10) (collectively, the
&#8220;Reverse Split&#8221;). Our board of directors will have the sole discretion to elect, as it determines to be in our best interests
and our stockholders, whether or not to effect the Reverse Split, and if so, at which ratio within the approved Split Range. Our board
of directors believes that approval of a proposal granting this discretion to our board of directors, rather than approval of an immediate
Reverse Split at a specified ratio, would provide our board of directors with maximum flexibility to react to current market conditions
and other factors it deems appropriate and to therefore achieve the purposes of the Reverse Split, if implemented, and to act in our
Company&#8217;s and our stockholders&#8217; best interests.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reverse Split has been proposed for approval at the Annual Meeting in order to attempt to remediate our current noncompliance with Nasdaq&#8217;s
Bid Price Rule (as defined below).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
effect the Reverse Split, our board of directors would authorize our management to file a Certificate of Amendment to our Certificate
of Incorporation with the Secretary of State of the State of Delaware. If our board of directors elects to implement the approved Reverse
Split within the Split Range, the number of issued and outstanding shares of our common stock (as well as common stock underlying derivative
securities such as options and warrants) would be reduced in accordance with the ratio for the selected Reverse Split, without a corresponding
decrease to the number of authorized shares of our common stock. The par value of our common stock would remain unchanged, however the
number of authorized and unissued shares of our common stock would effectively increase as a result of the Reverse Split.&#160;<b>If
approved by our stockholders, our board of directors may nonetheless elect not to implement the Reverse Split at its sole discretion.
This could occur if our common stock regains compliance with Nasdaq&#8217;s Bid Price Rule prior to the termination of the applicable
grace period discussed below.</b>&#160;The proposed form of the Certificate of Amendment to our Certificate of Incorporation to implement
the Reverse Split is attached to this Proxy Statement as&#160;<span style="text-decoration:underline">Annex A</span>&#160;(the &#8220;Certificate of Amendment&#8221;).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purpose
of the Reverse Split</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2025, we received a letter from the Listing Qualifications Department of Nasdaq notifying us of our noncompliance with Nasdaq
Rule 5550(a)(2) (based on the closing bid price of shares of our common stock for the previous 30 consecutive business days being below
a minimum of $1.00 per share) (the &#8220;Bid Price Rule&#8221;). The purpose of the Reverse Split is to regain compliance with Nasdaq&#8217;s
Bid Price Rule and avoid delisting of our common stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
letter from Nasdaq has no immediate effect on the listing of our common stock on The Nasdaq Capital Market. In accordance with Nasdaq
Listing Rule 5810(c)(3)(A), we have a period of 180 calendar days from March 28, 2025, to regain compliance with the Bid Price Rule.
To regain compliance during this 180-day compliance period, the closing bid price of shares of our common stock must be at least $1.00
for a minimum of ten consecutive business days. In the event that we do not regain compliance with the Bid Price Rule prior to the expiration
of the 180-day compliance period, we may be eligible for an additional 180-day compliance period. To qualify, we will be required to
meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq
Capital Market (including with respect to our Audit Committee as discussed below), with the exception of the Bid Price Rule, and will
need to provide written notice of our intention to cure the deficiency during the second compliance period, by effecting a reverse stock
split, if necessary. If we are not able to meet these requirements, we will receive written notification from Nasdaq that shares of our
common stock are subject to delisting. At that time, we may appeal the relevant delisting determination to a hearings panel pursuant
to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance that, if we do appeal the delisting
determination by Nasdaq to the panel, that such appeal would be successful.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously reported, on October 4, 2024, Craig Foster notified our Company that he was resigning from service on our board of directors
to pursue other current professional obligations, effective as of the same date. At the time of his resignation, Mr. Foster served on
the Audit Committee and the Nominating and Corporate Governance Committee of our board of directors. Mr. Foster&#8217;s resignation was
not a result of any disagreement with our Company on any matter relating to our operations, policies or practices. On November 21, 2024,
we received a notification letter from the Listing Qualifications Department of Nasdaq confirming that we have a cure period until the
earlier of (i) October 4, 2025 and (ii) our next annual meeting of stockholders, to fill the vacancy created by such resignation in order
to comply with the audit committee requirements set forth in Nasdaq Listing Rule 5605. To fill the vacancy created by Mr. Foster&#8217;s
resignation, we anticipate that one or more existing independent members of our board of directors will be appointed to our Audit Committee
and/or the Nominating and Corporate Governance Committee, and we are also continuing to conduct a search to find a well-qualified candidate
to serve on our board of directors and/or such committees that has the applicable experience and the necessary qualifications, skills
and perspective.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the above referenced letter from Nasdaq had no immediate impact on the listing of shares of our common stock, which have continued to
be listed and traded on The Nasdaq Capital Market, we are seeking stockholder approval of the Reverse Split to enable our board of directors
to take action to attempt to enable us to regain compliance with the Bid Price Rule and continue to be listed on The Nasdaq Capital Market.
By including our board of directors discretion to effect the Reverse Split within the Split Range, we will be positioned to react to
market conditions and actions taken by Nasdaq to increase our chances of achieving this goal.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has determined that maintaining listing on The Nasdaq Capital Market is an important goal, as our board of directors
believes that the listing of our common stock on a principal national securities exchange enhances the liquidity of the outstanding shares,
as well as our ability to raise capital, each of which is considered to be a benefit to our Company and our stockholders. Additionally,
our board of directors believes that continued listing on The Nasdaq Capital Market enhances visibility and credibility to the investment
community with respect to our common stock. If, on the other hand, shares of our common stock were delisted from The Nasdaq Capital Market
and we were unable to list shares of our common stock on an alternative national securities exchange, trading of shares of our common
stock would most likely take place on an over-the-counter market established for unlisted securities, such as the OTCQB or a lower-tiered
quotation system operated by The OTC Markets Group. In such an event, investors may find it more difficult to sell shares of our common
stock. The result could have a depressive effect on our stock price. In addition, if our common stock were delisted, it would become
subject to SEC rules regarding &#8220;penny stocks,&#8221; which impose additional disclosure requirements on broker-dealers and further
hindrances and expenses for investors seeking to sell the securities. For these reasons and others, delisting would likely adversely
affect the liquidity, trading volume and price of shares of our common stock, causing the value of an investment in us to decrease and
having an adverse effect on our business and an investment in us, as well as on our ability to raise capital as and when required.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we presently intend to effect the Reverse Split to regain compliance with The Nasdaq Capital Market&#8217;s minimum bid price requirement,
under Section 242(c) of the DGCL, our board of directors has reserved the right, notwithstanding our stockholders&#8217; approval of
the proposed amendment to the Certificate of Incorporation at the Annual Meeting, to abandon the proposed amendment at any time (without
further action by our stockholders) before the Certificate of Amendment is filed with the Secretary of State of the State of Delaware.
Further, our board of directors may consider a variety of factors in determining the appropriate range within the Split Range for any
such amendment, including overall trends in the stock market, recent changes, and anticipated trends in the per-share market price of
our common stock, business developments and our actual and projected financial performance. Again, our board of directors may decide
to abandon the proposed amendment of the Certificate of Incorporation in its entirety, particularly if the closing bid price of our common
stock on The Nasdaq Capital Market is then in compliance with Nasdaq&#8217;s $1.00 minimum bid price requirement. While we hope that
approval of this Proposal No. 2 will enable us to regain compliance prior to the termination of the grace period, we intend to continue
to monitor the bid price of our common stock and assess our options for maintaining the listing of our common stock on The Nasdaq Capital
Market.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in; ">For more information on the risks inherent in the Reverse Split, including
with respect to the Nasdaq deficiency notice and potential for delisting, see below under the heading &#8220;Certain Risks Associated
with the Reverse Split.&#8221; For additional information about the risks we and our investors face with respect to our common stock,
business and other matters, see &#8220;Item 1A. - Risk Factors&#8221; section in our Annual Report on Form 10-K for the fiscal year ended
March 31, 2025, filed with the SEC on July [&#9679;], 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Risks Associated with the Reverse Split</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">If
the Reverse Split does not result in a proportionate increase in the price of our common stock, we may be unable to regain compliance
with the Nasdaq listing requirements or meet those of another national securities exchange</span>.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that if approved the Reverse Split will increase the market price of our common stock so that we will be able to regain compliance
with Nasdaq&#8217;s minimum Bid Price Rule requirements. However, the effect of the Reverse Split on the market price of our common stock
cannot be predicted with certainty, and the results of reverse stock splits by companies under similar circumstances have varied. It
is possible that the market price of our common stock following the Reverse Split will not increase sufficiently for us to regain compliance
with the minimum bid price requirement. For example, if our stock price were to fall below $0.10 per share, the high end of the Split
Range of the Reverse Split, which is one-for-ten, would potentially be insufficient to enable us to comply with the minimum bid price
requirement post-Reverse Split. Further, the Reverse Split may result in a lesser number of round lot holders (holders of at least 100
shares), which could also cause us to be noncompliant with another Nasdaq Rule requiring that we have at least 300 round lot holders.
If we are unable meet the minimum bid price requirement or other requirements under Nasdaq rules, we may not be unable continue to have
or common stock listed on The Nasdaq Capital Market, and may be unable to list our common stock on an alternative national securities
exchange. This could have a material adverse effect on our liquidity and an investment in us, and impose additional hardships on investors
seeking to sell our common stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Even
if the Reverse Split results in the requisite increase in the market price of our common stock, there is no assurance that we will be
able to continue to comply with the minimum Bid Price Rule requirements</span>.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if the Reverse Split results in the requisite increase in the market price of our common stock to be in compliance with Nasdaq&#8217;s
minimum Bid Price Rule requirements, there can be no assurance that the market price of our common stock following the Reverse Split
will remain at the level required for continued compliance with such requirement. It is not uncommon for the market capitalization of
a company&#8217;s common stock to decline in the period following a reverse stock split. If the market price of our common stock declines
following the implementation of the Reverse Split, the percentage decline may be greater than would occur in the absence of the Reverse
Split. In any event, other factors unrelated to the number of shares of our common stock outstanding, such as negative financial or operational
results, could adversely affect the market price of our common stock and jeopardize our ability to meet or continue to comply with the
minimum Bid Price Rule requirements of Nasdaq.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">The
Reverse Split may decrease the liquidity of our common stock</span>. </i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
liquidity of our common stock may be adversely affected by the Reverse Split given the reduced number of shares that will be outstanding
following the Reverse Split, especially if the market price of our common stock does not sufficiently increase as a result of the Reverse
Split. In addition, the Reverse Split may decrease the number of stockholders who own round lots (less than 100 shares) of our common
stock, creating the potential for such stockholders to experience an increase in the cost of selling their shares and greater difficulty
effecting such sales.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">The
increased market price of our common stock resulting from the Reverse Split may not attract new investors, including institutional investors,
and may not satisfy the investing guidelines of those investors, and consequently, the liquidity of our common stock may not improve</span>.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe that a higher market price may help generate greater or broader investor interest in our common stock, there can be no assurance
that the Reverse Split will result in a per-share price increase sufficient to attract new investors, including institutional investors.
Additionally, there can be no assurance that the market price of our common stock will satisfy the investing guidelines of those investors.
As a result, the trading liquidity of our common stock may not necessarily improve following the Reverse Split.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal
Effects of the Reverse Split, Effective Increase in Authorized Common Stock and Par Value Increase</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reverse Split, if implemented, will have the following principal effects:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.35in"/><td style="font-family: Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of shares of our common stock held by individual stockholders will decrease based
                                            on the ratio, and the number of stockholders who own &#8220;round lots&#8221; of at least
                                            100 shares of will decrease;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.35in"/><td style="font-family: Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of shares of common stock issuable upon exercise of outstanding stock options and
                                            warrants or conversion of outstanding convertible securities (if any) and the exercise price
                                            of such outstanding options and warrants and the conversion price of such outstanding convertible
                                            securities (if any), will be adjusted in accordance with their respective terms based on
                                            the ratio at which the Reverse Split is effected;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of our common stock after the Reverse Split will be fully paid and non-assessable. The Certificate of Amendment will not change any of
the other terms of our common stock. Following the Reverse Split, the shares of our common stock will have the same voting rights and
rights to dividends and distributions and will be identical in all other respects to the shares of our common stock prior to the Reverse
Split. Following the Reverse Split, we will continue to be subject to the reporting requirements of the Exchange Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
the authorized common stock will not be reduced at the same ratio as the Reverse Split ratio, the Reverse Split will have an overall
effect of increasing the authorized but unissued shares of our common stock. These shares may be issued by our board of directors in
its sole discretion. See &#8220;Anti-Takeover Effects of the Reverse Split&#8221; below. Any future issuance will have the effect of
diluting the percentage of stock ownership and voting rights of the present holders of our common stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fractional
Shares</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares will be issued as the result of the Reverse Split. We will round up any fractional shares resulting from the Reverse
Split to the nearest whole share.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No
Going Private Transaction</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the decrease in the number of outstanding shares of our common stock following the proposed Reverse Split, our board of directors does
not intend for this transaction to be the first step in a &#8220;going private transaction&#8221; within the meaning of Rule 13e-3 under
the Exchange Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Procedure
for Implementing the Reverse Split</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reverse Split would become effective upon the filing with the Delaware Secretary of State of the Certificate of Amendment as of the time
of filing or such other time set forth in the Certificate of Amendment (the &#8220;Effective Time&#8221;), as determined by our board
of directors based on its evaluation as to when such action will be the most advantageous to us and our stockholders. Additionally, our
board of directors reserves the right, notwithstanding stockholder approval and without further action by the stockholders, to elect
not to proceed with the Reverse Split if, at any time prior to the effectiveness of the Certificate of Amendment, our board of directors,
in its sole discretion, determines that it is no longer in the best interests of our Company and our stockholders to effect the Reverse
Split. Beginning at the Effective Time, each certificate representing shares of our common stock will be deemed for all corporate purposes
to evidence ownership of the number of whole shares into which the shares previously represented by the certificate were combined pursuant
to the Reverse Split.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Effective Time, our common stock will have a new Committee on Uniform Securities Identification Procedures (&#8220;CUSIP&#8221;)
number, used to identify our equity securities. Stock certificates with the older CUSIP number will need to be exchanged for stock certificates
with the new CUSIP number by following the procedures described below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Effect
on Beneficial Owners of Common Stock</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the implementation of the Reverse Split, we intend to treat shares held by stockholders through a bank, broker, custodian or other nominee
in the same manner as registered stockholders whose shares are registered in their names with Vstock Transfer, LLC, our transfer agent
(the &#8220;Transfer Agent&#8221;). Banks, brokers, custodians or other nominees will be instructed to effect the Reverse Split for their
beneficial holders holding our common stock in street name. However, these banks, brokers, custodians or other nominees may have different
procedures for processing the Reverse Split. Stockholders who hold our common stock with a bank, broker, custodian or other nominee and
who have any questions in this regard are encouraged to contact their banks, brokers, custodians or other nominees.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Effect
on Registered &#8220;Book-Entry&#8221; Holders of Common Stock</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
registered holders of our common stock may hold some or all of their shares electronically in book-entry form with the Transfer Agent.
These stockholders do not have stock certificates evidencing their common stock ownership. Such stockholders are, however, provided with
a statement reflecting the number of shares registered in their accounts. Stockholders who hold shares electronically in book-entry form
with the Transfer Agent will not need to take action. The Reverse Split will automatically be reflected in the Transfer Agent&#8217;s
records and on their next statement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Exchange
of Stock Certificates</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that the Transfer Agent will act as exchange agent for purposes of implementing the exchange of stock certificates for record
holders (i.e., stockholders who hold their shares directly in their own name and not through a broker) in connection with the Reverse
Split. As soon as practicable after the filing of the Certificate of Amendment, registered holders of certificated pre-Reverse Split
shares may be asked to surrender to the Transfer Agent certificates representing pre-Reverse Split shares in exchange for a book entry
with the transfer agent or certificates representing post-Reverse Split shares in accordance with the procedures to be set forth in a
letter of transmittal to be sent by us. No new stock certificates will be issued to a stockholder until such stockholder has surrendered
such stockholder&#8217;s outstanding certificate(s) together with the properly completed and executed letter of transmittal to the Transfer
Agent.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
street name holders of pre-Reverse Split shares (i.e., stockholders who hold their shares through a broker), your broker will make the
appropriate adjustment to the number of shares held in your account following the Effective Time.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STOCKHOLDERS
SHOULD NOT DESTROY ANY STOCK CERTIFICATE(S) AND SHOULD NOT SUBMIT ANY CERTIFICATE(S) UNTIL REQUESTED TO DO SO.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No
Dissenters&#8217; Rights</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the DGCL, our stockholders are not entitled to dissenters&#8217; rights with respect to the Reverse Split.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Federal Income Tax Consequences</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Each
stockholder is advised to consult their own tax advisor as the following discussion may be limited, modified or not apply based on your
particular situation.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion of the material U.S. federal income tax consequences of the Reverse Split is based on the current provisions of
the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), Treasury regulations promulgated under the Code, Internal Revenue
Service (the &#8220;IRS&#8221;) rulings and pronouncements and judicial decisions now in effect. Those legal authorities are subject
to change at any time by legislative, judicial or administrative action, possibly with retroactive effect to the Reverse Split. No ruling
from the IRS with respect to the matters discussed below has been requested, and there is no assurance that the IRS or a court would
agree with the conclusions set forth in this discussion. The following discussion assumes that the pre-split shares of common stock were,
and post-split shares will be, held as &#8220;capital assets&#8221; as defined in the Code. This discussion may not address certain U.S.
federal income tax consequences that may be relevant to particular stockholders in light of their specific circumstances or to certain
types of stockholders (like dealers in securities, insurance companies, foreign individuals and entities, financial institutions and
tax-exempt entities) that may be subject to special treatment under the U.S. federal income tax laws. This discussion also does not address
any tax consequences under state, local or foreign laws.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PLEASE
CONSULT YOUR OWN TAX ADVISOR REGARDING THE U.S. FEDERAL, STATE, LOCAL, AND FOREIGN INCOME AND OTHER TAX CONSEQUENCES OF THE REVERSE SPLIT
IN YOUR PARTICULAR CIRCUMSTANCES UNDER THE INTERNAL REVENUE CODE AND THE LAWS OF ANY OTHER TAXING JURISDICTION.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not recognize any gain or loss for U.S. federal income tax purposes as a result of the Reverse Split.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
stockholder will not recognize gain or loss for U.S. federal income tax purposes on the exchange of pre-Reverse Split shares of our common
stock for post-Reverse Split shares of our common stock in the Reverse Split. A stockholder&#8217;s aggregate tax basis in the post-Reverse
Split shares of our common stock the stockholder receives in the Reverse Split will be the same as the stockholder&#8217;s aggregate
tax basis in the pre-Reverse Split shares of our common stock the stockholder surrenders in exchange therefor. A stockholder&#8217;s
holding period for the post-Reverse Split shares of our common stock the stockholder receives in the Reverse Split will include the stockholder&#8217;s
holding period for the pre-Reverse Split shares of our common stock the stockholder surrenders in exchange therefor. Stockholders who
have different bases or holding periods for pre-Reverse Split shares of our common stock should consult their tax advisors regarding
their bases or holding periods in their post-Reverse Split common stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Takeover
Effects of the Reverse Split</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effective increase in our authorized and unissued shares of common stock resulting from the Reverse Split could potentially be used by
our board of directors to thwart a takeover attempt. The overall effects of this might be to discourage, or make it more difficult to
engage in, a merger, tender offer or proxy contest, or the acquisition or assumption of control by a holder of a large block of our securities
and the removal of incumbent management. The Reverse Split could make it more difficult to accomplish a merger or similar transaction,
even if such transaction is beneficial to the stockholders. Our board of directors might use the additional shares to resist or frustrate,
by issuing additional shares of common stock, a third-party takeover effort favored by a majority of the independent stockholders that
would provide an above-market premium. The Reverse Split is not the result of our management&#8217;s knowledge of an effort to accumulate
our securities or to obtain control of our Company by means of a merger, tender offer, solicitation or otherwise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of votes cast &#8220;FOR&#8221; the proposal must exceed the number of votes cast &#8220;AGAINST&#8221; this proposal; provided
that our common stock is listed on Nasdaq immediately before the Reverse Split becomes effective and meets the Listing Condition, in
which case, abstentions and any broker non-votes with respect to this proposal will not be considered &#8220;votes cast&#8221; and will
have no effect on this proposal. If the Listing Condition is not met, this proposal must receive the affirmative vote of the holders
of a majority of our issued and outstanding shares of common stock as of the Record Date and abstentions and any broker non-votes with
respect to this proposal would have the same effect as a vote against this proposal. Brokerage firms will have discretionary authority
to vote their customers&#8217; unvoted shares held by the firms in street name on this proposal, and we do not anticipate receiving any
broker non-votes on this proposal.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board of Directors Unanimously Recommends a Vote&#160;<span style="text-decoration:underline">FOR</span>&#160;this Proposal No. 2.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="l_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
NO. 3 &#8212;&#160;RATIFICATION OF THE APPOINTMENT OF THE INDEPENDENT<br/>
REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee of our board of directors has appointed Macias Gini&#160;&amp; O&#8217;Connell LLP (the &#8220;Auditor&#8221;) as our
independent registered public accounting firm to audit our consolidated financial statements for the fiscal year ending March 31, 2026.
The Auditor was engaged as our independent registered public accounting firm on July&#160;25, 2022. Representatives of the Auditor are
expected to be present at the Annual Meeting to respond to appropriate questions and will have the opportunity to make a statement if
they so desire.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder
ratification of the appointment of the Auditor is not required by our bylaws or otherwise. However, our board of directors is submitting
the appointment of the Auditor to the stockholders for ratification as a matter of good corporate governance practice. If the stockholders
fail to ratify the appointment, the Audit Committee will reconsider whether to retain the Auditor. Even if the appointment is ratified,
the Audit Committee, in its discretion, may direct the appointment of a different independent registered public accounting firm at any
time during the 2026 fiscal year if it determines that such a change would be in the best interests of us and our stockholders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of a majority of the votes cast on this proposal at the Annual meeting is required to ratify the appointment of the
Auditor as our independent registered public accounting firm. For purposes of this vote, abstentions and broker non-votes will have no
effect on the outcome of this proposal.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board of Directors Unanimously Recommends a Vote <span style="text-decoration:underline">FOR</span> this Proposal&#160;No. 3.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
and Non-Audit Fees</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the aggregate fees billed by the Auditor, our independent registered public accounting firm, for the fiscal&#160;year
ended March 31, 2025 and 2024 (in thousands):</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Year Ended March&#160;31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Description of Service</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Fees<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,365</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,149</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related Fees<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Fees<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">All Other Fees</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total Fees</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,365</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,149</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Audit Fees consist of fees for audit of our annual financial statements
for the respective year, reviews of our quarterly financial statements, services provided in connection with statutory and regulatory
filings. Includes the audit fees for each of PodcastOne and Slacker, which are collectively $655,000 for the year ended March 31, 2025.</p></td>
</tr></table><div>

</div><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related
                                            Fees consist of fees for accounting consultations.</span></td>
</tr></table><div>

</div><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font-family: Times New Roman, Times, Serif; width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
                                            Fees consist of fees for professional services rendered for tax compliance.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Non-Audit
Fees</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no audit or non-audit services provided to us for the&#160;years ended March 31, 2025 and 2024 that were not approved by our board
of directors. Our board of directors determined that the services rendered by the Auditor are compatible with maintaining their independence
as our independent auditors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-Approval
Policies and Procedures</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
April&#160;1, 2018, our Audit Committee became responsible, and prior to such period, our board of directors was responsible, for the
pre-approval of all audits and permitted non-audit services to be performed for our Company by our independent registered public accounting
firm and any other independent accounting firms that we engage. The fees to be paid to the Auditor for the 2025 and 2024 fiscal&#160;years
were approved, and going forward shall be subject to approval, by our Audit Committee and our board of directors in accordance with the
procedures described below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee reviews and approves all audit and non-audit services proposed to be provided, other than de minimis non-audit services
which may instead by preapproved in accordance with applicable SEC rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="l_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
NO. 4 &#8212;&#160;ADJOURNMENT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are asking our stockholders to approve, if necessary, a proposal to adjourn the Annual Meeting to a later date and time to solicit additional
proxies in favor of one or more proposals submitted to a vote by the stockholders at the Annual Meeting. Any adjournment of the Annual
Meeting for the purpose of soliciting additional proxies will allow stockholders who have already sent in their proxies to revoke them
at any time prior to the time that the proxies are used.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of a majority of the shares present and entitled to vote at the Annual Meeting is required to approve this Proposal&#160;No.
4. Abstentions will have the same effect as the vote &#8220;AGAINST&#8221; this Proposal&#160;No. 4.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board of Directors Unanimously Recommends a Vote <span style="text-decoration:underline">FOR</span> this Proposal&#160;No. 4.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Matters</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as set forth above, the board of directors is not aware of any other business that may be brought before the Annual Meeting. If
any other matters are properly brought before the Annual Meeting, or any adjournment or postponement thereof, it is the intention of
the designated proxy holders, Mr.&#160;Ellin and Mr.&#160;Carhart, to vote on such matters in accordance with their best judgment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>YOUR
VOTE IS IMPORTANT. Accordingly, you are urged to sign and return the accompanying proxy card or voting instruction card, <br/>
as the
case may be, whether or not you plan to attend the Annual Meeting.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                            Order of the Board of Directors,</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Robert S.&#160;Ellin</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    S.&#160;Ellin</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beverly
    Hills, CA</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    [&#9679;], 2025</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="l_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REPORT
OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
report of the audit committee is required by the SEC and, in accordance with the SEC&#8217;s rules, will not be deemed to be part of
or incorporated by reference by any general statement incorporating by reference this proxy statement into any filing under the Securities
Act, or under the Exchange&#160;Act, except to the extent that we specifically incorporate this information by reference, and will not
otherwise be deemed &#8220;soliciting material&#8221; or &#8220;filed&#8221; under either the Securities Act or the Exchange&#160;Act.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee&#8217;s purpose is to assist our board of directors in its general oversight of our accounting, auditing and financial
reporting practices. Management is primarily responsible for our financial statements, systems of internal controls and compliance with
applicable legal and regulatory requirements. The Auditor was responsible for performing an independent audit of our consolidated financial
statements and expressing an opinion on the conformity of those financial statements with accounting principles generally accepted in
the United&#160;States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee members are not professional accountants or auditors, and their functions are not intended to duplicate or to certify
the activities of management and the independent registered public accounting firm, nor can the committee certify that our registered
public accounting firm is &#8220;independent&#8221; under applicable rules. The Audit Committee serves a board-level oversight role,
in which it provides advice, counsel and direction to management and the independent registered public accounting firm on the basis of
the information it receives, discussions with management and the independent registered public accounting firm and the experience of
the committee&#8217;s members in business, financial and accounting matters.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee reviewed and discussed the audited financial statements for the fiscal year ended March 31, 2025 with our management.
The Audit Committee discussed with our independent registered public accounting firm the matters required to be discussed by Auditing
Standard No. 1301, <i>Communications with Audit Committees</i>, as adopted by the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;).
The Audit Committee also received the written disclosures and the letter from our independent registered public accounting firm required
by applicable requirements of the PCAOB regarding the independent accountants&#8217; communications with the audit committee concerning
independence and has discussed with our independent registered public accounting firm the accounting firm&#8217;s independence. Based
on the foregoing, the Audit Committee has recommended to our board of directors that the audited financial statements be included, and
such audited financial statements were included, in our Annual Report on Form&#160;10-K for the fiscal year ended March 31, 2025, for
filing with the SEC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Respectfully
    submitted by:</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
    Audit Committee of the Board of Directors</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ramin
    Arani</i><br/></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Kenneth
    Solomon</i></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="l_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXECUTIVE
COMPENSATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
named executive officers, consisting of our principal executive officer and the next most highly compensated executive officer as of
March 31, 2025 (collectively, the &#8220;Named Executive Officers&#8221;), were:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
                                            Ellin, Chief Executive Officer, Chairman and Director; </span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ryan
                                            Carhart, our Chief Financial Officer, Senior Vice President, Controller, Corporate Secretary
                                            and Treasurer; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron
                                            Sullivan, our former Chief Financial Officer, Senior Vice President, Corporate Secretary
                                            and Treasurer, for whom disclosure would have been provided in the 2025 Summary Compensation
                                            Table but for the fact that he was not serving as our executive officer at the end of March
                                            31, 2025.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
did not have a third Named Executive Officers during our fiscal year ended March 31, 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025
Summary Compensation Table</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth, for the fiscal&#160;years ended March 31, 2025 and 2024, compensation awarded or paid to our Named Executive
Officers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Name
    and Principal Position</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Fiscal
    Year ended March&#160;31</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Salary<br/>
    ($)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Bonus<br/>
    ($)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Stock
    Awards<br/>
    ($)(1)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>&#160;</sup></span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Option
    Awards<br/>
    ($)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Non-Equity
    Incentive Plan Compensation<br/>
    ($)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Nonqualified
    Deferred Compensation Earnings<br/>
    ($)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">All
    Other Compensation<br/>
    ($)(2)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>&#160;</sup></span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total<br/>
    ($)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Robert&#160;Ellin,</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2025</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">500,000</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>(3)</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">58,584</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>(4)</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">558,584</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 9pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">CEO&#160;&amp;&#160;Chairman</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2024</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">500,000</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>&#160;</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">47,032</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>(4)</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">547,032</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>&#160;</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>&#160;</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ryan
    Carhart,</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2025</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">200,000</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">88,231</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>&#160;</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,560</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>(6)</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">305,790</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 9pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">CFO,
    SVP, Treasurer&#160;&amp; Secretary(5)</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2024</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">108,333</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>&#160;</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">11,370</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>(6)</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">119,703</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>&#160;</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>&#160;</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Aaron&#160;Sullivan,</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2025</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">325,730</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">582,230</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>&#160;</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">23,961</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>(8)</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">931,921</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 9pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">former
    CFO(7)</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2024</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">262,500</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">530,250</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>&#160;</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16,487</span></td><td style="font: 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>(8)</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">809,237</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            the aggregate grant date fair value of restricted units of our Company granted to the respective
                                            Named Executive Officer computed in accordance with FASB ASC Topic&#160;718. The assumptions
                                            used in calculating the amounts are discussed in Note&#160;2 &#8212;&#160;Summary of Significant
                                            Accounting Policies&#160;&#8212;&#160;&#8220;Stock-Based Compensation&#8221; of our financial
                                            statements for the fiscal year ended March 31, 2025 included in our 2025 Annual Report on
                                            Form&#160;10-K.&#160;Does not include restricted stock units of PodcastOne or Slacker granted
                                            to Messrs. Carhart and&#160;Sullivan pursuant to their respective employment agreements.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            otherwise indicated, the amount of perquisites and other personal benefits has been excluded
                                            as the total value of perquisites and other personal benefits for each Named Executive Officer
                                            per year was less than $10,000.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                            the 2023 and 2022 fiscal&#160;years, as a result of Mr.&#160;Ellin&#8217;s desire to demonstrate
                                            confidence in our Company and to assist our near term objectives in light of the ongoing
                                            COVID-19 epidemic and other costs realignment and reductions, Mr.&#160;Ellin agreed to accept
                                            payment of his monthly base salary for the period of January&#160;1, 2022 through December&#160;31,
                                            2022 in shares of our common stock. As of March&#160;31, 2025, our board of directors and
                                            Compensation Committee has not yet determined the number of shares of our common stock or
                                            our restricted stock units that should be issued to Mr.&#160;Ellin as such equity compensation
                                            and therefore, such equity compensation has not yet been awarded. Accordingly, the amounts
                                            shown under the &#8220;Stock Awards&#8221; column for the 2025 fiscal year does not include
                                            the amount of $986,560 as Mr.&#160;Ellin&#8217;s salary to be paid at a future date in shares
                                            of our common stock or our restricted stock units that shall be issued and vest in accordance
                                            with the terms as determined by our board of directors or Compensation Committee. The aggregate
                                            grant date fair value of such equity compensation will be included for Mr. Ellin in the fiscal
                                            year when such award is made.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            amount for 2025 represents personal benefits consisting of (i)&#160;car lease payments of
                                            $28,945, (ii)&#160;health, dental and vision insurance in the amount of $18,801, and (iii)&#160;life,
                                            accidental death and dismemberment insurance in the amount of $300, and (iii)&#160;401k match
                                            in the amount of $10,538, paid by us on Mr.&#160;Ellin&#8217;s behalf. The amount for 2024
                                            represents personal benefits consisting of (i)&#160;car lease payments of $28,945, (ii)&#160;health,
                                            dental and vision insurance in the amount of $17,967, and (iii)&#160;life, accidental death
                                            and dismemberment insurance in the amount of $120, paid by us on Mr.&#160;Ellin&#8217;s behalf.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.&#160;Carhart
                                            was appointed as our Chief Financial Officer effective as of February 19, 2025.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            amount for 2025 represents personal benefits consisting of (i)&#160;health, dental and vision
                                            insurance in the amount of $12,260, (ii)&#160;life, accidental death and dismemberment insurance
                                            in the amount of $300, and (iii)&#160;401k match in the amount of $5,000, paid by us on Mr.&#160;Carhart&#8217;s
                                            behalf. The amount for 2024 represents personal benefits consisting of (i)&#160;health, dental
                                            and vision insurance in the amount of $10,042, (ii)&#160;life, accidental death and dismemberment
                                            insurance in the amount of $78, and (iii)&#160;401k match in the amount of $1,250, paid by
                                            us on Mr.&#160;Carhart&#8217;s behalf.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                            Sullivan resigned from all of his positions with the Company effective as of February 19,
                                            2025.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            amount for 2025 represents personal benefits consisting of (i)&#160;health, dental and vision
                                            insurance in the amount of $17,235, (ii)&#160;life, accidental death and dismemberment insurance
                                            in the amount of $275, and (iii)&#160;401k match in the amount of $6,451, paid by us on Mr.&#160;Sullivan&#8217;s
                                            behalf. The amount for 2024 represents personal benefits consisting of (i)&#160;health, dental
                                            and vision insurance in the amount of $9,805, (ii)&#160;life, accidental death and dismemberment
                                            insurance in the amount of $120, and (iii)&#160;401k match in the amount of $6,562, paid
                                            by us on Mr.&#160;Sullivan&#8217;s behalf.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025
Outstanding Equity Awards at Fiscal Year Ended</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information with respect to grants of plan-based awards for the fiscal year ended March 31, 2025 to
our Named Executive Officers. Except as set forth below, all of the outstanding equity awards granted to our Named Executive Officers
were fully vested as of March 31, 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="18" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Option
    awards</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Stock
    awards</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Name</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Number
    of securities underlying unexercised options (#) exercisable</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Number
    of securities underlying unexercised options (#) unexercisable</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Equity
    incentive plan awards: Number of securities underlying unexercised unearned options (#)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Option
    exercise price ($)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Option
    expiration date</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Number&#160;of
    shares or units of stock that have not vested (#)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Market
    value of shares&#160;of units of stock&#160; that have not vested ($)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Equity
    incentive plan awards: Number&#160;of unearned shares, units or other rights that have not vested (#)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Equity
    incentive plan awards: Market&#160;or payout value&#160;of unearned shares, units or other rights&#160;that have&#160;not vested
    ($)<sup>(6)</sup></b></span></td><td style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font: bold 9pt Times New Roman, Times, Serif; text-align: left; width: 19%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Robert&#160;
    Ellin</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">666,666</span></td><td style="white-space: nowrap; font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>(1)</sup>&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4.00</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9/7/2027</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="white-space: nowrap; font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="white-space: nowrap; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">88,660</span></td><td style="white-space: nowrap; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>(2)</sup>&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">61,973</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font: bold 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ryan
    Carhart</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="white-space: nowrap; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">100,000</span></td><td style="white-space: nowrap; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><sup>(3)(4)</sup>&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">69,900</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="white-space: nowrap; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="white-space: nowrap; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font: bold 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Aaron
    Sullivan</b><sup>(5)</sup></span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="white-space: nowrap; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="white-space: nowrap; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            666,666 stock options granted on September&#160;7, 2017, which have fully vested and are
                                            fully exercisable as of the date of this Proxy Statement.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            restricted stock units, with each vested restricted stock unit to be settled by issuance
                                            to Mr.&#160;Ellin of one share of our common stock, which shall one-time cliff vest on September&#160;20,
                                            2026.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            restricted stock units of our Company, with each vested restricted stock unit to be settled
                                            by issuance to Mr.&#160;Carhart of one share of our common stock, which restricted stock
                                            units shall vest as follows: (i)&#160;50% of such restricted stock units shall vest on September
                                            18, 2025 (the &#8220;Initial Vesting Date&#8221;), and (ii) the remaining 50% of such restricted
                                            stock units shall vest on September 18, 2026, in each case subject to Mr. Carhart&#8217;s
                                            continued employment by our Company on each applicable vesting date (except as provided herein).
                                            In the event of a Change of Control (as defined in Mr. Carhart&#8217;s employment offer letter),
                                            50% of any then unvested restricted stock units of our Company shall vest in full effective
                                            immediately prior to such event.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does
                                            not include 20,000 restricted stock units of PodcastOne granted to Mr.&#160;Carhart pursuant
                                            to his employment offer letter with our Company, which shall vest on the same schedule as
                                            set forth in footnote #3 above (except as provided herein). In the event of a Change of Control
                                            (as defined in Mr.&#160;Carhart&#8217;s employment offer letter), 50% of any then unvested
                                            restricted stock units of PodcastOne shall vest in full effective immediately prior to such
                                            event.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a result of Mr. Sullivan&#8217;s resignation from all of his positions with our Company effective
                                            as of February 19, 2025, Mr. Sullivan forfeited all of his unvested restricted stock units.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            market value of unearned restricted stock units is based on the price of $0.699, the closing
                                            price of our common stock on March&#160;31, 2025 (the last&#160;trading&#160;day of our 2025
                                            fiscal year, as required under the applicable rules).</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
in Control Provisions</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a more detailed description of the &#8220;change in control&#8221; provisions applicable to our Named Executive Officers under their
employment agreements, see &#8220;Named Executive Officer Employment Agreements&#8221; below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Named
Executive Officer Employment Agreements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
material terms of employment agreements with the Named Executive Officers previously entered into by our Company are described below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Robert
S.&#160;Ellin &#8212; </i></b>Mr.&#160;Ellin&#8217;s employment agreement expired on September&#160;7, 2023. We anticipate entering into
a new employment agreement with Mr.&#160;Ellin in the near future. A summary of the terms of Mr.&#160;Ellin&#8217;s last employment agreement
is set forth below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;7, 2017, we entered into an employment agreement with Mr.&#160;Ellin for an initial term of five&#160;years at an annual
salary of $650,000, which salary was lowered to $500,000 pursuant to Amendment No. 1 to Mr.&#160;Ellin&#8217;s employment agreement,
dated as of December&#160;14, 2017. Pursuant to Amendment No. 2 to Mr.&#160;Ellin&#8217;s employment agreement, dated as of February&#160;6,
2023 and effective as of September&#160;7, 2022, Mr.&#160;Ellin&#8217;s employment agreement was extended to September&#160;7, 2023.
On September&#160;7, 2017, in connection with his employment agreement, we entered into an option award agreement whereby we issued stock
options to purchase 1,166,667 shares of our common stock with an exercise price of $4.00 per share (the offering price of our public
offering completed in December&#160;2017) (the &#8220;Ellin Options&#8221;). The Ellin Options were granted pursuant to our 2016 Equity
Incentive Plan (as amended, the &#8220;2016 Plan&#8221;). The first tranche of 666,667 shares underlying the Ellin Options (the &#8220;Ellin
Service Options&#8221;) have fully vested and are fully exercisable as of the date of this Proxy Statement. The second tranche of 500,000
shares underlying the Ellin Options were forfeited as a result of certain non-performance vesting conditions for such grant having not
been met. From August&#160;2021 until December&#160;31, 2022, Mr.&#160;Ellin agreed to receive his monthly base salary in shares of common
stock or our restricted stock units. Effective as of January&#160;1, 2023, we resumed paying the monthly base salary of Mr.&#160;Ellin
in cash instead of shares of our restricted common stock or our restricted stock units.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Mr.&#160;Ellin&#8217;s employment is terminated by us &#8220;Without Cause&#8221; or by Mr.&#160;Ellin for &#8220;Good Reason&#8221;
(each as defined in his employment agreement, subject to our right to cure), he will be entitled to termination benefits, pursuant to
which (i)&#160;we will pay Mr.&#160;Ellin certain accrued obligations and prior year bonus amounts, if any; and (ii)&#160;subject to
timely execution and non-revocation of a release as provided in his employment agreement (v)&#160;we will be required to pay Mr.&#160;Ellin
a one-time payment of $10,000,000; (w)&#160;any unvested Other Equity Awards (as defined in his employment agreement) shall automatically
accelerate and become vested and exercisable for a period of twelve&#160;months from the termination date, but in all events no later
than the end of the applicable term for each such award; (x)&#160;the Ellin Service Options and any such accelerated Other Equity Awards
shall remain outstanding and be exercisable, to the extent applicable, for a period of twelve&#160;months from the later of the termination
date or the date the award first becomes vested and exercisable, but in all events no later than the applicable term for each such award;
(y)&#160;all restrictions on the Other Equity Awards shall automatically and immediately lapse; and (z)&#160;we will continue to cover
costs for Mr.&#160;Ellin&#8217;s and his dependents continued participation in our medical plans from the termination date through and
inclusive of the lesser of twelve&#160;months or the period through the date on which he obtains other coverage. Mr.&#160;Ellin&#8217;s
employment agreement contains covenants for the benefit of our Company relating to non-competition during the term of his employment
and protection of our confidential information, customary representations and warranties and indemnification obligations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ryan
Carhart &#8212; </i></b>On August 29, 2023 and effective as of September 18, 2023, we entered into an employment offer letter (the &#8220;RC
Employment Agreement&#8221;) with Mr. Carhart at an annual salary of $200,000. Pursuant to the RC Employment Agreement, Mr. Carhart is
eligible to earn an annual discretionary performance bonus for each whole or partial fiscal year of his employment period with our Company
as determined by our board of directors or our Compensation Committee in their sole and absolute discretion based on achieving certain
objectives to be established by our management. Mr. Carhart&#8217;s &#8220;target&#8221; performance bonus is 35% of his average annualized
base salary during the fiscal year for which the performance bonus is earned. Under the RC Employment Agreement, Mr. Carhart was also
granted: (i) 150,000 restricted stock units of our Company (the &#8220;Company RSUs&#8221;) and (ii) 30,000 restricted stock units of
PodcastOne (the &#8220;PodcastOne RSUs&#8221; and together with the Company RSUs, the &#8220;RSUs&#8221;). The Company RSUs were granted
pursuant to the 2016 Plan, and the PodcastOne RSUs were granted pursuant to PodcastOne&#8217;s 2022 Equity Incentive Plan. 33.3% of the
RSUs vested on September 18, 2024 (the &#8220;Initial Vesting Date&#8221;), and the remaining 33.3% of the RSUs shall vest in two equal
increments of one-third each on each of the first two anniversaries of the Initial Vesting Date with the last third vesting date being
September 18, 2026 (each a &#8220;Subsequent Vesting Date&#8221; and collectively with the Initial Vesting Date, the &#8220;Vesting Dates&#8221;),
subject to Mr. Carhart being continuously employed by and being in good standing with our Company and the RC Employment Agreement being
in effect, in each case through each applicable Vesting Date (except as provided below). Each vested Company RSU shall be settled by
delivery to Mr. Carhart of one share of our common stock promptly following the applicable Vesting Date. Each vested PodcastOne RSU shall
be settled by delivery to Mr. Carhart of one share of PodcastOne&#8217;s common stock promptly following the applicable Vesting Date
(except as provided below).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a Change of Control (as defined in the RC Employment Agreement), if Mr. Carhart remains employed by our Company through
the date of such Change of Control, 50% of then unvested RSUs shall vest in full effective immediately prior to such event. The RSUs
grants were evidenced by a standard form of the Company&#8217;s or PodcastOne&#8217;s restricted stock units award agreement, as applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Mr. Carhart&#8217;s employment is terminated by our Company without &#8220;Cause&#8221; (as defined in the RC Employment Agreement),
subject to our Company&#8217;s right to cure, he will be entitled to termination benefits, pursuant to which we will be obligated to
pay Mr. Carhart certain accrued obligations and to continue to pay Mr. Carhart his base salary for a period of 2 months from the effective
termination date. The foregoing termination benefits are subject to Mr. Carhart&#8217;s delivery to our Company of an executed release
of claims against it and its affiliates and subsidiaries and continued compliance with his confidentiality agreement with our Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Executive
Officers Salary Adjustments</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of August&#160;1, 2020, Mr.&#160;Ellin, desiring to continue to demonstrate confidence in our Company and to assist our then near
term objectives in light of the ongoing COVID-19 coronavirus pandemic, agreed to have 50% of his monthly base salary from August&#160;1,
2020 to August&#160;15, 2020, and 100% of his monthly base salary from August&#160;16, 2020 through December&#160;31, 2020 paid in equity
of our Company. Furthermore, effective as of May&#160;23, 2022, Mr.&#160;Ellin, desiring to continue to demonstrate confidence in our
Company and to assist our objective to achieve annual cost and expense reductions, agreed to continue to forego his monthly cash base
salary through December&#160;31, 2022 in exchange for equity of our Company that is anticipated to be awarded and vest in full in our
2025 fiscal year (unless Mr.&#160;Ellin defers such vesting date), and will vest, be calculated and issued subject to our board of directors&#8217;
approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025
and 2024 Fiscal Years Annual Bonus Plan</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of October&#160;1, 2023, we adopted the 2023 Annual Bonus Plan (the &#8220;ABP&#8221;), which was approved by our board of directors
effective as of such date. Any bonuses that may be earned under the ABP were solely for our fiscal years ended March 31, 2024 and 2025.
As of the date of this Proxy Statement, our board of directors has not renewed or extended the ABP to apply to future fiscal years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
bonuses that may be earned under the ABP shall be tied to the financial performance of our Company and the price of our common stock
for our applicable fiscal year. The ABP will be administered by a committee (the &#8220;ABP Committee&#8221;) currently consisting of
the following two persons: Robert Ellin, our Chief Executive Officer and Chairman of the Board, and Jay Krigsman, a director of our Company
(so long as he is serving as a director of our Company), with the former third member, Aaron Sullivan, our former Chief Financial Officer,
having resigned from all of his positions with our Company effective as of February 19, 2025. If for any reason any such ABP Committee
member shall be removed or is no longer serving on the ABP Committee, our board of directors shall appoint a replacement member of the
ABP Committee that will be an executive officer of our Company with direct ties to our operations or a member of our board of directors.
The ABP provides our employees and executive officers (the &#8220;Participants&#8221;) with the opportunity to earn annual incentive
compensation awards based upon the achievement of certain pre-determined performance measures during the applicable performance period.
Such performance measures may differ among Participants and awards, may be in terms of our Company-wide and/or individual objectives,
and may include a variety of quantitative and/or qualitative metrics as set forth in the ABP and as determined by the ABP Committee,
which may include, among others, our revenue, adjusted EBITDA, stock price and the achievement of such other Company key operating metrics
and such other objectives as the ABP Committee determines, each with a specified weighting as determined by the ABP Committee based on
the recommendation of our Chief Executive Officer, subject to our board of directors&#8217; or our Compensation Committee&#8217;s final
approval of the applicable performance goals for our Company for each applicable fiscal year, the cash versus equity split of such awards
and the amount of any such awards. All incentive awards payable under the ABP will be paid in cash or in the form of equity issued by
our Company under our 2016 Plan, or both.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ABP Committee will have the discretion to increase, reduce, or eliminate an incentive award that would otherwise be payable to one or
more Participants on the basis of the certified level of attained performance. Unless the ABP Committee determines otherwise and subject
to certain exceptions, no Participant will have any right to receive payment of an award under the ABP for a performance period unless
the Participant remains employed with our Company through the last business&#160;day of the applicable fiscal year, unless otherwise
provided in such Participant&#8217;s agreement with us. Awards under the APB may be granted to Participants selected by the ABP Committee
in its sole discretion; provided that our Chief Executive Officer and Chief Financial Officer shall be mandatory Participants under the
ABP.&#160;The ABP Committee may at any time amend, suspend or terminate the ABP, and subject to the approval of the Board. The ABP contains
target and maximum potential payouts, which are based on our Company reaching certain predetermined performance targets and will be in
the form of cash and equity of our Company, and the applicable performance measures for the applicable fiscal&#160;years ending March&#160;31,
2024 and 2025 (the &#8220;Fiscal&#160;Years&#8221;), and which targets may be adjusted based on individual objectives. The ABP further
provides that in no event shall the actual bonuses payable under the ABP to all Participants for the applicable Fiscal Year exceed in
the aggregate the dollar amount provided in the ABP, as may be subsequently adjusted by its terms.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Narrative
Disclosure of Compensation Policies and Practices as They Relate to the Company&#8217;s Risk Management</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our compensation policies and practices for all employees and other individual service providers, including executive officers,
do not create risks that are reasonably likely to have a material adverse effect on us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_PvpTableTextBlock-c0_cont_1" escape="true" name="ecd:PvpTableTextBlock" id="ixv-7025"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PAY
VERSUS PERFORMANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Introduction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a disclosure pursuant to the SEC&#8217;s new pay versus performance (&#8220;PVP&#8221;) rules. The PVP rules create a new
definition of pay, referred to as Compensation Actually Paid (&#8220;CAP&#8221;), which is compared to certain performance measures as
defined by the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Compensation Table Versus Compensation Actually Paid</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2025 Summary Compensation Table (&#8220;SCT&#8221;) set forth above discloses a mix of compensation earned during the year, e.g., base
salary and annual cash incentive, and the full grant date fair value of equity awards granted during the year. The new CAP definition
of pay adjusts compensation reported for a particular year to reflect an annualized value of compensation by removing the values mandated
by the SCT for equity awards granted during the year and instead including the value of equity awards vesting during the year and the
potential change in value of unvested equity awards granted in prior&#160;years. It is important to note that the executive did not actually
earn or receive the amount defined as CAP in the applicable year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pay
Versus Performance Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the SCT compensation and CAP for our principal executive officer (&#8220;PEO&#8221;) and the average for our
non-PEO Named Executive Officers (&#8220;NEOs&#8221;) for our 2025, 2024 and 2023 fiscal&#160;years. In accordance with the PVP rules,
the table also includes certain prescribed performance related measures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal Year</b></span></p></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary <br/> Compensation <br/> Table Total <br/> Compensation <br/> for PEO<sup>(4)</sup>&#160;<br/> ($)</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average <br/> Summary <br/> Compensation <br/> Table Total <br/> Compensation <br/> for Non-PEO <br/> NEOs<sup>(4)</sup> <br/> ($)</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation <br/> Actually&#160;Paid&#160;to <br/> PEO<sup>(5)</sup> <br/> ($)</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average <br/> Compensation <br/> Actually <br/> Paid to <br/> Non-PEO <br/> NEOs<sup>(5)</sup> <br/> ($)</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value of <br/> Initial <br/> Fixed $100 <br/> Investment <br/> Based on <br/> Total <br/> Shareholder <br/> Return <br/> ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">GAAP <br/> Net Loss <br/> (in&#160;thousands) <br/> ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b><sup>(1)</sup></span></td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_4_fact" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd">558,584</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_5_fact" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd">618,855</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_6_fact" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd">558,584</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_7_fact" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd">166,169</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" id="ix_19_fact" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd">17.48</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">20,370</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b><sup>(2)</sup></span></td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" id="ix_8_fact" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd">547,032</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" id="ix_9_fact" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd">809,237</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" id="ix_10_fact" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd">547,032</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" id="ix_11_fact" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd">438,236</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" id="ix_20_fact" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd">44.93</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">11,966</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b><sup>(3)</sup></span></td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" id="ix_12_fact" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd">552,360</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" id="ix_13_fact" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd">247,314</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" id="ix_14_fact" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd">182,680</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" id="ix_15_fact" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd">230,395</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" id="ix_21_fact" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd">26.57</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" id="ix_3_fact" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,019</ix:nonFraction></td><td style="text-align: left">)</td></tr> </table></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_2" id="_PvpTableTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_NamedExecutiveOfficersFnTextBlock-c0_cont_1" escape="true" name="ecd:NamedExecutiveOfficersFnTextBlock" id="ixv-7227"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><ix:footnote id="ix_0_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2025 fiscal year, <ix:nonNumeric contextRef="c0" name="ecd:PeoName" id="ixv-8520">Robert S.&#160;Ellin</ix:nonNumeric> was our Chief Executive Officer and our remaining NEOs consisted of Ryan Carhart, our Chief
Financial Officer, and Aaron Sullivan, our former Chief Financial Officer. We did not have any other NEOs for such fiscal year.</span></ix:footnote></td>
</tr></table></ix:nonNumeric>

<ix:continuation continuedAt="_NamedExecutiveOfficersFnTextBlock-c0_cont_2" id="_NamedExecutiveOfficersFnTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2024 fiscal year, <ix:nonNumeric contextRef="c1" name="ecd:PeoName" id="ixv-8521">Robert S.&#160;Ellin</ix:nonNumeric> was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer. We did not have any other NEOs for such fiscal year.</span></ix:footnote></td>
</tr></table></ix:continuation>

<ix:continuation id="_NamedExecutiveOfficersFnTextBlock-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><ix:footnote id="ix_2_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2023 fiscal year, <ix:nonNumeric contextRef="c2" name="ecd:PeoName" id="ixv-8522">Robert S. Ellin</ix:nonNumeric> was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer and Dermot McCormack, our former President.</span></ix:footnote></td>
</tr></table></ix:continuation>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
in this column represent the &#8220;Total&#8221; column set forth in the 2025 Summary Compensation Table on page 34. See the footnotes
to the 2025 Summary Compensation Table for further detail regarding the amounts in these columns.</span></ix:footnote></td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="text-align: justify"><ix:footnote continuedAt="ix_4_footnote_cont_1" id="ix_4_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
dollar amounts reported in these columns represent the amounts of &#8220;compensation actually paid.&#8221; The amounts are computed
in accordance with Item&#160;402(v)&#160;of Regulation&#160;S-K by deducting and adding the following amounts from the &#8220;Total&#8221;
column of the 2025 Summary Compensation Table (pursuant to SEC rules, fair value at each measurement date is computed in a manner consistent
with the fair value methodology used to account for share-based payments in our financial statements under GAAP):</span></ix:footnote></td>
</tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_3" id="_PvpTableTextBlock-c0_cont_2"><ix:continuation continuedAt="ix_4_footnote_cont_2" id="ix_4_footnote_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides additional information on how CAP for each reporting year was determined, starting with SCT compensation, and
applying each of the required adjustments, as applicable, in accordance with the PVP rules.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="ix_4_footnote_cont_3" id="ix_4_footnote_cont_2"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Fiscal Year</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Summary <br/> Compensation <br/> Table&#160;Total <br/> Compensation <br/> ($)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value&#160;of <br/> Equity <br/> Awards <br/> Deducted <br/> from&#160;SCT <br/> ($)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair&#160;Value&#160;of <br/> Equity&#160;Awards <br/> Compensation <br/> Granted&#160;in <br/> Current&#160;Year <br/> ($)<sup>(1)</sup></b></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year-Over-Year <br/> Change&#160;in <br/> Fair&#160;Value&#160;of <br/> Unvested<br/> Equity&#160;Awards <br/> ($)<sup>(2)</sup></b></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year-Over-Year <br/> Change&#160;in <br/> Fair&#160;Value&#160;of <br/> Equity&#160;Awards <br/> that&#160;Vested <br/> During&#160;the&#160;Year <br/> ($)<sup>(3)</sup></b></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Compensation <br/> Actually&#160;Paid <br/> ($)</td><td style="font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold">PEO</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold; text-align: left">2025</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-8523">558,584</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-1">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-2">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-3">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-4">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-8524">558,584</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-8525">547,032</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-5">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-6">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-7">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-8">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-8526">547,032</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2023</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-8527">552,360</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-8528">552,360</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; font-weight: bold">Average&#160;Non-PEO&#160;NEOs</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2025</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-8529">618,855</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-8530">335,230</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" id="ix_16_fact" name="ecd:AdjToCompAmt" scale="0" unitRef="usd">218,750</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" id="ix_25_fact" name="ecd:AdjToCompAmt" scale="0" unitRef="usd">0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" id="ix_0_fact" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd">336,206</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-8534">166,123</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-8535">809,237</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-8536">530,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" id="ix_17_fact" name="ecd:AdjToCompAmt" scale="0" unitRef="usd">152,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" id="ix_26_fact" name="ecd:AdjToCompAmt" scale="0" unitRef="usd">0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" id="ix_22_fact" name="ecd:AdjToCompAmt" scale="0" unitRef="usd">6,999</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-8540">438,236</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2023</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-8541">285,654</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-8542">33,838</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" id="ix_18_fact" name="ecd:AdjToCompAmt" scale="0" unitRef="usd">85,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" id="ix_23_fact" name="ecd:AdjToCompAmt" scale="0" unitRef="usd">3,191</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" id="ix_24_fact" name="ecd:AdjToCompAmt" scale="0" unitRef="usd">4,666</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-8546">230,395</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr> </table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><ix:continuation id="_PvpTableTextBlock-c0_cont_3"><ix:continuation continuedAt="ix_4_footnote_cont_4" id="ix_4_footnote_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><ix:footnote id="ix_5_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the fair value as of the indicated fiscal year-end of the outstanding and unvested equity awards granted during such
fiscal year, calculated in accordance with the methodology used for financial reporting purposes. The fair value differs from the value
in the SCT because for&#160;purposes of CAP the fair value for equity awards granted in the current year is determined as of the last&#160;day
of the applicable year. Fair values in the SCT are determined as of the grant date.</span></ix:footnote></td>
</tr></table></ix:continuation>

<ix:continuation continuedAt="ix_4_footnote_cont_5" id="ix_4_footnote_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><ix:footnote id="ix_6_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the change in fair value during the indicated fiscal year of each equity award that was granted in a prior fiscal year
and that remained outstanding and unvested as of the last&#160;day of the indicated fiscal year, calculated in accordance with the methodology
used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on an estimate of the probable
outcome of such performance-based vesting conditions as of the last&#160;day of the fiscal year.</span></ix:footnote></td>
</tr></table></ix:continuation>

<ix:continuation id="ix_4_footnote_cont_5"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><ix:footnote id="ix_7_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the change in fair value, measured from the prior fiscal year-end to the vesting date, of each equity award that was
granted in a prior fiscal year and which vested during the indicated fiscal year, calculated in accordance with the methodology used
for financial reporting purposes.</span></ix:footnote></td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Analysis
of Information Presented in the Pay versus Performance Table</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive compensation program reflects a variable pay-for-performance philosophy. While we utilize several performance measures to align
executive compensation with our performance, all of those measures are not presented in the PVP table. Moreover, we generally seek to
incentivize long-term performance, and therefore do not specifically align our performance measures with CAP (as computed in accordance
with SEC rules) for a particular year. In accordance with SEC rules, we are providing the following narrative disclosure regarding the
relationships between information presented in the PVP table.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Relationship
between CAP and TSR</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the 2025, 2024 and 2023 fiscal&#160;years, compensation actually paid to our PEO decreased from $552,360 in fiscal 2023 to $547,032 in
fiscal 2024 and increased from $547,032 in fiscal 2024 to $558,584 in fiscal 2025. Average compensation actually paid to our Non-PEO
NEOs increased from $230,395 in fiscal 2023 to $438,236 in fiscal 2024 and decreased from $438,236 in fiscal 2024 to $166,123 in fiscal
2025. Over the same period, the value of an investment of $100 in our common stock on the last&#160;trading&#160;day of 2023 increased
by $18.36 to $44.93 during fiscal 2024 and decreased by $27.45 to $17.48 during fiscal 2025, for a total decrease over fiscal 2023 to
2025 of $9.09.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Relationship
between CAP and Net Loss (GAAP )</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the 2025, 2024 and 2023 fiscal&#160;years, compensation actually paid to our PEO decreased from $552,360 in fiscal 2023 to $547,032 in
fiscal 2024 and increased from $547,032 in fiscal 2024 to $558,854 in fiscal 2025. Average compensation actually paid to our Non-PEO
NEOs increased from $230,395 in fiscal 2023 to $438,236 in fiscal 2024 and decreased from $438,236 in fiscal 2024 to $166,123 in fiscal
2025. Over the same period, our net loss decreased by $33,983,000 during fiscal 2023, from a net loss in fiscal 2022 of $43,912,000 to
a net loss in fiscal 2023 of $10,019,000, increased by $1,947,000 during fiscal 2024, from a net loss in fiscal 2023 of $10,019,000 to
a net loss in fiscal 2024 of $11,966,000, and increased by $5,715 during fiscal 2025, from a net loss in fiscal 2024 of $11,966,000 to
a net loss in fiscal 2025 of $20,370.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2016
Equity Incentive Plan</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in">The following summary of the principal features of the 2016 Plan is
qualified in its entirety by reference to the full text of the 2016 Plan, which is incorporated by reference as Exhibit 10.2 to our Annual
Report on Form&#160;10-K for the fiscal year ended March 31, 2025, filed with the SEC on July [&#9679;], 2025 (the &#8220;2025 Annual
Report&#8221;), Amendment No. 1 to the 2016 Plan, which is incorporated by reference as Exhibit 10.3 to the 2025 Annual Report, and Amendment
No. 2 to the 2016 Plan, which is incorporated by reference as Exhibit 10.4 to the 2025 Annual Report. Pursuant to the 2016 Plan, there
are 17,600,000 shares of our common stock reserved for future issuance to our employees, directors and consultants. As described below,
incentive awards authorized under the 2016 Plan include, but are not limited to, incentive stock options within the meaning of Section&#160;422
of the Code. If an incentive award granted under the 2016 Plan expires, terminates, is unexercised or is forfeited, or if any shares are
surrendered to us in connection with the exercise of an incentive award, the shares subject to such award and the surrendered shares will
become available for further awards under the 2016 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Administration&#160;&#8212;&#160;</i>The
2016 Plan is administered by our Compensation Committee or our board of directors in the absence of such a committee. Subject to the
terms of the 2016 Plan, the 2016 Plan administrator may select participants to receive awards, determine fair market value of our shares,
determine the types of awards and terms and conditions of awards and interpret provisions of the 2016 Plan, to institute an exchange
program (without stockholder approval) pursuant to which outstanding awards may be surrendered or cancelled in exchange for awards of
the same type (which may have lower exercise prices and different terms), awards of a different type, and/or cash (except that the 2016
Plan administrator may not, without stockholder approval, reprice any options or stock appreciation rights (&#8220;SARs&#8221;), or pay
cash or issue new options or SARs in exchange for the surrender and cancellation of outstanding options or SARs), modify awards granted
under the 2016 Plan, and make all other determinations deemed necessary or advisable for administering the 2016 Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Grants&#160;&#8212;</i>&#160;The
2016 Plan authorizes the grant to participants of nonqualified stock options, incentive stock options, restricted stock awards, restricted
stock units, performance grants intended to comply with Section&#160;162(m)&#160;of the Code and SARs, as described below:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
                                            granted under the 2016 Plan entitle the grantee, upon exercise, to purchase up to a specified
                                            number of shares from us at a specified exercise price per share. The exercise price for
                                            shares of common stock covered by an option generally cannot be less than the fair market
                                            value of common stock on the date of grant unless agreed to otherwise at the time of the
                                            grant. In addition, in the case of an incentive stock option granted to an employee who,
                                            at the time the incentive stock option is granted, owns stock representing more than 10%
                                            of the voting power of all classes of stock of our Company or any parent or subsidiary, the
                                            per share exercise price will be no less than 110% of the fair market value of our common
                                            stock on the date of grant.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
                                            stock awards and restricted stock units may be awarded on terms and conditions established
                                            by the Compensation Committee or our board of directors, which may include performance conditions
                                            for restricted stock awards and the lapse of restrictions on the achievement of one or more
                                            performance goals for restricted stock units.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Compensation Committee or our board of directors may make performance grants, each of which
                                            will contain performance goals for the award, including the performance criteria, the target
                                            and maximum amounts payable, and other terms and conditions.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            2016 Plan authorizes the granting of stock awards. The Compensation Committee or our board
                                            of directors will establish the number of shares of our common stock to be awarded (subject
                                            to the aggregate limit established under the 2016 Plan upon the number of shares of our common
                                            stock that may be awarded or sold under the 2016 Plan) and the terms applicable to each award,
                                            including performance restrictions.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
                                            entitle the participant to receive a distribution in an amount not to exceed the number of
                                            shares of our common stock subject to the portion of the SAR exercised multiplied by the
                                            difference between the market price of a share of our common stock on the date of exercise
                                            of the SAR and the market price of a share of our common stock on the date of grant of the
                                            SAR.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-Transferability
of Awards&#160;&#8212;</i>&#160;Unless the 2016 Plan administrator provides otherwise, the 2016 Plan generally does not allow for the
transfer of awards and only the recipient of an award may exercise an award during his or her lifetime.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Certain
Adjustments&#160;&#8212;</i>&#160;In the event of certain changes in our capitalization, to prevent diminution or enlargement of the
benefits or potential benefits available under the 2016 Plan, the 2016 Plan administrator will adjust the number and class of shares
that may be delivered under the 2016 Plan and/or the number, class and price of shares covered by each outstanding award, and the numerical
share limits set forth in the 2016 Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dissolution,
Liquidation&#160;&#8212;</i>&#160;The 2016 Plan provides that in the event of a proposed dissolution or liquidation of our Company, to
the extent it has not been previously exercised, an award will terminate immediately prior to the consummation of such proposed action.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends
or Dividend Equivalents for Performance Awards.&#160;</i>Notwithstanding anything to the foregoing herein, the right to receive dividends,
dividend equivalents or distributions with respect to a performance award will only be granted to a participant if and to the extent
that the underlying award is earned.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Merger,
Change of Control&#160;&#8212;</i>&#160;The 2016 Plan provides that in the event of a merger or a change of control, as defined under
the 2016 Plan, each outstanding award will be treated as the 2016 Plan administrator determines, including, without limitation, that
each award will be assumed or an equivalent option or right substituted by the successor corporation or a parent or subsidiary of the
successor corporation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Duration,
Amendment, and Termination&#160;&#8212;</i>&#160;Our board of directors has the power to amend, suspend or terminate the 2016 Plan without
stockholder approval or ratification at any time or from time to time. No change may be made that increases the total number of shares
of our common stock reserved for issuance pursuant to incentive awards or reduces the minimum exercise price for options or exchange
of options for other incentive awards, unless such change is authorized by our stockholders within one year of such change. Unless sooner
terminated, the 2016 Plan would terminate ten&#160;years after it was adopted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compliance
with Section&#160;162(m)&#160;of the Code.&#160;</i>Section&#160;162(m)&#160;of the Code generally precludes a tax deduction by any publicly
held company for compensation paid to any &#8220;covered employee&#8221; to the extent the compensation paid to such covered employee
exceeds $1&#160;million during any taxable year of the company. The Tax Cuts and Jobs Act&#160;of&#160;2017 (the &#8220;2017 Tax Act&#8221;)
included changes to Section&#160;162(m)&#160;effective for&#160;years after 2017. Prior to 2018, &#8220;covered employees&#8221; included
the Chief Executive Officer of the Company and the three other highest paid officers of the Company (other than the Chief Financial Officer).
For 2018 and later&#160;years, &#8220;covered employees&#8221; will include the Chief Executive Officer of the Company, the Chief Financial
Officer of the Company, the three highest paid officers of the Company (other than the Chief Executive Officer and the Chief Financial
Officer) and any employee who qualified as a &#8220;covered employee&#8221; for any tax year beginning after 2016. For&#160;years beginning
prior to January&#160;1, 2018, the $1&#160;million deduction limit did not apply to &#8220;qualified performance-based compensation&#8221;
that was based on the attainment of pre-established, objective performance goals established under a stockholder-approved plan. Effective
for the&#160;years beginning on or after January&#160;1, 2018, there is no exception for &#8220;qualified performance-based compensation&#8221;;
but a transition rule provides that the &#8220;qualified performance-based compensation&#8221; exemption will continue to apply to grandfathered
arrangements made pursuant to a binding contract in effect on or before November&#160;2, 2017 that is not materially modified thereafter.
We believe that it is important to preserve flexibility in administering compensation programs to promote various corporate goals. Accordingly,
we have not adopted a policy that all compensation must qualify as deductible under Section&#160;162(m). Amounts paid under our compensation
programs may not be deductible as the result of Section&#160;162(m). While our policy has generally been to preserve corporate tax deductions
by qualifying compensation over $1&#160;million paid to executive officers as performance-based, the Compensation Committees may, from
time to time, conclude that compensation arrangements are in our best interests and the best interests of our stockholders despite the
fact that such arrangements may not, in whole or part, qualify for tax deductibility. Going forward, we intend to continue to design
our executive compensation arrangements to be consistent with our best interests and those of our stockholders; accordingly, the Compensation
Committees, while considering the tax deductibility as a factor in determining executive compensation, may not limit such compensation
to those levels that will be deductible, particularly in light of the elimination of the expansion of the covered employee group and
the elimination of the exception for performance-based compensation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Forfeiture
Provisions.&#160;</i>The 2016 Plan administrator may provide by rule or regulation or in any award agreement, or may determine in any
individual case, the circumstances in which awards shall be paid or forfeited in the event a participant ceases to be employed by us,
or to provide services to us, prior to the end of a performance period, period of restriction or the exercise, vesting or settlement
of such award. Except as set forth for options, generally awards will be forfeited if not earned or vested upon termination, unless otherwise
provided for in an award agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Adjustments
for Stock Dividends and Similar Events.&#160;</i>The 2016 Plan administrator will make appropriate adjustments in outstanding awards
and the number of shares of common stock available for issuance under the 2016 Plan, including the individual limitations on awards,
to reflect dividends, splits, extraordinary cash dividends and other similar events.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Compensation Plan Information</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the number of shares of our common stock issuable upon the exercise of awards granted under our equity compensation
plans approved and not approved by shareholders and the weighted average exercise price for such awards as of March 31, 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Name of Plan</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number&#160;of <br/> shares&#160;of <br/> common <br/> stock&#160;to&#160;be <br/> issued&#160;upon <br/> exercise&#160;of <br/> outstanding <br/> options, <br/> warrants&#160;and <br/> rights</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price&#160;of <br/> Outstanding <br/> Options <br/> ($)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number&#160;of <br/> shares <br/> remaining <br/> available&#160;for <br/> issuance <br/> under&#160;equity <br/> compensations <br/> plans&#160;(excluding <br/> the&#160;shares <br/> reflected&#160;in <br/> column<sup>(1)</sup></b></span></td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation plans approved by security holders<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,875,984</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3.72</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,329,285</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Equity compensation plans not approved by security holders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,875,984</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3.72</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,329,285</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 0in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
securities issued under our 2016 Plan.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August&#160;29, 2016, our board of directors approved and adopted and our shareholders approved the 2016 Plan, as amended on February&#160;11,
2019 and June&#160;29, 2021. The 2016 Plan provides for the grant of incentive stock options, qualified stock options, restricted stock
awards, restricted stock units, stock appreciation rights, and performance shares or units and cash awards. Awards may be granted under
the 2016 Plan to our employees, officers, directors and consultants.</span></p><div>


</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="l_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following includes a summary of transactions since April&#160;1, 2024 to which we have been a party, in which the amount involved in
the transaction exceeded $120,000 (which was less than 1% of the average of our total assets at year-end for our last two completed fiscal&#160;years),
and in which any of our directors, executive officers or, to our knowledge, beneficial owners of more than 5% of our capital stock or
any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest, other than
equity and other compensation, termination, change in control and other arrangements, which are described in this Proxy Statement below
under the section captioned &#8220;Executive Compensation.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Issued to Related Parties</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March&#160;31, 2022, we had outstanding notes in aggregate principal amount of $5,879,000 payable to Trinad Capital, a fund wholly
owned by Mr.&#160;Ellin, our Chief Executive Officer, Chairman, director and principal stockholder, for both short- and long-term working
capital requirements (the &#8220;Trinad Notes&#8221;) issued to Trinad Capital as more fully discussed below. The Trinad Notes were convertible
into shares of our common stock at a fixed conversion price of $3.00 per share.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
first Trinad Note was issued on February&#160;21, 2017, to convert aggregate principal and interest of $3.6&#160;million under the first
senior promissory note and second senior promissory note with Trinad Capital previously issued on December&#160;31, 2014 and April&#160;8,
2015, respectively. The first Trinad Note was due on March&#160;31, 2018 and was extended to May&#160;31, 2019 and further extended to
May&#160;31, 2021 (as discussed below). At March&#160;31, 2021, the balance due of $4.4&#160;million, which included $1.0&#160;million
of accrued interest, was outstanding under the first Trinad Note. At March&#160;31, 2021, the balance due of $4.1&#160;million, which
included $0.5&#160;million of accrued interest, was outstanding under the first Trinad Note. Between October&#160;27, 2017 and December&#160;18,
2017, we issued six unsecured convertible notes payable to Trinad Capital for aggregate total principal amount of $0.9&#160;million.
The notes were due on various dates through December&#160;31, 2018 and were extended to May&#160;31, 2019 and further extended to May&#160;31,
2022 (as discussed below). For the year ended March&#160;31, 2021, we amortized less than $0.1&#160;million of discount to interest expense,
and the unamortized discount was fully amortized as of March&#160;31, 2021. As of March&#160;31, 2021, $0.1&#160;million of accrued interest
was added to the principal balance.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January&#160;11, 2021, we entered into an Amendment of Notes Agreement with Trinad Capital pursuant to which the maturity date of all
of the Trinad Notes was extended to May&#160;31, 2022, and in consideration of such extension, the interest rate payable under such notes
increased to 8.5%, and in consideration of such extension, we issued to Trinad Capital 280,000 shares of our common stock. On August&#160;11,
2021, we entered into another Amendment of Notes Agreement with Trinad Capital pursuant to which the maturity date of all of the Trinad
Notes was extended to May&#160;31, 2023, and in consideration of such extension, we issued to Trinad Capital 33,654 shares of our common
stock. Effective as of July&#160;8, 2022, we entered into an Amendment of Notes Agreement with Trinad Capital pursuant to which the maturity
date of all of the Trinad Notes was extended to July&#160;1, 2024, and in consideration of such extension, we issued to Trinad Capital
500,000 shares of our common stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February&#160;3, 2023, we entered into an exchange agreement (collectively, the &#8220;Exchange Agreements&#8221;) with (i)&#160;Harvest
Small Cap Partners Master, Ltd. (&#8220;HSCPM&#8221;) in regard to that certain 8.5% Senior Secured Convertible Note in the aggregate
amount of $10,503,965 issued by us on September&#160;15, 2020, as amended on June&#160;3, 2021 and July&#160;6, 2022, to HSCPM (the &#8220;HSCPM
Note&#8221;), (ii)&#160;Harvest Small Cap Partners, L.P. (&#8220;HSCP&#8221;) in regard to that certain 8.5% Senior Secured Convertible
Note in the aggregate amount of $4,496,035 issued by us on September&#160;15, 2020, as amended on June&#160;3, 2021 and July&#160;6,
2022, to HSCP (the &#8220;HSCP Note&#8221;); and (iii)&#160;Trinad Capital (and collectively with HSCPM and HSCP, the &#8220;Holders&#8221;)
in regard to all promissory notes in the aggregate principal and interest amount of $6,177,218 issued by us to Trinad Capital (the &#8220;Trinad
Notes&#8221; and collectively with the HSCPM Note and the HSCP Note, the &#8220;Notes&#8221;). Pursuant to the Exchange Agreements, the
Holders exchanged the Notes, and with respect to Trinad Capital, together with interest, due and payable thereon, and relinquished any
and all rights thereunder, for 21,177 shares of our newly designated and issued Series&#160;A Perpetual Convertible Preferred Stock,
par value $0.001 per share (the &#8220;Series&#160;A Preferred Stock&#8221;), with a stated value of $1,000 per share (the &#8220;Stated
Value&#8221;), having the terms as set forth in our Certificate of Designation of Preferences, Rights and Limitations of Series&#160;A
Perpetual Convertible Preferred Stock (the &#8220;Certificate of Designation&#8221;) filed by us on February&#160;2, 2023 with the Secretary
of State of the State of Delaware.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"></p><div>

</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration for entry into the Exchange Agreements and the Holders&#8217; willingness to forego certain rights to our common stock
previously agreed by the parties, we issued to the Harvest Funds an aggregate of 600,000 shares of our common stock and to Trinad Capital
200,000 shares of our common stock. In connection with the entry of the Exchange Agreements, unless otherwise agreed to by the Harvest
Funds, Mr.&#160;Ellin agreed to (i)&#160;to serve as our Company&#8217;s Chief Executive Officer and (ii)&#160;extend the period during
which he cannot dispose of any equity or convertible securities of our Company owned by him or any entity of which he is the beneficial
owner and not to cease to be the beneficial owner of any other equity or convertible securities of our Company of which Mr.&#160;Ellin
is the beneficial owner (subject to certain exceptions), in each case until the time that the Harvest Funds no longer own any shares
of our Series&#160;A Preferred Stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April&#160;1, 2024, we entered into Letter Agreements (collectively, the &#8220;Agreements&#8221;) with the Holders. Pursuant to the
Agreements (i)&#160;the Holders converted approximately $11.4&#160;million worth of shares of our Series&#160;A Preferred Stock into
shares of our common stock, at a price of $2.10 per share, as follows: HSCPM converted 5,602.09 shares of Series&#160;A Preferred Stock
into 2,667,664 shares of our common stock, HSCP converted 2,397.91 shares of Series&#160;A Preferred Stock into 1,141,860 shares of our
common stock, and Trinad Capital converted 3,395.09 shares of Series&#160;A Preferred Stock into 1,616,709 shares of our common stock,
and (ii)&#160;HSCPM, HSCP and Trinad Capital received 910,340, 389,660 and 535,399 three-year warrants to purchase shares of our common
stock exercisable at a price of $2.10 per share. In addition, pursuant to the Agreements, HSCPM and HSCP agreed (x)&#160;that any future
dividends payable on our Series&#160;A Preferred Stock shall be paid in-kind or in cash at our option; provided, that as long as any
Series&#160;A Preferred Stock is held by HSCPM or HSCP, Trinad Capital shall receive the dividend solely in kind, (y)&#160;to remove
the requirement for us to purchase from HSCPM and HSCP $5,000,000 in aggregate of the then outstanding shares of our Series&#160;A Preferred
Stock held by HSCPM and HSCP on or before August&#160;3, 2024.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of July&#160;1, 2025, Trinad Capital holds 4,298.80 shares of our Series&#160;A Preferred Stock. From April 1, 2024 through July 1, 2025,
we issued 598.70 shares of our Series&#160;A Preferred Stock to Trinad Capital as dividend payments required by the terms of the Series&#160;A
Preferred Stock.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the&#160;years ended March 31, 2025 and 2024, we issued or reserved 102,359 and 123,425 shares of our common stock with a value of $0.2&#160;million
and $0.1&#160;million to relatives of our Chief Executive Officer for services performed, respectively.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of September&#160;2022, a subsidiary of our Company issued a promissory note in the amount of $0.3&#160;million in consideration of
a loan in the same amount made to such subsidiary, which loan matured on October&#160;17, 2022. The loan was made by an affiliate of
Robert Ellin, our Chief Executive Officer, Chairman, director and principal stockholder. The note was paid off in October&#160;2022 in
full.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the&#160;years ended March 31, 2025 and 2024, we participated in a production agreement for a podcast and related show with an affiliate
of Mr.&#160;Wachsberger, a director of our Company. We incurred cost of none and none for the&#160;years ended March&#160;31, 2025 and
2024, respectively, attributed to the arrangement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employment
Arrangements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relationships and related party transactions described herein are in addition to any employment arrangements with our executive officers
and directors, which are described in this Proxy Statement below under &#8220;Executive Compensation&#160;&#8212;&#160;Named Executive
Officer Employment Agreements.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification
Agreements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws provide that none of our officers or directors shall be personally liable for any obligations of our Company or for any duties
or obligations arising out of any acts or conduct of said officer or director performed for or on behalf of our Company, including without
limitation, acts of negligence or contributory negligence. In addition, our Bylaws provide that we shall indemnify and hold harmless
each person and their heirs and administrators who shall serve at any time hereafter as a director or officer of our Company from and
against any and all claims, judgments and liabilities to which such persons shall become subject by reason of their having heretofore
or hereafter been a director or officer of our Company, or by reason of any action alleged to have heretofore or hereafter taken or omitted
to have been taken by him or her as such director or officer, and that we shall reimburse each such person for all legal and other expenses
reasonably incurred by him or her in connection with any such claim, judgment or liability, including our power to defend such persons
from all suits or claims as provided for under the provisions of the DGCL; provided, however, that no such persons shall be indemnified
against, or be reimbursed for, any expense incurred in connection with any claim or liability arising out of his (or her) own willful
misconduct. In addition, we intend to enter into indemnification agreements with our directors and officers and some of our executives
may have certain indemnification rights arising under their employment agreements with us. We believe that these bylaw provisions and
indemnification agreements are necessary to attract and retain qualified persons as directors and officers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
limitation of liability and indemnification provisions in our Bylaws may discourage stockholders from bringing a lawsuit against our
directors for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against our directors and
officers, even though an action, if successful, might benefit us and our stockholders. A stockholder&#8217;s investment may be harmed
to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policies
and Procedures for Transactions with Related Persons</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to adopt a written Related-Person Transactions Policy that will set forth our policies and procedures regarding the identification,
review, consideration and oversight of &#8220;related-person transactions.&#8221; Our Audit Committee is charged with the responsibility
of reviewing, approving and overseeing all related-person transactions, as defined in the SEC regulations. This responsibility will be
set forth, in part, in our Related-Person Transactions Policy and is set forth in the Audit Committee Charter. Generally, this policy
will cover any transaction in which we were or will be a participant, the amount involved exceeds $120,000 and any &#8220;related person&#8221;
had, or will have, a direct or indirect material interest in the transaction. &#8220;Related person&#8221; includes, generally, any of
our (i)&#160;directors or executive officers, (ii)&#160;nominees for director, (iii)&#160;stockholders who beneficially own more than
5% of any class of our voting securities and (iv)&#160;family members of any of the persons set forth in (i)&#160;through (iii)&#160;above.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="l_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OTHER
INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deadline
for Submission of Stockholder Proposals and Nomination of Directors for Next Year&#8217;s Annual Meeting</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder
Proposals for the 2026 Annual Meeting</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may submit proposals for consideration at future stockholder meetings. For a stockholder proposal to be considered for inclusion in our
proxy materials for our 2026 Annual Meeting of Stockholders, the proposal must (i)&#160;be delivered to us no later than March 31, 2026
and (ii)&#160;comply with all applicable SEC rules and regulations, including Rule&#160;14a-8 of the Exchange&#160;Act. Any proposals
not received by this deadline will be untimely and not included in our 2026 proxy materials.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in">Alternatively, under our Bylaws, a stockholder may bring a proposal
before our 2026 Annual Meeting of Stockholders, without including the proposal in our proxy materials, if (i)&#160;the stockholder provides
us notice of the proposal between May&#160;11, 2026 and June&#160;10, 2026, and (ii)&#160;the proposal concerns a matter that may be properly
considered and acted upon at the annual meeting in accordance with our Bylaws and corporate governance policies. Any such proposal not
received by this deadline will be considered untimely and will not be considered at our 2026 Annual Meeting of Stockholders. Stockholders
are advised to review our Bylaws, which contain additional requirements with respect to advance notice of stockholder proposals. Our bylaws
are publicly available in the &#8220;SEC Filings&#8221; section of our investor relations/corporate governance website at <i>http://ir.liveone.com/ir-home</i>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposals
should be addressed to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LiveOne,
Inc.<br/>
269 South Beverly Drive, Suite 1450<br/>
Beverly Hills, CA&#160;90212<br/>
Attention: Office Manager</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nomination
of Directors for the 2026 Annual Meeting</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may propose a director nominee for consideration at the next annual meeting of our stockholders by complying with our Bylaws, which provide
for a notice that must (i)&#160;be delivered to us at our principal executive offices set forth immediately above no earlier than the
90<sup>th</sup>&#160;day prior to September 8, 2026 (the first anniversary of our 2025 Annual Meeting of Stockholders) and not later
than the 120<sup>th</sup>&#160;day prior to September 8, 2026 (the first anniversary of our 2025 Annual Meeting of Stockholders), (ii)&#160;provide
all information relating to the director nominee that is required to be disclosed in a solicitation of proxies for the election of directors
in an election contest, or that is otherwise required, in each case pursuant to Regulation&#160;14A under the Exchange&#160;Act, and
(iii)&#160;provide the director nominee&#8217;s written consent to serve as a director if elected. Stockholders are advised to review
our Bylaws with respect to director nominations. These documents are publicly available in the &#8220;SEC Filings&#8221; section of our
investor relations/corporate governance website at <i>http://ir.liveone.com/ir-home.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Participants
in the Solicitation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable regulations of the SEC, directors and certain officers of our Company may be deemed to be &#8220;participants&#8221; in the
solicitation of proxies by our board of directors in connection with the Annual Meeting.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expenses
of Solicitation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
costs of solicitations of proxies will be borne by us. In addition to solicitations by mail, our directors, officers and regular employees,
without additional remuneration, may solicit proxies by telephone, telecopy, e-mail, personal interviews, and other means. Brokers, custodians
and fiduciaries will be requested to forward proxy soliciting material to the owners of stock held in their names, and we will reimburse
them for their out-of-pocket expenses in connection therewith.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Annual
Report on Form&#160;10-K</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in">An electronic copy of our Annual Report on Form&#160;10-K for the year
ended March 31, 2025, as filed with the SEC on July [&#9679;], 2025 is available free of charge in the &#8220;SEC Filings&#8221; section
of our investor relations/corporate governance website at <i>http://ir.liveone.com/ir-home. </i>A paper copy of the Annual Report may
be obtained upon written request to: LiveOne, Inc., 269 South Beverly Drive, Suite 1450, Beverly Hills, CA&#160;90212, attention: Office
Manager. Exhibits will be provided upon written request and payment of an appropriate processing fee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Householding&#8221;
of Proxy Materials</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted rules that permit companies and intermediaries, such as brokers, banks and other nominees, to satisfy the delivery requirements
for proxy materials with respect to two or more stockholders sharing the same address by delivering a single copy of proxy materials,
other than the proxy card, to those stockholders. This process is commonly referred to as &#8220;householding.&#8221; Your nominee may
engage in householding. Through householding, beneficial owners who have the same address and last name will receive only one copy of
the proxy materials unless one or more of these owners notifies us or their nominee that they wish to continue receiving individual copies.
Beneficial owners who participate in householding will receive separate proxy cards. This procedure will reduce printing costs and postage
fees.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
commence or discontinue householding, please notify your broker, bank or other nominee. Alternatively, you may direct such requests in
writing to LiveOne, Inc., 269 South Beverly Drive, Suite 1450, Beverly Hills, CA&#160;90212, Attention: Office Manager, or by phone at
(310)&#160;601-2505. Individual copies of the proxy materials also may be requested at any time at this same address and telephone number.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Robert S.&#160;Ellin</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    S.&#160;Ellin</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beverly
    Hills, California <br/>
    July [&#9679;], 2025</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Annex
A</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF AMENDMENT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TO
THE</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF INCORPORATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OF</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LIVEONE,
INC.</b></span></p><div>

</div><p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LiveOne,
Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIRST:
That at a meeting of the Board of Directors of LiveOne, Inc., a Delaware corporation (the &#8220;Corporation&#8221;), resolutions were
duly adopted setting forth a proposed amendment to the Certificate of Incorporation of said corporation, declaring said amendment to
be advisable and calling a meeting of the stockholders of said corporation for consideration thereof. The resolution setting forth the
proposed amendment is as follows:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESOLVED,
that the Certificate of Incorporation of this corporation be amended to effect a one (1) for ____ (____) reverse stock split of all of
the Corporation&#8217;s issued and outstanding common stock, $0.001 par value per share (the &#8220;Common Stock&#8221;), whereby, automatically
upon the filing and effectiveness of this Certificate of Amendment pursuant to the General Corporation Law of the State of Delaware (the
&#8220;DGCL&#8221;), each ____ (____) issued and outstanding shares of Common Stock shall automatically be changed into one (1) validly
issued, fully paid and non-assessable share of Common Stock, and, in that connection, to reduce the stated capital of the Corporation.</span></p><div>

</div><p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to effectuate the amendment set forth above:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Upon the filing and effectiveness of this Certificate of Amendment pursuant to the DGCL, all of the Corporation&#8217;s issued and outstanding
shares of Common Stock, having a par value of $0.001 per share, shall be changed into new validly issued, fully paid and non-assessable
shares of Common Stock on the basis of one (1) new share of Common Stock for each ____ (____) shares of Common Stock issued and outstanding
as of the record date of selected for such change; provided, however, that no fractional shares of Common Stock shall be issued pursuant
to such change. Each stockholder who otherwise would be entitled to a fractional share as a result of such change shall have only a right
to receive, in lieu thereof, a whole new share of Common Stock at no additional cost;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Corporation&#8217;s 500,000,000 authorized shares of Common Stock, having a par value of $0.001 per share, shall not be changed;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Corporation&#8217;s 10,000,000 authorized shares of preferred stock, having a par value of $0.001 per share, shall not be changed;
and</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Corporation&#8217;s stated capital shall be reduced by an amount equal to the aggregate par value of the shares of Common Stock issued
prior to the effectiveness of this Certificate of Amendment which, as a result of the reverse stock split provided for herein, are no
longer issued shares of Common Stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECOND:
That thereafter, pursuant to resolution of its Board of Directors, an annual meeting of the stockholders of said corporation was duly
called and held upon notice in accordance with Section 222 of the General Corporation Law of the State of Delaware at which meeting the
necessary number of shares as required by statute were voted in favor of the amendment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIRD:
That said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of
Delaware.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOURTH:
This Certificate of Amendment to the Certificate of Incorporation shall be effective at ____ p.m., Eastern Time, on __________ ____,
____.</span></p><div>

</div><p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<i>Signature
page follows</i>]</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 54; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, said corporation has caused this Certificate of Amendment to be signed by this ____ day of _______, ____.</span></p><div>

</div><p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>LIVEONE, INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 35%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Name:&#160;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title:</span></td>
    <td>&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 55; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:DocumentType">PRE 14A</ix:nonNumeric>
<ix:nonFraction contextRef="c3" id="hidden-fact-1" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-2" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-3" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-4" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-5" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-6" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c10" id="hidden-fact-7" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-8" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-8558">0001491419</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-8559">false</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="lvo-20250908.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><ix:relationship xmlns="" fromRefs="ix_0_fact hidden-fact-4 hidden-fact-8 ix_22_fact ix_24_fact" toRefs="ix_7_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_1_fact ix_4_fact ix_5_fact ix_6_fact ix_7_fact ix_19_fact" toRefs="ix_0_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_2_fact ix_8_fact ix_9_fact ix_10_fact ix_11_fact ix_20_fact" toRefs="ix_1_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_3_fact ix_12_fact ix_13_fact ix_14_fact ix_15_fact ix_21_fact" toRefs="ix_2_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-2 hidden-fact-6 ix_16_fact ix_17_fact ix_18_fact" toRefs="ix_5_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-3 hidden-fact-7 ix_23_fact ix_25_fact ix_26_fact" toRefs="ix_6_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_4_fact ix_5_fact ix_8_fact ix_9_fact ix_12_fact ix_13_fact" toRefs="ix_3_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_6_fact ix_7_fact ix_10_fact ix_11_fact ix_14_fact ix_15_fact" toRefs="ix_4_footnote"/>
<xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:ValueOfEquityAwardsDeductedFromSCTMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">lvo:PEOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:ValueOfEquityAwardsDeductedFromSCTMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">lvo:PEOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">lvo:PEOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c14">
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZ7cK/v2ueV/4B0uxoMe+pKQp0EY9NNhkgK+JBfvn4FqT9xCfg4PmlpicZXEV65/omqQUJCtXDxzz/YYV6vtexWmtgAqQA1hARLtZWoAcGBw+CYyu6zS/RgxqhxZhAhxm/NIZZiL7PkLFtd+OBQ4HE9LNkr+cYQ6G+3zUeUZ2W/mRStDxT2c0fAncP7tU7psG45wG2R9o6kzezUrZEhWSMjbY/hNzTATbXaL3OjZV2C0MpelfwyyU4lNIctytIYmhI=] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">lvo:AverageNonPEONEOsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:ValueOfEquityAwardsDeductedFromSCTMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-01</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">lvo:AverageNonPEONEOsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:ValueOfEquityAwardsDeductedFromSCTMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">lvo:AverageNonPEONEOsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:ValueOfEquityAwardsDeductedFromSCTMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !. 4@# 2(  A$! Q$!_\0
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M<MO#<5AH5IHL]I);VU[>WJW,CZC:3SB=GO7C8*XCV(F%W9)^<_\ ASY\+?\
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M)?@SP_'>?!#0[N[CT3POXSUK0]*CNKIM25[FX2PL8%FN'4/-*'D8 MBO(?\
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MGZKHMU+,FGZA.UH\>H1"&Y$<C+(JE&_U*/\ @Z'_ .4(G[8O_73X'_\ J_\
MX8U_G<_\&^?[(/[/O[='_!3_ .$?[.7[3W@B?XA_"#Q5X*^,.KZWX7M_%'BK
MP?+=ZCX4^'.OZ_H5P-=\&:SH&OVXLM5L;:Y:&UU.&*Y$?DW230.\3 'Z/?\
M$93_ ,%6O^A._9/_ /#6^+__ )Y5?U@_\&VG_!7C]J+_ (*S^!?VK_$O[36D
M?"W2;_X*>+?A1H?A!?ACX:U;PW;SV?C;1O'%_K!UB+5?$/B!KN:.;PYIXLWA
MEMEB1[A720LC+ZK_ ,0L?_!#O_HT#5O_ !(C]I3_ .>U7Z.?L)_\$Q_V+/\
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M#TVVTRT>YD7XCQI)</!:QO.\<<4;2ERD4:$(O\['[8'_ "=I^U%_V<5\;?\
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MO8I(^.KNQ(%>GT44 ?S^_P#!T/\ \H1/VQ?^NGP/_P#5_P#PQK_,J_X)0_\
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M&I2=/%YIBG./LZ52C"=64<+0J."I8=2D\3B)*I.+Y:%-;/@3P+XJ^)7B[0_
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M[]FS_P!-_P 9:_77_@MI_P &\US_ ,%?OV@_A;\<(OVF(O@I'\-_A##\+?\
MA'I/AZ_B\ZHT7C#Q+XJ.L+?)X@T;[-O_ .$A^Q&U:*7'V19ED'FLM>Y_\$-/
M^")5Q_P1OTW]H[3YOCY'\<1\>[_X:7D;Q^"F\'#PX/A[;>,X&5E?6M9:_;5#
MXNSN#PI;K8 !7:9B #]Y]5TO3=<TS4M%UFPL]5T?5["\TO5=+U&WBN]/U+3=
M0MY+2_L+ZTG22"YL[RUEEM[JWF1XIX9'CD1D8@_X_?\ P<%_\$H-2_X)>_MJ
MZY9>"=(O%_9>^/$^L?$3]G_5O*EDL]!LYKQ)/$_PJNKW:8SJ?P_U*]CM]/25
MQ<7?A.\T"]D,MPUVZ_["=?FG_P %6_\ @F?\)O\ @JG^R;XD_9N^)%ZGA3Q!
M#J=AXO\ A3\4;;2(-7UGX:>/-*9D@U>SMWEM9;O2]7TV:\T+Q'I*7MM'J.F7
MK.7%Y96,T !_B9U_N_\ [*__ ";#^SC_ -D&^$'_ *KWP[7\.1_X,?;W _XS
M\M=QP/\ DB,Q&>YR/'&?Q('N<]?[R/A3X)/PT^%WPV^'+:A_:S> / /@[P2V
MJ^1]F_M,^%?#NG:$=0^S!Y!;_;#8?:?(#OY7F>7O;;D@'^&?^V!_R=I^U%_V
M<5\;?_5E^)J_L\\"?\'K][X)\#^#/!J?L"6E\OA+PGX<\,"]_P"%Z3P?;!H.
MCV>E?:A ?AY.81<?9/-$1FE,8<*9'(+']IOB#_P:)?\ !*;XE>/?&_Q&\1:_
M^UBGB#Q_XO\ $OC774T[XP>$+?3UUCQ5K-[KNIK8P3_"JZF@LUO;^<6T,US<
M2QP!$DGF=3(W(?\ $&[_ ,$CO^AA_:]_\/+X+_\ G1T ?EG_ ,1PU]_TCZM/
M_#]3?_.WHK]3/^(-W_@D=_T,/[7O_AY?!?\ \Z.B@#^KNBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _&[_@H+^R_P#'#XT_&/P_XG^&W@B;Q)H=
MCX$L-'N;Z/6-"T\1:C#J^KW4ML8=3U*SG8K!=02>8L;1G?M#[E8#X3_X=_\
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M/(P4&6:3=-,V7EE=R6/05^O< ^!G#/"*HX_-5#B3/H*,_K6,HK^S<'534O\
MA/RZK[2#E"27)BL:L17NE.G3H.W+]_PIX79'P][+%XZ,<YS6%I*OB:2>$PU3
M1WPF$FIQO&27+6Q'M:J:YH0HMZ,C01J$4!54 *!T"@ !5'\(& ,8QQQ[/HHK
@]N2L?IVP4444P"BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lvo-20250908.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Jul 03 20:00:41 UTC 2025 -->
<xs:schema elementFormDefault="qualified" targetNamespace="http://www.liveone.com/20250908" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://xbrl.us/us-types/2009-01-31" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:lvo="http://www.liveone.com/20250908" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="lvo-20250908_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="lvo-20250908_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="lvo-20250908_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:element name="AverageNonPEONEOsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_AverageNonPEONEOsMember"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZ7cK/v2ueV/4B0uxoMe+pKQp0EY9NNhkgK+JBfvn4FqT9xCfg4PmlpicZXEV65/omqQUJCtXDxzz/YYV6vtexWmtgAqQA1hARLtZWoAcGBw+CYyu6zS/RgxqhxZhAhxm/NIZZiL7PkLFtd+OBQ4HE9LNkr+cYQ6G+3zUeUZ2W/mRStDxT2c0fAncP7tU7psG45wG2R9o6kzezUrZEhWSMjbY/hNzTATbXaL3OjZV2C0JZJGWcueia//lK3Qnrqt5o=] CSR-->
  <xs:element name="EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember"/>
  <xs:element name="EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember"/>
  <xs:element name="EquityAwardsAdjustmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_EquityAwardsAdjustmentsMember"/>
  <xs:element name="EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember"/>
  <xs:element name="EquityAwardsValueInCompensationTableForTheApplicableYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_EquityAwardsValueInCompensationTableForTheApplicableYearMember"/>
  <xs:element name="FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember"/>
  <xs:element name="NetAdjustmentsForEquityAwardsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_NetAdjustmentsForEquityAwardsMember"/>
  <xs:element name="NetAdjustmentsForPensionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_NetAdjustmentsForPensionMember"/>
  <xs:element name="PEOMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_PEOMember"/>
  <xs:element name="PensionAdjustmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_PensionAdjustmentsMember"/>
  <xs:element name="PensionAdjustmentsPriorServiceCostMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_PensionAdjustmentsPriorServiceCostMember"/>
  <xs:element name="PensionAdjustmentsServiceCostMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_PensionAdjustmentsServiceCostMember"/>
  <xs:element name="PensionValueInCompensationTableForTheApplicableYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_PensionValueInCompensationTableForTheApplicableYearMember"/>
  <xs:element name="ValueOfEquityAwardsDeductedFromSCTMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_ValueOfEquityAwardsDeductedFromSCTMember"/>
  <xs:element name="YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember"/>
  <xs:element name="YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>lvo-20250908_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Jul 03 20:00:41 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#IndividualsOnly" roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <loc xlink:type="locator" xlink:label="lvo_ValueOfEquityAwardsDeductedFromSCTMember" xlink:href="lvo-20250908.xsd#lvo_ValueOfEquityAwardsDeductedFromSCTMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="lvo_ValueOfEquityAwardsDeductedFromSCTMember" order="5" xbrldt:closed="true"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZ7cK/v2ueV/4B0uxoMe+pKQp0EY9NNhkgK+JBfvn4FqT9xCfg4PmlpicZXEV65/omqQUJCtXDxzz/YYV6vtexWmtgAqQA1hARLtZWoAcGBw+CYyu6zS/RgxqhxZhAhxm/NIZZiL7PkLFtd+OBQ4HE9LNkr+cYQ6G+3zUeUZ2W/mRStDxT2c0fAncP7tU7psG45wG2R9o6kzezUrZEhWSMjbY/hNzTATbXaL3OjZV2C0GXPpLR4UWtMLtP67FqW49I=] CSR-->
    <loc xlink:type="locator" xlink:label="lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember" xlink:href="lvo-20250908.xsd#lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember" xlink:href="lvo-20250908.xsd#lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember" xlink:href="lvo-20250908.xsd#lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <loc xlink:type="locator" xlink:label="lvo_PEOMember" xlink:href="lvo-20250908.xsd#lvo_PEOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="lvo_PEOMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="lvo_AverageNonPEONEOsMember" xlink:href="lvo-20250908.xsd#lvo_AverageNonPEONEOsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="lvo_AverageNonPEONEOsMember" order="4" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>lvo-20250908_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Jul 03 20:00:41 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="lvo_AverageNonPEONEOsMember" xlink:href="lvo-20250908.xsd#lvo_AverageNonPEONEOsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_AverageNonPEONEOsMember_lbl" xml:lang="en-US">Average Non-PEO NEOs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_AverageNonPEONEOsMember" xlink:to="lvo_AverageNonPEONEOsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="lvo_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember" xlink:href="lvo-20250908.xsd#lvo_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember_lbl" xml:lang="en-US">Adjustments For Equity Awards Failed To Meet Performance Conditions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember" xlink:to="lvo_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on adjustments for equity awards that failed to meet performance conditions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember" xlink:to="lvo_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember" xlink:href="lvo-20250908.xsd#lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember_lbl" xml:lang="en-US">Change In Fair Value As Of Vesting Date Of Current Year Awards Vested During Current Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember" xlink:to="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value (as of vesting date) of current  year awards vested during current year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember" xlink:to="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:href="lvo-20250908.xsd#lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl" xml:lang="en-US">Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:to="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value (as of vesting date) of prior year awards vested during current year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:to="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:href="lvo-20250908.xsd#lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl" xml:lang="en-US">Change In Fair Value As Of Vesting Date Of Awards Vested During Current Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:to="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value (as of vesting date) of awards vested during current year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:to="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:href="lvo-20250908.xsd#lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl" xml:lang="en-US">Change In Fair Value Of Outstanding And Unvested Awards Granted In Prior Fiscal Years [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:to="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:to="lvo_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember" xlink:href="lvo-20250908.xsd#lvo_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember_lbl" xml:lang="en-US">Dividends Or Other Earnings Paid On Equity Awards Not Otherwise Reflected In Fair Value [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember" xlink:to="lvo_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on dividends or other earnings paid on equity awards not otherwise reflected in fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember" xlink:to="lvo_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_EquityAwardsAdjustmentsMember" xlink:href="lvo-20250908.xsd#lvo_EquityAwardsAdjustmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_EquityAwardsAdjustmentsMember_lbl" xml:lang="en-US">Total Equity Awards Adjustments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsMember" xlink:to="lvo_EquityAwardsAdjustmentsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_EquityAwardsAdjustmentsMember_lbl0" xml:lang="en-US">This member presents the total equity awards adjustments, which may be comprised of adjustments for (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards granted in prior years that vest in the applicable year, the amount equal to the change in value as of the vesting date (from the end of the prior fiscal year); (iv) adjustments for equity awards that failed to meet performance conditions; and (v) dividends or other earnings paid on equity awards not otherwise reflected in fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsMember" xlink:to="lvo_EquityAwardsAdjustmentsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:href="lvo-20250908.xsd#lvo_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl" xml:lang="en-US">Year-end Fair Value Of Awards Granted In The Current Fiscal Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:to="lvo_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:to="lvo_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_EquityAwardsValueInCompensationTableForTheApplicableYearMember" xlink:href="lvo-20250908.xsd#lvo_EquityAwardsValueInCompensationTableForTheApplicableYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_EquityAwardsValueInCompensationTableForTheApplicableYearMember_lbl" xml:lang="en-US">Equity Awards Value In Summary Compensation Table (Grant Date Value) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsValueInCompensationTableForTheApplicableYearMember" xlink:to="lvo_EquityAwardsValueInCompensationTableForTheApplicableYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_EquityAwardsValueInCompensationTableForTheApplicableYearMember_lbl0" xml:lang="en-US">This member presents the adjustment (deduction) for equity awards value from summary compensation table.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_EquityAwardsValueInCompensationTableForTheApplicableYearMember" xlink:to="lvo_EquityAwardsValueInCompensationTableForTheApplicableYearMember_lbl0"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZ7cK/v2ueV/4B0uxoMe+pKQp0EY9NNhkgK+JBfvn4FqT9xCfg4PmlpicZXEV65/omqQUJCtXDxzz/YYV6vtexWmtgAqQA1hARLtZWoAcGBw+CYyu6zS/RgxqhxZhAhxm/NIZZiL7PkLFtd+OBQ4HE9LNkr+cYQ6G+3zUeUZ2W/mRStDxT2c0fAncP7tU7psG45wG2R9o6kzezUrZEhWSMjbY/hNzTATbXaL3OjZV2C0NAZSK6AGo1Z1ZwIbbp/zII=] CSR-->
    <loc xlink:type="locator" xlink:label="lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember" xlink:href="lvo-20250908.xsd#lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember_lbl" xml:lang="en-US">Fair Value of Equity Awards Compensation Granted in Current Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember" xlink:to="lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember_lbl"/>
    <loc xlink:type="locator" xlink:label="lvo_NetAdjustmentsForEquityAwardsMember" xlink:href="lvo-20250908.xsd#lvo_NetAdjustmentsForEquityAwardsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_NetAdjustmentsForEquityAwardsMember_lbl" xml:lang="en-US">Total Net Adjustments For Equity Awards [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_NetAdjustmentsForEquityAwardsMember" xlink:to="lvo_NetAdjustmentsForEquityAwardsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_NetAdjustmentsForEquityAwardsMember_lbl0" xml:lang="en-US">This member presents the net compensation adjustment for equity awards, which is comprised of equity awards value from summary compensation table, net of total equity awards adjustments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_NetAdjustmentsForEquityAwardsMember" xlink:to="lvo_NetAdjustmentsForEquityAwardsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_NetAdjustmentsForPensionMember" xlink:href="lvo-20250908.xsd#lvo_NetAdjustmentsForPensionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_NetAdjustmentsForPensionMember_lbl" xml:lang="en-US">Total Net Adjustments For Pension [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_NetAdjustmentsForPensionMember" xlink:to="lvo_NetAdjustmentsForPensionMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_NetAdjustmentsForPensionMember_lbl0" xml:lang="en-US">This member presents the net compensation adjustment for pension, which is comprised of pension value from summary compensation table, net of total pension adjustments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_NetAdjustmentsForPensionMember" xlink:to="lvo_NetAdjustmentsForPensionMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_PEOMember" xlink:href="lvo-20250908.xsd#lvo_PEOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lvo_PEOMember_lbl" xml:lang="en-US">PEO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_PEOMember" xlink:to="lvo_PEOMember_lbl"/>
    <loc xlink:type="locator" xlink:label="lvo_PensionAdjustmentsMember" xlink:href="lvo-20250908.xsd#lvo_PensionAdjustmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_PensionAdjustmentsMember_lbl" xml:lang="en-US">Total Pension Adjustments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_PensionAdjustmentsMember" xlink:to="lvo_PensionAdjustmentsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_PensionAdjustmentsMember_lbl0" xml:lang="en-US">This member presents the total pension adjustments, which may be comprised of adjustments for service cost and prior service cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_PensionAdjustmentsMember" xlink:to="lvo_PensionAdjustmentsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_PensionAdjustmentsPriorServiceCostMember" xlink:href="lvo-20250908.xsd#lvo_PensionAdjustmentsPriorServiceCostMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lvo_PensionAdjustmentsPriorServiceCostMember_lbl" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_PensionAdjustmentsPriorServiceCostMember" xlink:to="lvo_PensionAdjustmentsPriorServiceCostMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_PensionAdjustmentsPriorServiceCostMember_lbl0" xml:lang="en-US">This member presents the total pension adjustments, prior service cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_PensionAdjustmentsPriorServiceCostMember" xlink:to="lvo_PensionAdjustmentsPriorServiceCostMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_PensionAdjustmentsServiceCostMember" xlink:href="lvo-20250908.xsd#lvo_PensionAdjustmentsServiceCostMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lvo_PensionAdjustmentsServiceCostMember_lbl" xml:lang="en-US">Pension Adjustments Service Cost [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_PensionAdjustmentsServiceCostMember" xlink:to="lvo_PensionAdjustmentsServiceCostMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_PensionAdjustmentsServiceCostMember_lbl0" xml:lang="en-US">This member presents the pension adjustments, service cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_PensionAdjustmentsServiceCostMember" xlink:to="lvo_PensionAdjustmentsServiceCostMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_PensionValueInCompensationTableForTheApplicableYearMember" xlink:href="lvo-20250908.xsd#lvo_PensionValueInCompensationTableForTheApplicableYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_PensionValueInCompensationTableForTheApplicableYearMember_lbl" xml:lang="en-US">Pension Adjustments Pension Value In Summary Compensation Table [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_PensionValueInCompensationTableForTheApplicableYearMember" xlink:to="lvo_PensionValueInCompensationTableForTheApplicableYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lvo_PensionValueInCompensationTableForTheApplicableYearMember_lbl0" xml:lang="en-US">This member presents the adjustment (deduction) for pension value from summary compensation table.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_PensionValueInCompensationTableForTheApplicableYearMember" xlink:to="lvo_PensionValueInCompensationTableForTheApplicableYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="lvo_ValueOfEquityAwardsDeductedFromSCTMember" xlink:href="lvo-20250908.xsd#lvo_ValueOfEquityAwardsDeductedFromSCTMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_ValueOfEquityAwardsDeductedFromSCTMember_lbl" xml:lang="en-US">Value of Equity Awards Deducted from SCT [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_ValueOfEquityAwardsDeductedFromSCTMember" xlink:to="lvo_ValueOfEquityAwardsDeductedFromSCTMember_lbl"/>
    <loc xlink:type="locator" xlink:label="lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember" xlink:href="lvo-20250908.xsd#lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember_lbl" xml:lang="en-US">Year-Over-Year Change in Fair Value of Equity Awards that Vested During the Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember" xlink:to="lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember_lbl"/>
    <loc xlink:type="locator" xlink:label="lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember" xlink:href="lvo-20250908.xsd#lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember_lbl" xml:lang="en-US">Year-Over-Year Change in Fair Value of Unvested Equity Awards [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember" xlink:to="lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_PensionAdjustmentsPriorServiceCostMember_lbl1" xml:lang="en-US">Pension Adjustments Prior Service Cost Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_PensionAdjustmentsPriorServiceCostMember" xlink:to="lvo_PensionAdjustmentsPriorServiceCostMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_PEOMember_lbl0" xml:lang="en-US">PEOMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_PEOMember" xlink:to="lvo_PEOMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lvo_PensionAdjustmentsServiceCostMember_lbl1" xml:lang="en-US">Pension Adjustments Service Cost Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lvo_PensionAdjustmentsServiceCostMember" xlink:to="lvo_PensionAdjustmentsServiceCostMember_lbl1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>lvo-20250908_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Jul 03 20:00:41 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"/>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <loc xlink:type="locator" xlink:label="ValueOfEquityAwardsDeductedFromSCTMember" xlink:href="lvo-20250908.xsd#lvo_ValueOfEquityAwardsDeductedFromSCTMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ValueOfEquityAwardsDeductedFromSCTMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember" xlink:href="lvo-20250908.xsd#lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember" xlink:href="lvo-20250908.xsd#lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember" xlink:href="lvo-20250908.xsd#lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <loc xlink:type="locator" xlink:label="PEOMember" xlink:href="lvo-20250908.xsd#lvo_PEOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="PEOMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AverageNonPEONEOsMember" xlink:href="lvo-20250908.xsd#lvo_AverageNonPEONEOsMember"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZ7cK/v2ueV/4B0uxoMe+pKQp0EY9NNhkgK+JBfvn4FqT9xCfg4PmlpicZXEV65/omqQUJCtXDxzz/YYV6vtexWmtgAqQA1hARLtZWoAcGBw+CYyu6zS/RgxqhxZhAhxm/NIZZiL7PkLFtd+OBQ4HE9LNkr+cYQ6G+3zUeUZ2W/mRStDxT2c0fAncP7tU7psG45wG2R9o6kzezUrZEhWSMjbY/hNzTATbXaL3OjZV2C0EJ/VVyRTs+v9sgRNUYNJxU=] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="AverageNonPEONEOsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <loc xlink:type="locator" xlink:label="PEOMember" xlink:href="lvo-20250908.xsd#lvo_PEOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="PEOMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AverageNonPEONEOsMember" xlink:href="lvo-20250908.xsd#lvo_AverageNonPEONEOsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="AverageNonPEONEOsMember" order="0.01" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <loc xlink:type="locator" xlink:label="PEOMember" xlink:href="lvo-20250908.xsd#lvo_PEOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="PEOMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AverageNonPEONEOsMember" xlink:href="lvo-20250908.xsd#lvo_AverageNonPEONEOsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="AverageNonPEONEOsMember" order="0.01" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <loc xlink:type="locator" xlink:label="PEOMember" xlink:href="lvo-20250908.xsd#lvo_PEOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="PEOMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AverageNonPEONEOsMember" xlink:href="lvo-20250908.xsd#lvo_AverageNonPEONEOsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="AverageNonPEONEOsMember" order="0.01" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">PRE 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIVEONE,
INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001491419<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Mar. 31, 2025</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2024</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PAY
VERSUS PERFORMANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Introduction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a disclosure pursuant to the SEC&#8217;s new pay versus performance (&#8220;PVP&#8221;) rules. The PVP rules create a new
definition of pay, referred to as Compensation Actually Paid (&#8220;CAP&#8221;), which is compared to certain performance measures as
defined by the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Compensation Table Versus Compensation Actually Paid</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2025 Summary Compensation Table (&#8220;SCT&#8221;) set forth above discloses a mix of compensation earned during the year, e.g., base
salary and annual cash incentive, and the full grant date fair value of equity awards granted during the year. The new CAP definition
of pay adjusts compensation reported for a particular year to reflect an annualized value of compensation by removing the values mandated
by the SCT for equity awards granted during the year and instead including the value of equity awards vesting during the year and the
potential change in value of unvested equity awards granted in prior&#160;years. It is important to note that the executive did not actually
earn or receive the amount defined as CAP in the applicable year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pay
Versus Performance Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the SCT compensation and CAP for our principal executive officer (&#8220;PEO&#8221;) and the average for our
non-PEO Named Executive Officers (&#8220;NEOs&#8221;) for our 2025, 2024 and 2023 fiscal&#160;years. In accordance with the PVP rules,
the table also includes certain prescribed performance related measures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal Year</b></span></p></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary <br/> Compensation <br/> Table Total <br/> Compensation <br/> for PEO<sup>(4)</sup>&#160;<br/> ($)</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average <br/> Summary <br/> Compensation <br/> Table Total <br/> Compensation <br/> for Non-PEO <br/> NEOs<sup>(4)</sup> <br/> ($)</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation <br/> Actually&#160;Paid&#160;to <br/> PEO<sup>(5)</sup> <br/> ($)</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average <br/> Compensation <br/> Actually <br/> Paid to <br/> Non-PEO <br/> NEOs<sup>(5)</sup> <br/> ($)</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value of <br/> Initial <br/> Fixed $100 <br/> Investment <br/> Based on <br/> Total <br/> Shareholder <br/> Return <br/> ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">GAAP <br/> Net Loss <br/> (in&#160;thousands) <br/> ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b><sup>(1)</sup></span></td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">558,584</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">618,855</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">558,584</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">166,169</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17.48</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(20,370</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b><sup>(2)</sup></span></td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">547,032</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">809,237</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">547,032</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">438,236</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">44.93</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(11,966</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b><sup>(3)</sup></span></td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">552,360</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">247,314</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">182,680</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">230,395</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">26.57</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(10,019</td><td style="text-align: left">)</td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2025 fiscal year, Robert S.&#160;Ellin was our Chief Executive Officer and our remaining NEOs consisted of Ryan Carhart, our Chief
Financial Officer, and Aaron Sullivan, our former Chief Financial Officer. We did not have any other NEOs for such fiscal year.</span></td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2024 fiscal year, Robert S.&#160;Ellin was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer. We did not have any other NEOs for such fiscal year.</span></td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2023 fiscal year, Robert S. Ellin was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer and Dermot McCormack, our former President.</span></td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
in this column represent the &#8220;Total&#8221; column set forth in the 2025 Summary Compensation Table on page 34. See the footnotes
to the 2025 Summary Compensation Table for further detail regarding the amounts in these columns.</span></td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
dollar amounts reported in these columns represent the amounts of &#8220;compensation actually paid.&#8221; The amounts are computed
in accordance with Item&#160;402(v)&#160;of Regulation&#160;S-K by deducting and adding the following amounts from the &#8220;Total&#8221;
column of the 2025 Summary Compensation Table (pursuant to SEC rules, fair value at each measurement date is computed in a manner consistent
with the fair value methodology used to account for share-based payments in our financial statements under GAAP):</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides additional information on how CAP for each reporting year was determined, starting with SCT compensation, and
applying each of the required adjustments, as applicable, in accordance with the PVP rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Fiscal Year</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Summary <br/> Compensation <br/> Table&#160;Total <br/> Compensation <br/> ($)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value&#160;of <br/> Equity <br/> Awards <br/> Deducted <br/> from&#160;SCT <br/> ($)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair&#160;Value&#160;of <br/> Equity&#160;Awards <br/> Compensation <br/> Granted&#160;in <br/> Current&#160;Year <br/> ($)<sup>(1)</sup></b></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year-Over-Year <br/> Change&#160;in <br/> Fair&#160;Value&#160;of <br/> Unvested<br/> Equity&#160;Awards <br/> ($)<sup>(2)</sup></b></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year-Over-Year <br/> Change&#160;in <br/> Fair&#160;Value&#160;of <br/> Equity&#160;Awards <br/> that&#160;Vested <br/> During&#160;the&#160;Year <br/> ($)<sup>(3)</sup></b></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Compensation <br/> Actually&#160;Paid <br/> ($)</td><td style="font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold">PEO</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold; text-align: left">2025</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">558,584</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-1">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-2">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-3">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-4">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">558,584</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">547,032</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-5">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-6">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-7">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-8">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">547,032</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2023</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">552,360</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">552,360</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; font-weight: bold">Average&#160;Non-PEO&#160;NEOs</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2025</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">618,855</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">335,230</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">218,750</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(336,206</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">166,123</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">809,237</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">530,250</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">152,250</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">6,999</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">438,236</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2023</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">285,654</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">33,838</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">85,500</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">3,191</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4,666</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">230,395</td><td style="text-align: left">&#160;</td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the fair value as of the indicated fiscal year-end of the outstanding and unvested equity awards granted during such
fiscal year, calculated in accordance with the methodology used for financial reporting purposes. The fair value differs from the value
in the SCT because for&#160;purposes of CAP the fair value for equity awards granted in the current year is determined as of the last&#160;day
of the applicable year. Fair values in the SCT are determined as of the grant date.</span></td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the change in fair value during the indicated fiscal year of each equity award that was granted in a prior fiscal year
and that remained outstanding and unvested as of the last&#160;day of the indicated fiscal year, calculated in accordance with the methodology
used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on an estimate of the probable
outcome of such performance-based vesting conditions as of the last&#160;day of the fiscal year.</span></td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the change in fair value, measured from the prior fiscal year-end to the vesting date, of each equity award that was
granted in a prior fiscal year and which vested during the indicated fiscal year, calculated in accordance with the methodology used
for financial reporting purposes.</span></td>
</tr></table><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2025 fiscal year, Robert S.&#160;Ellin was our Chief Executive Officer and our remaining NEOs consisted of Ryan Carhart, our Chief
Financial Officer, and Aaron Sullivan, our former Chief Financial Officer. We did not have any other NEOs for such fiscal year.</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2024 fiscal year, Robert S.&#160;Ellin was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer. We did not have any other NEOs for such fiscal year.</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2023 fiscal year, Robert S. Ellin was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer and Dermot McCormack, our former President.</span></td>
</tr></table><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 558,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 547,032<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 552,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">558,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">547,032<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">182,680<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">618,855<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">809,237<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">247,314<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">166,169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">438,236<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">230,395<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17.48<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">44.93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">26.57<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (20,370,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">$ (11,966,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">$ (10,019,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Robert S.&#160;Ellin<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">Robert S.&#160;Ellin<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">Robert S. Ellin<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=lvo_PEOMember', window );">PEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 558,584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 547,032<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 552,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=lvo_AverageNonPEONEOsMember', window );">Average Non-PEO NEOs [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">618,855<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">809,237<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">285,654<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">166,123<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">438,236<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">230,395<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Value of Equity Awards Deducted from SCT [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Fair Value of Equity Awards Compensation Granted in Current Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-Over-Year Change in Fair Value of Unvested Equity Awards [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-Over-Year Change in Fair Value of Equity Awards that Vested During the Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Value of Equity Awards Deducted from SCT [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">335,230<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">530,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">33,838<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Fair Value of Equity Awards Compensation Granted in Current Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">218,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">152,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">85,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-Over-Year Change in Fair Value of Unvested Equity Awards [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,191<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-Over-Year Change in Fair Value of Equity Awards that Vested During the Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="num">$ (336,206)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 6,999<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
in this column represent the &#8220;Total&#8221; column set forth in the 2025 Summary Compensation Table on page 34. See the footnotes
to the 2025 Summary Compensation Table for further detail regarding the amounts in these columns.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2025 fiscal year, Robert S.&#160;Ellin was our Chief Executive Officer and our remaining NEOs consisted of Ryan Carhart, our Chief
Financial Officer, and Aaron Sullivan, our former Chief Financial Officer. We did not have any other NEOs for such fiscal year.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2024 fiscal year, Robert S.&#160;Ellin was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer. We did not have any other NEOs for such fiscal year.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2023 fiscal year, Robert S. Ellin was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer and Dermot McCormack, our former President.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
dollar amounts reported in these columns represent the amounts of &#8220;compensation actually paid.&#8221; The amounts are computed
in accordance with Item&#160;402(v)&#160;of Regulation&#160;S-K by deducting and adding the following amounts from the &#8220;Total&#8221;
column of the 2025 Summary Compensation Table (pursuant to SEC rules, fair value at each measurement date is computed in a manner consistent
with the fair value methodology used to account for share-based payments in our financial statements under GAAP):</span><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides additional information on how CAP for each reporting year was determined, starting with SCT compensation, and
applying each of the required adjustments, as applicable, in accordance with the PVP rules.</span></p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Fiscal Year</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Summary <br/> Compensation <br/> Table&#160;Total <br/> Compensation <br/> ($)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value&#160;of <br/> Equity <br/> Awards <br/> Deducted <br/> from&#160;SCT <br/> ($)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair&#160;Value&#160;of <br/> Equity&#160;Awards <br/> Compensation <br/> Granted&#160;in <br/> Current&#160;Year <br/> ($)<sup>(1)</sup></b></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year-Over-Year <br/> Change&#160;in <br/> Fair&#160;Value&#160;of <br/> Unvested<br/> Equity&#160;Awards <br/> ($)<sup>(2)</sup></b></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year-Over-Year <br/> Change&#160;in <br/> Fair&#160;Value&#160;of <br/> Equity&#160;Awards <br/> that&#160;Vested <br/> During&#160;the&#160;Year <br/> ($)<sup>(3)</sup></b></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Compensation <br/> Actually&#160;Paid <br/> ($)</td><td style="font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold">PEO</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold; text-align: left">2025</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">558,584</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-1">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-2">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-3">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-4">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">558,584</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">547,032</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-5">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-6">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-7">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-8">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">547,032</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2023</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">552,360</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">552,360</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; font-weight: bold">Average&#160;Non-PEO&#160;NEOs</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2025</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">618,855</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">335,230</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">218,750</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(336,206</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">166,123</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">2024</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">809,237</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">530,250</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">152,250</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">6,999</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">438,236</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">2023</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">285,654</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">33,838</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">85,500</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">3,191</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4,666</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">230,395</td><td style="text-align: left">&#160;</td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the fair value as of the indicated fiscal year-end of the outstanding and unvested equity awards granted during such
fiscal year, calculated in accordance with the methodology used for financial reporting purposes. The fair value differs from the value
in the SCT because for&#160;purposes of CAP the fair value for equity awards granted in the current year is determined as of the last&#160;day
of the applicable year. Fair values in the SCT are determined as of the grant date.</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the change in fair value during the indicated fiscal year of each equity award that was granted in a prior fiscal year
and that remained outstanding and unvested as of the last&#160;day of the indicated fiscal year, calculated in accordance with the methodology
used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on an estimate of the probable
outcome of such performance-based vesting conditions as of the last&#160;day of the fiscal year.</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the change in fair value, measured from the prior fiscal year-end to the vesting date, of each equity award that was
granted in a prior fiscal year and which vested during the indicated fiscal year, calculated in accordance with the methodology used
for financial reporting purposes.</span></td>
</tr></table></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the fair value as of the indicated fiscal year-end of the outstanding and unvested equity awards granted during such
fiscal year, calculated in accordance with the methodology used for financial reporting purposes. The fair value differs from the value
in the SCT because for&#160;purposes of CAP the fair value for equity awards granted in the current year is determined as of the last&#160;day
of the applicable year. Fair values in the SCT are determined as of the grant date.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the change in fair value during the indicated fiscal year of each equity award that was granted in a prior fiscal year
and that remained outstanding and unvested as of the last&#160;day of the indicated fiscal year, calculated in accordance with the methodology
used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on an estimate of the probable
outcome of such performance-based vesting conditions as of the last&#160;day of the fiscal year.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the change in fair value, measured from the prior fiscal year-end to the vesting date, of each equity award that was
granted in a prior fiscal year and which vested during the indicated fiscal year, calculated in accordance with the methodology used
for financial reporting purposes.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=lvo_PEOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=lvo_PEOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=lvo_AverageNonPEONEOsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=lvo_AverageNonPEONEOsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=lvo_ValueOfEquityAwardsDeductedFromSCTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=lvo_ValueOfEquityAwardsDeductedFromSCTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>29</ContextCount>
  <ElementCount>18</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>8</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="ea0248124-pre14a_liveone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea0248124-pre14a_liveone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea0248124-pre14a_liveone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea0248124-pre14a_liveone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="PRE 14A" isUsgaap="true" original="ea0248124-pre14a_liveone.htm">ea0248124-pre14a_liveone.htm</File>
    <File>lvo-20250908.xsd</File>
    <File>lvo-20250908_def.xml</File>
    <File>lvo-20250908_lab.xml</File>
    <File>lvo-20250908_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="56">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0248124-pre14a_liveone.htm": {
   "nsprefix": "lvo",
   "nsuri": "http://www.liveone.com/20250908",
   "dts": {
    "inline": {
     "local": [
      "ea0248124-pre14a_liveone.htm"
     ]
    },
    "schema": {
     "local": [
      "lvo-20250908.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_def.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_pre.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "lvo-20250908_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "lvo-20250908_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lvo-20250908_pre.xml"
     ]
    }
   },
   "keyStandard": 18,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 6,
   "hidden": {
    "total": 11,
    "http://xbrl.sec.gov/ecd/2025": 8,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 29,
   "entityCount": 1,
   "segmentCount": 8,
   "elementCount": 272,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2025": 56,
    "http://xbrl.sec.gov/dei/2025": 4,
    "http://fasb.org/us-gaap/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0248124-pre14a_liveone.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0248124-pre14a_liveone.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0248124-pre14a_liveone.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0248124-pre14a_liveone.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:AwardTmgPredtrmndFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0248124-pre14a_liveone.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:AwardTmgPredtrmndFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0248124-pre14a_liveone.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0248124-pre14a_liveone.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0248124-pre14a_liveone.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r105",
      "r121",
      "r156"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r108",
      "r124",
      "r159"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r151",
      "r160",
      "r164",
      "r172"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "lvo_AverageNonPEONEOsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.liveone.com/20250908",
     "localname": "AverageNonPEONEOsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Non-PEO NEOs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r101"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r128"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r128"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101",
      "r152"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101",
      "r152"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221"
     ]
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r105",
      "r121",
      "r156"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r102",
      "r118",
      "r153"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "lvo_FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.liveone.com/20250908",
     "localname": "FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Equity Awards Compensation Granted in Current Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r112"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r151",
      "r160",
      "r164",
      "r172"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r176"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r176"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r176"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r117"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r195"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r117"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r151",
      "r160"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r107",
      "r123",
      "r158"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r110",
      "r126",
      "r161"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r110",
      "r126",
      "r161"
     ]
    },
    "lvo_PEOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.liveone.com/20250908",
     "localname": "PEOMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO [Member]",
        "label": "PEOMember"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r102",
      "r118",
      "r153"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r92",
      "r103",
      "r119",
      "r154"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r93",
      "r104",
      "r120",
      "r155"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r100",
      "r111",
      "r127",
      "r162"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r106",
      "r122",
      "r157"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "lvo_ValueOfEquityAwardsDeductedFromSCTMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.liveone.com/20250908",
     "localname": "ValueOfEquityAwardsDeductedFromSCTMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Equity Awards Deducted from SCT [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "lvo_YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.liveone.com/20250908",
     "localname": "YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-Over-Year Change in Fair Value of Equity Awards that Vested During the Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lvo_YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.liveone.com/20250908",
     "localname": "YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-Over-Year Change in Fair Value of Unvested Equity Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001213900-25-061546-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-061546-xbrl.zip
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M"E>K 1LTGK->PL-$KB"A@H-^E(6NUL!$6G'^0$I*7\(>/C$1^1 *]J/-[.M
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MB=+@;N;DB%"2K$>SQK_3LN0*D".5S]&5\*-2R:'9@7O(8EI:47#324S@6]X
MTO1UC5XZA5ZZ\0312Y>??^YH/@MYJNXXE:C!J<$W/UAM[KO,T[HM:C6);)OS
MC?D2)373);'/.4,;Q3-TRF@517NUX"6=GXH_>;)./FO6X8J>5CY$RSGF<&YB
MXK4]3>_O8+U?9.JE1HM?/$:R91:-1*.\MC4:U&UJEB*'J@]^28238H5S7K5\
M%U34< &>+*2F8?C2J$?X]M)R2* N3*.&L660Z9J*%<R U#,TTI=-<:$O3:U%
MN=3!SLKP<4NP\ !MBR9MZTK*7),OS!VH@V)*'6S<1!WT7+;H/'WP'EAQP1*
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M^"K*8,\"_4W]9#).8Z[ LJ!Y/YXY04;AXB8ETL+F0C;_@N^D[(,W[Y-)59G
M-!O:>*Y-TNRL*<@@@E6AJ^0TPJ;X>=3,QFS4S)LB879F3U0GI!?CC-PCZ N7
M04Q32@=PX0E^T3BS,VF)7_@X(^&-3T&D'M39[+Z;U78Q@S(C_X@LBMDRE YF
M<YAQU1HWV'M3R%I*+[\V2Z;H*[H?:5RGFBQ\P'11PYJ8:M*N4TV>PL^"&CR5
MX6MTW^::F&1"S!R&<9%RD/>2HE:?D6LF4^>D/'<16^>D+![_WS(;97YAG<VW
M,*$VJ[SULM1*"VOOH]YOZN6*QDDUGT=1O;>PD=R[2G/Z2>Q+S 8WZBSG3P]!
MC_4EFT)&J>Y%J/K#+VS317%2S1%MK*!9.3)%W9=\+KP,=LZSP/F+Y0W5UH-,
M%M3+,14>YDNJ]$2#U4FE=RJ%:+(@Q%9*1AGLEC*Y-16'I88)$0$GG\]\/H+T
ME-_!]UT#-[.L3J#[JLJH4BEXTQK!-W6-X%2-X*NZ1G!QN:?6L!9<P[KED^\;
M 9!;<U0YUD(NLI)SD-TJ(P%>H1<[T*HB:#.-( H1:0!!GT>H86%=99]R<%'9
MX==$I.IT"SF[<,E^"$K2*(I)'\)K5+]/YW+%?DFGJ'$D2IR- E!"5DY,MW9Q
M%+7$QLLF\RR^)>^1T[?CC728\LJP-H:6V4B1>59(>ZX6A<IZ@?9L!C)%!G0\
MS,?%X\'!O7II,$JFEZZX9T74ZVKY&I88=!_4,LQ\0PCQ&0/9?-EDY8VZWC,&
MHL4<E'>@A TQU!BWQ!>JRX.YP@*1J(RS !D#=="D@)K()KP!<2RHCJ3\E^I]
MJZ9+:..6)<ST0:%B&7$K"Y7!QKKH%] ZROHA3PG&#L17;12P&4F&RUQ6O/U(
ML6O<9I.4XB;DN)^H7C; (=AS"C>O8H-:S(7GT$+"ADLB/)FD&)B9W@[4F[$A
M1F%,^9!BT/4O$8BD$#NH,A:SUC*Q2[W#*[*K$R]6^"XDV]]QB*Z6^ZN35RR#
M>I+ 1VRV3X#MKZKE;V(W\@CG/SEY+D0O8IK.'Y^S!&DI2X9@Q>9K58W&IA4E
M,:>3FJ7$V&?QG**3S$>#F1[XCBIE Z#K%Q\^'I\ZQ:;WX39L7I:\1O#>U4C$
M#/E)<W[,F19$:&N*)JEU @6(1N;R)!>^"2U2FV; !U5U)IXCJ.=8L\T\_\N(
M'!='HVB7[\CY5GG/Q'LZ<7-U<FE2UA@!;@O@_=D2IZ)HESW"4$:6F"TW9PBI
M:<$SB=G;NA5M<%=$PC9*E#(EZ?_*5$)BL[W5(ED!:LM?&7 OG?&F%AT;-H*D
M8?>4 ["BRRJ#_[)&H?A(Q_W_G]J9L;PY+/MI@V$8C'C70U"<4TDJO"1/GO-N
MENB?4U&FO'Q)Y.XKI;\P0_*A!9IC,+YG()(Z)+V0UORB1C4P)+U1AZ2?PL\B
M^F%N%9).7$J7TQOJ@/-S%Z!+X@Y]5@'G3Z#XQXC]6RVN.<7=(O(\;+M'1:5%
M;Q2FU+M<0.KS-]W*W>*"D:)5W250"%U*,9)(FED@<P,37NC)#*R/%?W2@<^[
M,0UDR</DFR!XQ8K_'WBE>)Z3HR6/EQOEB@_?8/&MB<)31F:UGHX*'2S80+UL
M8=.Z<Y:_3MFG-F'<HJ]&9NG >'/B\AVP1!7]:&8IB^O";MT5/6L/,.283 S'
M8O=&5\H!"E9KKH*K:VN.OSCP,_*NHDE\#K\<R<27?XFNA(7'0(&,OR'P0TZQ
MS@$YO6#5BG^+L[EYP-TX5(5QS(*Y[EE?_2TS(\[O-"11#C-4&LA42()WYV<B
M$B;*4$V2W4M$XG850S>)2*"L).^%%(96#)&X,4YZUV3%^LD"&5KZJU,^EME+
MTF\4\\2F3J49W:>:Y7((<E@FRJ22L>!AQWM8JD!Q.53PGN%T=ZK:6?)\=/U%
MU<C16?*J=I8\A9]%-*=@EP[EV.3C5VM".Y#AA<)\?3*G9#_%*C'.ZP>5$[0,
M_(ZR=VM/RG.7KK4G9?%8_P]5T1*S_5YB=1E]*\%TH29OY$&.3&(2UU(8A47'
MRHN1=2+4=Q5[.JD*V7):!#!/:$#FU9P89)#'%Q:TL/VFM;%UMSU':T24&A%E
M4:6,K):& @\+QDU&.FHR[M*J+QV@2'FZ-5/73%TS]9(PM;B*,0TX1.>TYAPO
M5"2,YY3+_4R6,*H0Q_T^7G4H0WFA* N>U0T=>GHD ]0>O"S5%3/=(WIJ@H_;
M>+TMSJ(L'8@== G# '=C>!Q,.L.81GMS:[WIOOJL@P#6H]MAKMQ>ISRO**[%
M42V.:G'TZ.+(0J#]-.SB+2#07 FR0:5Y>HACSR?R,-5(;ZYYR<!T8VW!FZ8@
MLJ(POV&B1)U@HI*Z.=PR4<8?4=9(!H11AG!55QR< EF1:*2#:U$8\PQ]+"4)
MJ>)#IXD*^I3XG^HT2[E!AU.'#,@<&SUU0.HYNDP7U;&) :G-.B#U%'X649>[
M5>\RS(^:64^75]Z1M*Y[G-42M@Y*+;(I=YQ5ZVYS'<LG>575)&31PD:':KC\
MVG'S?!PWC.E]FX)OQCVO[.\IYB-34JI)@K72PV80)H0OX7/C$8MA+!R&\8Q<
MUVK-3UXN:B"KEC^U_*GESTWECRL,N45-_X)5,]0"J19(M4!:=H%462&:+%\Z
M!.*3B?BD0\U\\@\Y!%OZV/1_Z$9A")PA#@Y.$'#E?K'6++I77R= RV*L9"R,
MD_U0QJ"\O6I3"[;7LVN@WJ.OO99JM52KI=ISDVJ5JQYO4,GXH'']A8[)/<(,
MJ^!-OZWQIJ?PIC=KO.DE9+3G&YI9U  *!K^WZN#W4_A94$7I]ZJH(04 2F.Q
M,0HE_W(]%.5,>,DZ*OZL16\=%5] N7!SZVG/1+BJHF:[^+E9BUE&4/MEWG:X
M)&7V$7?]KRR*LZ$@\&"5 ,\B+-$HR&)8E[0:^) QT@IXYLE !@3)G618PJ&-
MNYSB>878_PI%_!EC-8_EH2,)757NNFJ078/(H;D3ACCBBU^6<,)I&,I_V1(?
M,5<\BV'A%&$V<< QO"A"?!ODL*KYZA'C,&'AJ^OS:K.139*QP662O02[U%I,
MIA4",7,H*#F:+"&B54/\L0BTY9:I\$0[M'Q<3=BY("A"6D] L)GQO33=9*NA
M#Z"G$)^-P(VT"D@FD_#IM#\$A!6ZL(E!EX^RU(N&RI*:^EFV>8*(0Q-MQI]^
MDG<%,=LQ'J;&'<?PS#+SND_&Z*:DKR@(WD91\++KO(#C;CII&GW/9^RR,!OV
M&$^I(&D-KWX\/K7RPU3M\W.&L.Q"??>4Z2T^\8Q&\1F=3YW]H[/S_#F% ;W/
MFXAS^YD)1"<4"@$&$Z@?1 'Z[HR^9> [<7#0%2OF;?R]%2H-/1PJ7\/Z!^,B
M_$"YS4P/<\5@YKP=*.%1@ R52OD(P1&@8(US)9O$NAE+K ))WYONWB -]1#.
M0+<H#0M34!P-0:7<:# K>)&9WH$92C<*?8UD9&?:Q"P5ACZ$Q0>QB^(?^_51
MPWAL\QV.&Y.8^%.0?F5J*?;F+C0G,$/)J<5N+;YFKK MMA-H[+.\G9J-;2D^
M1#C#\F"(Y(HGL.QC?$C2$C&6)S_4+C:U@2FV^J X%;?UIOJ++(4#DBO&YK0P
ME(E]J,&;V$5.IM6<7MU);-$?KB[5D=!242\<D!X-LV#Y>28O)-8,3;9CV'&]
MX7$-DL*JSP/'++3=T<!CL)A 97%B(GHB"QDNGA>B83%0.?"&;YAH03FYI7SF
M7BG;EU+"VF");JK,GN$VSURD*>)X A51]9EYS9D9P'%9QGJ<,C82D;>$H;B+
MXS&^DQN!XOU4EPTTE5T,TJ* +T=VYELLC=D62R%R5$@03%01GW)J1!4&9(\2
M3DYN3)@YP&M]>1G1>4IPL))5]L*!6[@Z&L&(\)F%2Z=-D$)OJ/+90.F.SA1!
M]%Z+S%D6_T[35IIF7!@!65;Q;%DU2Q?'9W*K+IBIKU+L#1;:JCE9T*DFUMS*
MO9*(O:%N7WK._8H8CB'=P)=%(>:Z$/,6,P5-L '<DP6LB,V2&YL.G[NG.5T$
M<UMF-VE>I"!G'5VJHTOMUW5TZ2G\+*07^1:-409P*"O0%72_@#$/AWP6DO3
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M(?5'(^WR>\41]=2J&E7O7$H=R)[&^LSF;*!3*H>Q[^3 -W4O015U;F>32N/
M=&7U70[A!03#0V%Q5TAHPNF@CY:7JN?*( QJ&'6 +ZYMQ6P'ZYJ=-ZO<^SKU
M:DHSL!WK)>%/NP:EU481EF?-U?H64FUZ$; >@^=--LALHOIYTB!SQ&V]FZU[
MG26/1+&=,TV_\*TT.>B5!D+K?>3ZQ97I-1]2N0_3Q+XY#' SWMKL6!8@I^T:
MR&D*R&FK!G):*$:K8426S[#?6*\-^Z?PLXC& +D'HEOXCR6G&'A1PDH4'DB>
M3DUM'->P?0>-O_8!U#Z V@>P:&Q_PLQYJR0CP^EDX '#RP#+B,= >SIHB8]9
M3!GTYB))=@U:N7#C4/HJ[SN+5AKF*:E C09@^%7+:U?X.GQ$7WJ)AD4@6*&A
MPF3]Q$(H#*D9-_H%6N*KLA.0'-Q1W[%0B.RT48S&-,6WL&%WY7 [.1U@/"S\
MYG@ET/@>POZ-2[:FQ5\A% >3HM\27T:P/EAXK9*TVKI<*6M;ZV$O0ZP.-O^!
M%A *B?P@M%Z$39["_J'=SI!/,BE#4('J#?M$<LLL5C6"T:&'T3QR!,#SKL"Z
MQ=>4/4%L%>?K,0E1,E&-SI]62P1S37*%:9)KR*,(H%%;V;4-L+#G"=H [=H&
M> H_BZ@,_&R=K<^(2(A\1' <[ @V$"6(Q)'6J62U75#;!4M@%QRC\EXQ?4LR
MB$W?]'\W\":^2KQ8]^;W)&RBKFJ!3[A!/6$3&IRB:BJ>R?BRJ(%4:YNA$CU3
M]MPPC<VFIE6+#YIHTT4L4?%G_99KCMGNL:T:95(NS&W"%H'QDHJS%HN,O0 ,
MBB:C,PXD LA50_M$HZ,[T*HO]KXK+R/TN6,$HU4Q8Z"=CF'KNC(>R#BU[\'+
M/^I0AJ0ON\MS\**JVG>.\N: W8HA0]PBVH6I,\1!5.4'29^ 81EMKG*289W-
M5RO\RZ3P;]0*_U/X6<13_A9.?P]>/5#!"*1U<J5B,1P+\DYA:5ZMRM>J?*W*
M+QJ35\3/<>@NJ(XYUA:R%V4,=CWIJ)U3.XS/06'AP7BD1[=6&@>KG.*07/>H
MI;][*,ER[SMR7Z"7,\?/F3UW.?P#,"".,4ZS'WKWAT-YW[/8>+W=. .:'H@=
M!#,'^V(WAHG!#9D&NZ*]N;6^M',S,VI\!FL-+NMVF.*VUS?:&TL[J4YJ( #>
M-<JR86EGM/*JO6YPGE^OMU<WMM:WEG8N#Y.X^0"S^+_@9]GG\'@[425-MKU>
MY\E.Y<F^KO-D%Y1CZ \IM/_KB^!_U]<WD-KEAY^=8@50\GN9>/?X].3XM'.^
MU_AT_/O>Z5'GJ+OW@()C'LS\ W>9_]E)V?_G&)SW/KVOJL$VFQ^-*-(JNI%/
M<92]=*"]&9WDFO E^?2Y+80:CH)HK/ =U)&'JO#!=/LS"[DDA2KM?]0@JMG8
M&0?RBA\YC:QJ.[=@OHT&;4X)#T,.%/.  0[I^?T8).)5%'^C,5]$H,EB%$*U
M1"<(\LX(?N1EW-6(8LR(8N!ABR*NM E4PT#GZ_ 23%A*8@IHC,F:'; J/%U<
MJ5ZB*9X@?M$?!FDZ>K>VIN-6 #;!=_RC!:.&#U8'V* !VW)$L<UGBWK8M<Y&
MFJYBG)M+VVJDT;NEU25J2W4!9E%;JDLVJ<>V5.\G4O#@1L7]3..3D_E =!<#
M>-4@36J-9PDU'CSXK2I!3<&'< KC28SYP0/85T&@[USUW<]S0T"M\3./D[%G
MZ0)&!<*TE)X*M+KD]!2X%;F:6U+&64BO0:^V>["R'7Z#<5,D*KXT5Y22NN&Q
M06 SQ=UP655)U05UOM.<23.D7I$CL&)!^SDK-'T=.,+-4YC-/!H%G8:K[]7]
MJ1_7IS3<,>-.=*B[1X9];-KFR5(JYE<E=E%_O.<9<S!UZV;!U-4'%U9/-*!Z
M)SDH=Q(FO=N]W'[]9OO]HH=%7U=%EGA3:.:!YP&RPT@13Y3F>M\I#S67UESZ
M;+B4LPJJ501:?'/,(@95:Z(6<$;#GY5$*=>0D8D<FS*V7]9\7?-US=<+PM?2
MO]1)%(]-4W"PP22.JG@."YGY&IV]<SCZ5<W1-4?7''TO''VJDC367EH5P8Y\
M(Z8@>Z!'Y!G18:)]Q%Z.)56*7V3P*_9B3VK^K?FWYM_[X=^++) 5R^VF=>E$
M!?U5F20J24QX-H7+T@$>T_I2^Y@CS(Y7&P,.U*4*:L:N&;MF['MA[!UDTMOW
MK<T9U1K2A!8+AO4C.<#J>,/]QAM*SZ4W^P@,+"F@G<$@8M3$7GS8C4*3T&.W
MOPY5U!*\EN!W+XR.JI5HQFH$AAA%E?N"&/8*B[6LI37B@BY,Z,.2KD)L&CM"
MQM&E#&IEK&;EFI47@)4'RK\PC-QET$ PL+PL9KB^$;"L_7B$.(OCFG%KQJT9
M=P$8=Q1<R[GV\!W%RIZYC\?-=?+HC:>Q:\SBQKZS?3U5)X\NF\%[C%F;T[Y+
MCWM.!F-,$4VT!317ERHL%L[P!_#-U2 :3J8"B16)F&>@;P^I)*0WGI-U\+*)
M76X:]C&8+@IS@)N+.%_787>UQ/'L=(:!1/3<2ZVNE&_:O^?$:M,@"KE,H=\8
ME =-K6>HAPU<?:B2!+&(?XOU14*KVXEEJ)OB*UR0]%1\@<!@9U$0#2,>\-<8
M<U/IGX=PXX[$_NM_9;#)_3'.$.957#$[E,8HBY,,T=+22)QF@6(JW'J]OK4B
M7ZYLF%)I&-*13'SY%Z,ICT8@*NG QQZ@,=S&Y4<Q^;/)UFF)?<2>_N9@F>U4
MZ>MF:8,:1<\7AZ',*KH"HH$>)>4EXI(D[#!OZZ@FMH.JIS(>&+K."-D.(:M3
M_LS3L9<-,5W94PDG%4_OJZ\4XL7!.-0EKI(.W40,VKZ.2WO]4"4O]9%QS338
M_8H'>Y00M!UMN#U(Q+^(+;"<#DFK/DJ6\2@YBEB6 !-VG;<<U#D=^:C"8UDB
M!<140H*$-+Y1K+'J !]EXV&.0.9FJC5%RE),AR B31<WKC 8*0_)J!$JY8/
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M 6=CMIC1/FEUS<*CIF>W=89JVBSAOY:^R/UO<%QS^(NYRV2X%89)KVJP>4X
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M7H\&<21^HFH:IU,$9%R:EG$V*H\@=!PB9.%]@A5_5(>8TA4B8[MC[K87I%B
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MS^-06HC#-?2ZNO (JS&LQK :8S4:0Z3(54$ZJ*LQ"NG$@A,YK#[J!2@<TK_
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MKUE\_L-[HB7*HH920<-^>=U7H?!Q'(@0KM^.[T092^XJB4=QZLN)4HBD?:B
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MTF*4A2\I)V+PDE YY2+^!*O>VG_)@]"&:M]M2NG@?DO)M1 /"3^4E?JAN(/
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MY.^@9;Z,8(5WL@OK4)ZZ4\Y6E%R6;TE=@#.&(\39.V-W7@9 Y,?)*$C/]G#
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MQ@/I _2\Q%<?NVWUI8=Q*\)W'E@[Y!,WH/?WP\'^H=%YQJ>(>+/HV^B\&2[
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M_M@**P(T(-1PT*4')V+7>\T,:PATZ@N4^U(G0!FV%A2OV@?.81>D\*ZG!IV
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M^-T#(O<\!&XI*9"61P6%7]WH6(+ZD) ^8-=@#=X6-!"6L/8+L#YT+^%^O^_
M_Q= 6RG!-@S=S-I:DK4]*/)K.MX:.GZ@&P*V$+,UD=9$NO&8K8ET:XBTV_CZ
M6QZW$*TUA6X-A1Z^V7_3;K:__EJ6[4-M3:5;0Z6UL*^)M";2C<5L3:0OA$BW
MP4=54^YFHK)FKT\>;WF8:,J= &P8Q6WFB=WX8[JM4F7#$5M3XY91XTO!84UX
M->'5A+<M2*L)KR:\FO"V%(<UX=6$5Q/>MB"M)KR:\%X@X1T<./W^HFR2C76Q
M<$9I^P$S2FO2W#C2[+><P_W.=K'$;[#\X2%+'N8NEU?+>PWJ(_W"CO12"#=6
MVM3RY=LCQI>"PIKN:KJKZ6Y+D%;374UWS[^K-=W5=%?3W9:@L*:[FNYJNML2
MI#TNW;6:3;P7=MN\*^S+[[S>[=;N_)=,GOU#Y_#KZY:WWIU?9]?7YW$CSF/M
MBZ^)<3N(\:6@L*:[FNYJNML2I-5T5]/=\^]J37<UW=5TMR4HK.FNIKN:[K8$
M:;5SI2;&C4%:S03K1/H'C:D-WA^YD;RK["+U?>_:#>A."0JV]?0M$_5)?V$G
MO>Z84U/C=E#C2\%A37@UX=6$MRU(JPFO)KR:\+84AS7AU817$]ZV(*TFO)KP
MOCG"JWTL-35N#C5N* Z5<_]-X@Y\\?[[D7?]WK*^?X/__7Z6![[5O!OZJ1M=
M>0 Y/MJD?[>[LR2_JO^D<>*-YP7??=,+'F:I"&9IK;/"TOZ_O3W[HR?\T5O[
M//7%WIE[)>R]/7I*S<]KV4O"&:U'+4[?K4W?R>L&VCV\:,)XV00(GY/W<M-@
MI4NY,W )N!*(;THP/NLFE;!)Q&,/A>_+*,T/.\V=^\*U&L);S>9W&JO(Y&%6
M?.+V'0"8A:J*$2@8NW*=.^\M4W3P',U&)XLQ/?B19#KERWBK.$8EE \W\;F8
M12*&78V)W:_ZC[P#&4 (@8;#6>*%06Q?16Z0B)$=!C#?+!'3@8B8I/<=N]UL
MP;]!' \G=.^Z/4Y]?RXO7;?= /X?B;6 X '$K8B&7DRTY\9V.+:3B;!';B+X
M;R^VSZ+P=FY?)/#=%);:R$DY8GYW<+X<298)LCX,#WL8VMMU&."=)/*&2,9\
M'M+ 2V":&R^9V,(%>I=$7OD@X-\>"#L62>+##X.Y[<5QZ@;#]0X#C/)+U.#3
M1A?3(_6' 0P\@7-%']+('H;3:1CP[.HPP@.^CX_N)8 >>^A[XS%!7'&.VTUG
M+:C:S7:_/FX;?MPZ+^&X*0H_#J< W_Q^IV\M.(R3FCM]LE?BRN>O"-=:0/#:
M^0C3F041. Y]/[R)W]J[WFL&J=?\#B&(TXKIRD.8QWXM8%H'*.;;/7L713!:
M0NWFNT\PO.?Z]F\P-)P0^P-(8?JI]>ZU0W)_U_->D]".Q-3U GRH&N"U@%EA
M<0K@OF,#OR1:&;HQ;%DZ^(\8)G)75?-+LNSVWZU'K$,@>B]( =EB.O/#.>H?
M2#D&J2)(-+<[F_G *9"174MDD1JS*VZ' #)N[2P*K[T1C#81D?""UXVU@/D4
M$)K%-0(!Z'7MXXD;7!%U'@.@4>C;NS#+2(R] "8!I%2LWUQ).!X#&GTX/2)Z
MO9YHD%N," "@ MBI9>>T>+[-+04P416T!0 S3+SK]02G-YV*D0=X!EUR%GEA
MA-M.A$=XJJ77ADNO[C-)KP^A6(\5!"&2ZM!/1P*8#G8&64+J9^$(6%%R"@)$
M6555,F:61BB!DG551;2*%AQC%IQY46KHB8J)(B.)7= 7X^%$C%(ROM;CSR(!
MI$8P%Y[?,$P /\+^KX[M#L+KY4QO%4:V%BQEII=#\]V<;R$W>R#-QB"'98QO
M,3-;"XZ:\6T#X^L]$^,[6N^<NTC6J4_G%+4)E?VL#Q7\#*"ZZ$*RQU$XM<D<
M'1./FH6QQ[ZE(E>ZI[1G#]%',8A2-YK;K4/66)T<:,B7QL(COU0&RQT*2GU>
M-OR\])_IO%Q.UB-1V(LO(!NO73\E@98&PHV"Q8HQD.8 K):1DLK ]X?TXJMF
MHW\(!(Y?#GTX2<'56H#H@8J6*\[TBQL-)RPE.RW3[/-!3O'W2>0BB?*'D3M7
M0^&SZSEZO1@HRYX#'AP\P9'X,_4B6'$: %'2^@S;*0)E)'Z]_G&\9^1D 94_
M'/U\/]!QH<'[A:&LQUK&LI@9AJ+>P6A_IB+ \'H71OD-R1;FST)4N(/RW05A
MM5:[@@?UC7B9^JXB9':?A9LK'8*J(Z*56.).;O%JV>_LR_D,5GP4N0-O^,[^
M#$HQH^9SB$CH]',Q//4:X0>1JS&S"%.#2+A?]@8"A!(,/".<F]#V*Z!%C.Z4
M1(U<A:*FA9.;\#Y.N/&%'YJ'7 9;-A;H^LI%<X;V4(Q:T=,OKA@))L']A!'[
M[5S4QS"R7'L*!QC,S,3U,- S$O$P\BARJH*6TF,Z9%L6=GS(.R[=I6P(T\:;
M\@XL/)2JR'=&]LFM&*9D"IZ.QR"^HS@3DEYD&0:L>Q4)"H<"W+'0DR\8QC[)
MWCS2;RK !L(/;QI;?<Q>"+>@[;-6W+Z:?6S'HM""F+J@IF <!?XS)2.V\BRS
MG8S,9"$_F$7BV@O3&',G4/<AGQ>&P?)1"9>8%?*H 8:EG^&$/SI>X;Q\[VF2
M\=Z_P// 2SP/!V">6Q>Y_ "9J6BKE>?3!ZI\GIK,;'$[(P-L0:9/N].P?P>C
M+$B\H3?#&!91&D:TD-1 %@:P@LJ1B7X+F0P>&[9H!]OC-$DCT;"/[#B=3M&'
M(X6G/A<+UH%V:>64%AC0F3/Z11+ZB^2*IX&U,,M,Y%D;S+@RL0$9X/.>#%LC
M62%5C8&'\F/HA@ %+,&GW"!(7=^*75]2XJM^CT([.FC"O]RX0(#A#4$$\+SJ
M<6MX';_!+X\ I!&!]3EL@ %=RNA9>B0="V/%(^G@_""&!EY:749,PSY;.%][
MW?EL<S[E4.6W^XZ%/(""^UEL@I^L9!=M9YVI"9M 6P ^HW,!"[).%^<ALG(=
M(&C PX@."C$Q8Z45Y,0IC[9[XT8C$S(,48$@A3<P-T2G=*@,27@9MAP4_%C8
M+:=%693[G"(25WK:"#(D7\YR-+U[W082$.AVG&%"SC>*2B&;S?GN9ND C 5+
M_P@SS'R1<+ K3RJ(G=>Y_ T^%:>\ )6XT;!!)[%S/]E(W3I8:1(V^_Q:??OD
MS]1+YM:G )TN2!)G/BP-@V_NE#;3,<T@>@6?R$\Z]B)@Y G,,Z0%RUQ4C44R
M=_PYKC,IP5A:&+"0Z!I155C@XA35^Z>=$OBQ +H;F?!+7F"M C_AV(A.Q+GP
M"JAW8%P&=A &>T 8\-R4LI-4-@G.+,,IR.4HR8$V#%>+#P1A8@V$".RI ' _
M8C#F*+U*E4,73E4+X$L\OT UT@-<.L9\,NB,1O ";CDB!L@[F0 .!Y1LPQP2
M'LZ. 1\!2SJ;(Z*@!5$7^Z3 8/[A!ADG8K@Z=(013Z@2SUR-W"I 2AH$NEZ&
M;HQQ:J #=T2)2;D3:X"6=Y,OA?R%B>,7J6-\&EMW"R:@:-02O( $(G#_-%8\
MYG=@WV&:V,=N&JNL-R0+>*A"[9 O_12&(_M<N'&H6)^URPEBN2R%Q?+*R%\C
M^L,2)_PP!,WYM6,#X=]XOH]YC\B'*>T8?E5K0+DV$ %,A*XA@Y%;K-+HK,(;
M.0X<J.)J%"=RA\,(I6 ( NC*9=:#?)1S$U"3L@=AD*( "%-R17F41/%.)P;R
MJ-F*+$Q29OZ+ABW*8'@2.1Z8M>'05?XTY(N^P'-M9I L09N]>UU8UT!DD284
MW*5E@AVCTZ;A5YD78K]JL0H(_W]G[][(4=&FUB'D4^ ^D92']A$J$7$Q"641
MG*]E!HB;)D#"%'/UYQ8@&I8;H?A!? Q RDR%*;E,>44J+JH.7DC<++D1OM)N
MB27&'(A79I6B"I1NCCU(*?,$8:!$D1BP#]85/&@E$U=FY@0C)1)-3R7JTC@Y
M43.)'U*@ $NW$DN9R"L(9A:_F/A'K^GE5N+28A1Q/BF<@21.X'7D^HP<$QL.
MT3["C!IE8L#KK(4HPH!IC$JL6:P31)E^0%@AQ9%U&=ZL>,%N+4.XK1&^"I:M
MW;FB14(.2R5"K@P=5Y%E!;41B&:JD>_.8B'/[%^%4Z0R8(D!A== )<,P3E@#
M6<!;<1PD_Y&8"6+ML9%'.W,CZ55 DJ3MC6P$!4/$,U 7EQ O?!F%Z15JU".+
M<O%B5!SDIODBCN46EO=9;J"D!35.IO,%JK0)_AX@[X-7")NT9O=*-!:LMM(G
M3^NE0?#UP TDPG ^R9N+";' [ES2\@#/R Y1R1>)QVM/(Z7R*'LVSUXL9LIA
M(@TB;8H$8P\W "UA+R"%$G]W0)3$2! 1SBNS^ WV#I2#:J4G^"/*YVG@C3W%
MGC-IL!E:D!$1?3ZE9:U(>ZN.M)<C[?MUI'U#].9OQ[,^=P-+96,7/>JG@32?
M[3;G&=[A$E/U*)V[/)BY?&W3IW%^;%5%^K170SD\54U'SHUI6,"OVJR_YCV&
M.-'Y<64LT<F-ZH%4@]WP9'@:\]>,:49>/(P$LG^<S714L"V@=9>;2>B3ZD0R
M']XT$L'*,DS)YF*FJ$5Z-:L";)_ACX,0%3 89 3Z_3 )HUB9Z_B:"&(65?!A
MZ@&:A0Q">!&R0U:RW0'\F8+PSQ:49>(!_)X@IXJTA:R03!C8]E@6G8$"!@J;
M%T\RJ  -P 786U15>B.W.0'R%XE."RAA$/#2Z7VG4.2R B+1#R0\LDR'AZ$<
MF/C%76"51NH]Y3DX+[%A_ZK3\%:B#G3?NGX<6M)92(5J=JMW5TV$J>V81*^^
M.[_X-?/?Z<*RSAW#6D9NO3FJ\;4Q,(V;A(#]B2J5P'=,$').3!,F=@":C^9\
MIM:L<-2T Y3+Y/"K E"+?:[9@YIVT$&G=/N\"[9A=SJ-SG=2#[9H9&F,5)7+
M==>L[\N7]IE3\2+R%0W)#3",/S&J @IZ)*/:7$NYETP\.+3$&U31G!Q(>H5O
MD%,&L*XH=B-/:+]L%9#9[E%HD,?.%=X-!*;,ELL%;>F.42BX2 <Q*1M)%18(
M!\/0]_GT@[FD)ZX"*T<^Y@^:CARKND"1X56FDHSPTVED!L.V+P=A[2MT,FFS
MN)1=K_9MP8&6J,&J21)FA0)*91X5RQISZ*^J\*'H*QR4$Z-NUS@PDE1RY?+6
M"$0-;/B\B(V[ZF]QUNDL 21QP:QB@@O@S0.5/X@,EY4OXU\5KHJC^A5@6DO0
M^L(TL)?I<0ZL=6MTEYS3U^10-:F/&7&<8PSFP9='US*C6>1#*H&AB][RY;L5
M+'W5(C59>$9B$H=A!4%*.8&D#&*+61FS+O*AA>S0,,2P/D<P=,7I6J *%&*Y
M5&F0';+Z\&S!HCA<LZQ@O12K,6G_1D9KE%YI!FW6.7-6(0!3),M<0.;^\1BI
MGAOA"NE8H_<M&:_0)_^NF SY9S-?;?'UB:PS4F9#T3?>MHL>\:Q"K^B'E9'\
M,!)7(<FSBJ52K'UY)X:<B,UU5!C+G(EAR@5[% FR,++LN]X4QKY")@CDD+"#
M$J<;CST?N1)C V:./>!2D7)B9AYH2I_PR!32B2.FIQ05[$*.D0'<XS&2Y3W<
MMM:]\]3+TBFSEDZ9O6"2/QKAI#)U^D4ZM5ZD5- 9(A;[V\R4%DX0:1835QQ,
M??8B&4XQV>)( )L#_0%5(W7HAT+%H7+F$]BB<>QANX0T8B4),U@MCL!DSB!X
MU2>!()68,&"F>'SZVZ</>ZU#F"8* _?:BU)0Z5V,I7A#QTBMH50EJ8LM2J\9
M%W-Y6I2CUZ1$0//KGD((+@%K?]<;M<^O:PNP,D^H"<OP2(P*S@C+.W<:]L<T
M0O\*%LPX)7?I+ZY,[D$_:576T3TWSUJ\>7JWZ'OR["EWFHW13!FS1;<ANCI&
M*8=5S4TRP6#!E\,J)1@A:E4NZ5($M@EWM[)0B/RE[-<I>,F2B4LJ3Y:(/9*^
M1U)V9; YIZ9+7% ]K^D.W$T#C(\6$SU )4(&2=J[Z3N1KA]23/![!R>%P8:I
M[ZH@M\J0S"M+9<>L%/<6*.-@T+I^76BT <N@(F[<17((?F1*^8-2HX_X8/Q(
M;F+T+]:"<CL65124IW#\LB1R(S3ECL(9\1+R4K<[Y2W/N8B/?CS+/,+2:&'C
M&L[SLI",5>3]Q&?8@C@"_D:1"(RG()^;@L&")A0W2\A: \#L[$' P(W/A@M.
M9W"WV.9<<FIJ8$LFV[4E>?<:UM%*&;[.HLC2Q(VI_5,$MLT-FEZ1D;\N043)
M,IOY9,MPD4L.PLWP/VQ?HD2[3I0H)TH<U(D2&\)R7Z0< =9LK<R:=4@G\:3?
MB\)Y@1L,,31F!IX+VJV*42WL4V,I5F_$2@R>REXH$@_2?^:.IEX 2C_E79";
M>:CC_P6!EF4&Z)#S,(V P6.D!I1]M!U0&0['Y$HW8C<W(2XJAD?>VER8:4NS
MA18'QL6XHOX>%WL\<3U$A9)%/Z*D847['X#A?T;>54S[XVK94\"9M1N'MA]B
M(FR,?D<J?8PH38%J21:\]MK)8I:X&[1]&"Z=DFWBV'2YL>Z?Q2N1#_*"/NH-
ME0MR+%ESPNV_ -_WZ?VUJ)]7P_XTEI5\F*&(J?19\G!N]RQ>0D:&$=B(URRC
M/<ZT!73A Q)/,E4V-\A"P2^39V<SL.@3RDF?@;Q@QZ"<6 ;=<^/QJ=%4J5R9
MG*O*]% X"X0BGM>FO$MI384SS)+F'%_TUV:35D/<L-29D,'#F!Z4T2+I"BU!
MDR^L.E,9NEF'B-<9_82 C"C!D,O<R TB]=%360G6T,S!<3D1F5-KTIG< &F&
MJZ1[Y=V>16+/R/8QV<<4Z"#%LATCX\7@#.:C[-9N6!=(+Y5C($L;>92'Y4[Q
M0)FKYO0@ MM1S ^#!JI$V=BYO1M ,C[_!@DN *[OC1 7F8/((3,+1U'=0UW[
M&OW2;.__B=$ #[-OK_4XF#ZAOIH*#';%>%)R+3<5$1.HQ0RI,H7+X@\##$<N
MG-*<8T>6.EV+(,6?R%6*#0A^_'3YX<C1L6QDU8IQ%[:0#B<G32NR_B+FBH1A
M)KD4B_WS^F'#E^;&9="SI0&0G%=&195V/!-#;XQ2YT:@ TYRP3LPH5.\+,YK
M00D!FKQKYDTO8.*ERIR%OH[EN6@Z_H%BTM=^D8J*"Y-TKT+7C[7UHS"LD^VJ
M9:3L'H?>*4RJ >M.>IIB>#K;-:9U2V\L5?.HAJC&$V"V^<8Y5T=[YLYIXH+1
M)OF?<A82%'1*M""B/A@,D/0F#>:6N3P>45>@<C85%F !Z6R&257KDG?V/LF?
M/R(+\GF3/9[E7L*AHI0Q.)\.>V$%[;7P/0[X<EU_CO:DI U3?\3<Y :+K(GH
MYKJ[4H!)J!:U;\IQ>2F)@"%XVC^ <HB9B@^LC<ZDFZ!DR@LC3)HD?^HR=F5
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MDZ1\Y;#P"B7T[JCX]$=*C F#4H!Z)(;>%,Q=,N6X?SO&EI.W03K=&X7)GGQ
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MWQK,8;R#!D!-B\4+>94EL'BY^%)[O]'M\=K@KX/R2SWI'8!GL/^>>MM&,5K
M,B&#EG;8:![6$F #EK%4 GP6B8T7%=J[V!C;?EV+@^U8U(L2!P>];T4<(+P!
M'#D?CUR>"W<ZSN%!QVF"1"@QX([#@+C9RSE0VL1QNS!"JTTC "->]&Q'"AZ\
M=12?=0R<D0AQ#G&WJL#HW@%&<>AE8'3Y6;H$G<'($PZ"TG/V6[UJ<;0,C.+0
MR\!@6=4&(MEO;K.T>E8'U%H]_'MU#_]R#_]6W</_6SLT#[F,=K/5MV2[Z$_2
M@27L,]\-:E?L8R[J,N=.BV4G<QWX!&GFS4#.C(6;D.-/W[;3ZM/NV%YL_0D:
MC3?VV'_F);&-NQ<)V$D0@9$8BXA8@0P;C5/?)UA*8SDR!N21$A1&LS"B^$YN
M%#>V3VXGWL!+ #&-ME*ACH( H+#.*:B#QN?',)(=Q5O-O7^2]5<(MP*8(QC]
M%S>".3LM1PEFSX=O=10)?9$PW#]2T-G^]__]UV%___#=__&S]JYQ-1%]D8-"
MWE/TVK&/P%H>D<7\.6R T- WC-U_X1W;O*:,Y[5Y7GE1KIK3PCG;#S%G=_&<
M#?O,N%ZI,!%YFBUTX[;VG3XH2JC1T.5'1$\EUP&Z8Z-K%?9/D?  3!R=J0A?
M$-.9'\X%'H$1T-HP"2/* J [F5(_ 4AB4,%118V'D3? E0F@<D>[QX7*%7#3
M9!)&<#Q'\H*E H$'0S\="<<>I(EVS_O>U$OH1B=2/N6 TO,QX\ _DI!T*$^%
M2W<OPFHOQ#"[$:O;;JL,IN-P)!KV)^EBR8&H,S:JP!.W,U@_H(&3FF /X6\/
M[XH2MR(:>I360-E4@,VQ0*@=^F),UZ?*;8!_63%E7\$,?%-52GHFH#-@B+,C
MH0;6#J$<M.PQDN,:>1B4,<'KD>$'VYQ1OG#C^3Z8^)1FX5Z[GE^Z:T_N6@4N
M&B]%/CRCY^8IUG8T D+UXB1RLY,@F]QER\:+<$PI8[OR+:(6X%)TZZEI6L,'
M.)2)$$C>^.L@1&(#(LTXA#R/[B F_J82>5QB0/1RP[[(:!;C1WBNRG+/*1Q#
M-UL3S#YU,1R'84<9[P(ABED8,"1 (C+FXV39B)R* 3OT!<P\[7#%=?#1<*SL
M49P[ 7V<X%)L# \5P2K9H$I RC_BH2$P ^G,,;58/5)<70A/ D4D:2(H)^J6
M<T8L%5;=1780 DLDIC<)?3R.[@P'=?W7MGG;'@N:7!89PX-H&N39 "!OB'S>
M]UF=4/.:R5WAV-)N"<0"P$(SX'!T+S3P>0!&LRE08X:<(R:36BD-!E$%LEF/
M"41@_ K#DAQ]0P#%$WL7(!&SA%-:%+*L!7L/(L*QER'(H80<;RCOL)82 ^\$
M)!&"CXFAQW1-!2>QO2L5C8NC\SA3+>"5F3NW"$1B\S'030"GT1@3WRCA,L=_
MF608[SPID5ZV88718.)I"-@J)O):%5R9U9&I^T5PR%M=F"K%%0T[$F(*^PV2
M1L0Q*:  T@BH4W/_[/2K(+#)]E\:AWS)W)\NH8ES7!\7RE_DN;[6S&(C1QM3
M.DV>"I0:A$%F@^24L(7:&1Y .+$>W4$D#YWDR-D/%O^ I5;PO9D(0:#$Q$S)
MB "@T,T+-@(G,)A*7JO?WIUFMZ(J98^.!1XFNCZMH*:^?;1]IW]W>ZN5W^P]
MN>W[0*FIN:S3E?)4[TQ-77WRBB36?+[JVNN0V_#F_0,,\J![2>;PDJMLUO=4
M/H)[Z92///G^5OUGJ<D%_"3Q1<:3!.@*Z2P,M,I!^A.H0"!O0?](9Y0BIA*L
M@*^L TF03@>"<OJEB421 [#.0 \QQBRH.\BM^ 4N["G\"HQL+2 R:SUGJ0\Q
M?L[J.."%6:N1D08:!1K+H.+Y(-=1=0JRFB#6=->"0FO%59D&(YFQSU(B#6A*
M]RH2S)Y)[[A!#$C]+?&F*L-_?<K@M#5Y':>CZY?<"J/8%#N:K) > NW$  TY
M=-8"PEP#)TE73N=IS0PTQ1M0M)2#1::\H2XUQ11 VII6\[NU@)#"[#KD+&I2
MNG'UH.4-?3>6A6 2H+$VV$CCC4CQ!4%.>201.@IB;^2![N>LO2.:U(M4CLX$
MI+X@- BP!<O4Q1>+3"XFL/6.R$)B;.089"Z1O!;MM6BO1?O]P3S/=/7USZKA
M%2D9 Z3S*P<%/<CE894>%G@9:-N+)VN" 6*3K8'UO%C*=8_02>]TSCC)(%L+
M&C2S%QA%VF-+]PDC,.I!]@I(K]IPXHEKH5(#PX#6@/)E77:>V5FAZ\?5D-$.
MU:RU9JTU:WT4UGJYIA:VMB\>V1>Y!<N.%4??.4^<;BTX2.G#4CP7M/)J7D+,
MBF-5S#^53S''12,/O8TN>_H3(/XUK15V>]YZTW1JJS+,F3O'H\H^47:%5DF4
MFJW5;*UF:QO!UI9[HV50W]25V-^R C=<U];..">Q.*UT$C0E+U%58D42FMKL
MK@S.KP6'S.YPKZZPR@Z,7,J$,#7@2I<9><?NAO,>2CS%XXIZ>H1YDY60O-:J
MK.2[6>,86!I)'98,:X&221%3@I@Z<LW1:XY><_1'X>@80UOKM)K^>R.4F,O.
MP'IB.+R#E/VHU!>&E3C*_T)><3LDU[+)U.[I4R\QZCB7@F)3HPH.RE-*XM&Y
MG25W35,_\8")L1M^7=^I2GD =J4*JRAAC7VB[$:EW AVL%8!6W!Y*LCNXTK&
ME2G^_!4@< C@'KY]F/^I&/4Z\??':FRY5@[ 6B42_;I$HEPBT:Y+)#8G#>4E
MI]A@/>$E\, 86#O0HN\EU"CQB.R3!9DWOP8R1+8XJY&;<*#(4K'48A9D%OH=
MA? <2DH7:PN4U\5*)%2%I,0P\-D5CEEO,T\ZD!$ RA=&]5Z']O2WLJINXE%:
M&KI2?&\L,"1:9X1MU=J.0:%VO< Z&N&D&#Y81*2?6,Z+:TDA0WY3]C.+=2,"
M=^8EL(Z_7 [/8S)&Q"^-P%P-6*G#;J2!CWX]%;% "AT "8\Q]H,$'R:H*[H8
M1);?9CGIE:F.RXX/6>TNK='4&LGSA^'RS"BV3*-V)'R/LRRJ#&N9HIJ-Y\C!
M<%BM.TE5TTC78/]J,257=P;"P6##L!B8M2XR\V,[!HT,SG(R42D/=1;F=J[M
M@Q>#WD0'P;%^]OY,O9%;RL;/Y64:1*<% =&I5SB4V. OQ(9ZF&ZM9\'SY&?S
M%!)"\(Q:7%N"1\[V$GOBL@ 9H$V"Q]<+T]C/! $1JQ0%=+1T 8SM3:=BY,%?
M6&=/S0:E(47%0=.IAH"[>"IHN4M^3<A;M;8/'I)B,(HMV&;UP<9*TFO71U%"
MNH?9X(_5H$:&E,]A@EF[1H_;.59N7>F*1="WKT+2-8!]>I+-4UJ^Z3,8*4@<
M2_U)W3 5' "&Z5203=2 +\^DJ>_FO(<&99-Z-!"Y[+&<YX**N71C3CY#EJY4
M(+GASS67Q[0PX4:!&-6TOE5K^T6 LA(YUC&7<6"7=7@J"OT'X=I3&IU2\U2#
M6$JUI!EDDOJ8&D(305D%U:=:H] Y> D8K[)G]#(E2=<XQ49L-JNE(35$:76P
M#"OSV.N90/M)IQP%P!Q+?0)54B0FD]#9Q9Q#KG!2KC,4"%B"@D4_LB16ON%6
MYBHJI;'RM?IP;=7:/J2\;8ZE2Z=9';[,*I46G+/3Z@2'B:1USHQ%IHT#.T _
MP/(#(M!,9\D?"DGO5E7M&!$P@(.M.KFG4$+)M)0,C(6RU+T9/Z \0'/8_ARJ
M$RV-BJD[$HH/<+\:!I7;HQ6#=-:=5=JZ/-NL^RM56E,:UR@=RLGPW&-R1#DW
MW:PWTY6'"(3\FAZA[(GB'([*_";53O6YSA5YR]I1 [6Z5AM3UE0'?6. ABV]
M(W$(3T26WK51T>*["5-_9.ZJ"(P65K8[3A!F[L/OCF YM0S>LK6AP>)[1H/;
M%4J]#%USI<JPS(V&9:"8WXG=BQ/W%L0C'!\Z]%1R 0^D ]\;^G-K(OP1U:#A
MMV.21&8S9-EM#'^4=:3*&:"*$&1-:5Z)E%93Q4A\/ IC6!P4B^U7+5X5H-G'
MMZ2OCMB4>ZOO:5%Q'PDWITY<PCJ/TX1=&/\(![%]-$P4DOB_<.#V"]TWX M\
MD1[EXEA+YL:.M'L(P%Z(?S$>XT_7QG4VYIG%"1KVF3(FX>.!LPB3JCQ7)>>.
M2%4ZGGAB;)_H%M&G8V#@0J- 54;H](1)A/DBQ.0FH*Z(.&'<A_Q>7'QQ5Z:3
MJ2(;GN^C[G<OYWO=L#Z&M)X#F@M;Z)OKO7M5I&>IO./55^94064M>Y91\!6+
M+X.DL+L #,X.P0'-TAP[*RY%MGW7 1K+XA8\KT3D P%\B_I_:%KJ-[!!C4EF
M^B%+>RS^X08I*)F25AU)= A^Z7AIML#I."- %3G?9UB2"D-)D+.%E*\N,4^Y
M7(JE[XS1UZ-0\D^"3E?E- 46M6>D_SAV2+%KQ'HY^[*<)^2:@GB/=1R$#UV*
M]HDZE)8,(%1BS)8J.B%W(=*HB0R6 G$A/R(+![T?9MY9U W&IGB&QV7ZJ2\*
M-I;!H-8<'W6BZ4RV79'YK'B-%/%PM:GH#AB-75K;R,).Z '[LF/6[TQ=S+4'
M'IME9-"Y0[( F>E)_'%@$73%:X'JG^2TA,%]J2NR1P[OQHD\DD_4!< 3LIL\
M[4##^AUS"7PL!9"OT9O>%-,85 6WU![ML2]N/0Y1499%KLR_JI]_S*^'4[Q1
M!1OZAVFLK2Y)9@T0 ]A1'L;PYXYU([@M!)T(5KK0G@M!<,X90BI9,R>;HI.>
M]VS.EB\=L,SO7R%'8%:=Y>LI\I9JLQ[9TLN0?2+8Q:]'ER8#H"?UDU*_(#41
MWT] W?EY%6AJ9%H#N4Q-+&?XR2D1,79<EJLLX9M:(Q<9C9+^V4T'FB,#!"72
M=I;4MQ &N ^F95HKV.=5"Q?8FWS[5)/(,2XA(SX#E!#4V@3^R,I5"E^K?BJF
MY@^'=>:Q_67A%;4\*7>%R9\HV=8#9@29X MNO8'MMA2=$(_*\,M4W;!_(M<A
M_,@1EALAVP9PTX#L7 ,D>(D$=;>JOD@B!Q G<Z)'&\\+'"M]S40E,L)85*W_
MG;Q\@8]*:;NL;+NHZLB7,XZR/ARE%;.01%RB81AHEPZ^4+TP1Q\&%E]2MS3
M(*44E^ #5_$E>U4.G^SX.,;U$CXQ%)\\/5);$#A\H+W_K.;.D(-G7Q2ENHT7
MR\\0B=;"(4QYLIR]U\;>9N4I[==Y2N4\I4Z=IU0?KZ=8VT?N2)A&PCK3S<@,
M9TD^?E%NLR6U;>I9F;)$CL15JEI819RWJRZCHUX0[-:5[V<-U?A!"U5D&!'[
M6F(O!Y:'0R\:IE,,:PPYQ82K;]5-DQ.7I1#;IU'69C$?8LD'[(;2Y4HR7(H:
M\DRFL6.Q]:<6AQH<]2^CGHQ./J M[Q;.1PY5JW;^;Z%:UY;9(EFK$G6/'T8V
M1)+XA"-+M\;#98(EQMW/7#,%Q'#4.H;V*1&CI+.!CS')> X]XG3RLC\N#LF\
M[-J'J_/,+(D,Z6P.LLB_WM1:LF[5VHQ<+[+M+RBFH(/YW!P+5"V\)^P$#]"J
M?('(CKO-H2\!3@N:/6XV'9L,Q5Z$EI'X5"I0RL4]\EU)=>"C,ATL7UUJ<)<L
MCDG5\S)V85$V 5U79V03V/',IP9DL"F12[HZAAZIY=\HAS!V@L42;8+1MM5M
MP5](=W-N;&[E#&&B7>."RKK/^78L"@M(LX[I7-"F[YA<N123^ :YDU1E9*ZK
M<JZKIN%*DK?KYCU*0$BQK3VGR BD[Y>_&,@NS\KCH3C=C4#;&-^0%]54Q&$S
M%4!=9)UOE_[2I.[7E"]*TV\(M(%=4L!2DW\5ZA571TAUT2(8/DMNS&:#:D>:
M1UFYWEV&:?G:;(D>)A,<V ?K%8U%) .^F6'Q#=C*2JT80N$8KU560 *J$.4_
M[+2+Z%P"<&GL*D,90$XS=S9 _OT@>O->'LW"E_*$RB?PG,JKZT+^+VBS_!NU
MV1WQEW2 ^6MU@ K#FMJ&_$9IS?SQAAQ[*NL=SR=_SYU_OQ[-F[]'OTM>M"=7
MKN[.XD\GBC'QQS-D3P4<GY9P++L^RD^[KUY_"WA\4*UER<%1!"JF+CMV^;/6
MC?DEE"#9@2$UF3^20)-Q=Y9H^@!JN:;F(/'&SV(/;JE/\V\Z(EB BJ2Q.J!>
MH$?WTVGP?9S.WN^V@!SPCYS6]=7T@>6BJ[!G8.VPP^A9#D8H,,+HK1U=#7;;
MS:[3QIO:>KW7918NI4B_^UV963_DUI^4E0R[H&2@3B&&:83/2;VBB-=*G"I!
M^%WUT2@^5;7.ZO,H7SDLO$(<=.=]VSG8[SF'!]V%\*P]T]<LX=5ZT'<:^^W-
M /Q^N.^T#YWV0>_>2UC]5)7/3%FID9I;YGE&-KN,Z$O*=)'P"^M:,,$2G*^O
MFRW:BO5&DCND\UE76,?JH-1HJ-'PN/*P"%*7S'/,8+X+^.Y]M@!>LD=A"MK-
M5^[ HH'N$E85J[@_'6XT"JHDWK>S^H42\QXH4"?P\9I-M4M0+'#6/*FGQH@(
MGZ>^V#.CPE41_86-HZ26TNZ!VF2^; )D!/YIL(JHOP*7@"L'K4LP/NLF/5;;
MKG40SKZR.]MV533C6N#0M\JJ)_L/']>88HOH+OOR45ICRR;_L24U5@_#U^2Y
M,CS*%07\R \WI/-1'8M8NJC3P#I*KV RF:Q[2-FZ?6=1R]U<D$"GPF+D4%TS
MIX,$ZLE"1!-S^Z9\YQ%>LBH&D9%MW7+P\J9#+MQ( V%"U6YQ=4=%/:IJR:O;
M=BV\LVGA+4_%[N!6^3(G.W>9T\)[UKCFSTRG4%&<2#:%Y[O2XHGN]WF4N\TN
M%[3)%\E67%ZJTF>776-:)MI54ML.ZM2V<FI;]R6GMBUR6#Z8<'[ZX#[]R[6]
MT0\[_K^;K38J)^[[1^'9C^)"/SXYOSSZ]-DZ/_GYZ/+3Z>>+OW\ZN["//G^P
MZ9N3#_;9T?GE'_;E^='GBZ-C>J1.!-B.1>43 61!'*:^F[>H8WV0*Z_)B#UJ
M/S*+/-\H3VIWLSM25:4*%7!PQN#<R5(.J?B*FY!ZP77H7U.2(<D88R+9F11^
M>]5J\V7;\H)4K.0R+D+2UR"I! "9J,!%X'B!4T*WC&&YU1YF&HYE^VK?Q196
M-_+.0X'2CN]5-\JS7CL67S>KTB6#N1K?N,BDHHXDC!PE)[\$X8TO1E=X^38U
MX*)"QO FD!6 V=55O>]TE@7W_E(*0F3AQ%.A4C(H#TNU![)YZ[G7G+[U/FOW
M EI C!LW<2E=D5++:']<N0;.,95_J[(H77KAV%E5HB7C7%F:5KX (I?^J,K6
M ]5]PWC-K %1%\%@(4QV@22EG7JQ?1:%MW/[(@&PJ%:/+I8T;FB-Y;W>@#'\
M+[PI:]6RLDDS8:DA2].V.A'KA>2376B#SOK$!AV<F'/A4X>5,\PS%G$M1K9C
M44?47H/2JGA],K>J[; X&.7R1X(PX23TK ,_R), T\I])1M@N%<]YV#_D'B_
MO'($*>02GH3QCIE%.EBE!>R RMG\N85\E0)<OT0RU_;$][';%?5IJRZH=N '
MUXMHG8JMJ]:#$BBCVLPA"0(*Y02,JC!*]K@"/0RN]I#_V3=A] 4KH!4/CY!I
M1K+>S2SWEPOYC,A0Y?[*M5%:)]JL)"G&*74F!4F5QK&Z:5?V'# &!+1'5.9&
MOB5 G04,/5R6S$<W<8Z]6RKVPM=B+EB5W1=?=1JX#_I"SA=&P"_R5))RYT6@
MYQBD00J4)+.2]Z/-Q>;[CJSK1.JI/J6D%K&*(,FCGZ^RS60T@6#%(O"X_^X4
M&RI&5"O)%TB#$ _I/Y5/4$EHX308K12SI7P00Z/HFSE0JTLS&/KJ ?EW>HYJ
M6@>,P)=-.ZIQ-<(;-8,R<Y.])_ 1ZC,BK]#^Q9WGGF)/TCB-2/,QGK0*3[9;
M]BY.ES_:6)&=5'#6%M?U#%R?_#LCOO;S5;?1S6V#TJYT&Y%7K48S]P0R;G<X
MC%(Q,I0^7)7)L@N[:2)I70!;50!F?4Y>-1N]/"5]/8 _REL!3H&U9UT!]F5;
M -R?/.VTF$CVN="9"2SV;F$2\D)K%LGE[BS.%HHH[J6ASQ ;)I7RKMDXS*V\
M82%5!AD_EZ2H.@;@50%H!T5A>C6I)G])HR(2]R/2W),62O0%1/I1^C^I60B_
M74D3-V3] >:PBU5FQ\':6Z5=QUD(.=2'2S(;<8O:O'!TL4L:9 /J-Y \6%1F
M/QJYWWFH@((7_>140U:D1XM[84F<4;\TO<'R!-02<PL6=1I8^=XK)MV2;XTW
MG6Z^UBWVD")8ZSI2E7S54LOH99(Y0\#DYE0L=?.'Z_N6-./S*MUR28/*MO16
MJ/8&;JY',+T;R[:3(CM1U%-#L2_FH_0\,1Y+]=:C*0\:O>]6GR5CGF6FV#Y@
MK\YBC;1AGP*.C<@0AV:J-X/]"H^X(W9N1ZS5=J3S,+CJ=)Q^KUM]V9A$E6XR
M)+G</U)_KO2=S!![9 JV%N)K 05G4$HOXH/@R^HU[Z2M%\:W7BHSSELG'76H
M*DA9==C,BJGM7:Q=4AJ^8S:R.E$/:VK/+' B^UU/=M3[NQMA@;=U,46:!@(C
MSQ3Y;G]QL<638_^<C!KVKASY[Q?'9[]DUGR M?P8P2:M !L!R<L>D)'"PLG@
MN9 ZY;&A4Y+U(6OOM>YH&;IBJ^GTFAWGL-]3YX *[U$]O!"SQ%1F>X2V9C'N
MG06W.]+\X)"W.I)]Q3@ =EI6SGM!WQ ;5*MU &L%M-EEM &^&F=Y?'T]NJQ*
M=)FJ==?I'O:=9N<1L67EL%5"EFWBZAV]#?A2""OPV5T.GV?DRV3)VX"_X5\Y
MDOX[YSP8?2,-7.(F%,SJN(RN!=:]@<6^T]K?=]I@5>2P6)9893^79?JY[.KE
MX4N\Q,_*-:"^HF]R"\[YS1KVF2&9\*F*(TZO6Q)1FF'P'#0:2Y]B1_NBPS$)
MKP1I&_1@9I&B<49>0V4(8C<Y%%7X921\+_@SY::!V*6#DE=@6SAA@Q\FW8O]
MBZ#E *H+$BP0-^C[HQ9;KLIZD3N!3%35 A[A50$SD6"1OLE4SB(Q%A&>'>I4
MX%@SL-6N,;\"K9QFLY7Y]W([6!@[/TIV_ D?V J18.-QB56Q"[=Z:'K8HB2/
M;*2)>ZT[<_$-IX5;6\B;B\NB_M$TS0>)%JDO,)28& ';>LY(1G3];#8M&.?1
M9JV$MAS\BX'07&WL^2:_*3C<6*1E] _<+1()_(XF &%'WRN8Z$E\S-JI+<I-
M:<!U6&<IE;.4>B\Y2ZD^5\^]J$^!E;<1QW056A+-V218H -D2D6F+[7VN1\T
MB)R ')*A3)_0ZJ<2TF')D+2,2 19'OH6CAE'L N6*DTME>./*?>\,50PX.[]
M.XU7=4U.P>IMWVWUVI_(L@YDTH06.HPW*6<J-:=B,RNU6&S^-3=79=&JG$+\
MU7A<FU88CJ3&KN3)U[=HR1V)E[:_SBP-=B<PQKE5&+=IM]@]@:W/W "K'T=>
M/)/]0ZDW-J>R4(_Y3-0;2>;YN[UL'5B>>%-;-L>F.Y@);WHR+Y8]6U6F#T6D
M(]W0!,-JZ$V37=/RSW)6D,[D85_\NG J8/(;8)4 DY/M&M<T*W+7S4#CUY2X
M1??38"\Y((/$\UDO\Z8B:Q"=)^D@I'@X+N6&F]?EK^!8JD_66LT6+ IS]DLI
M@&6_S,\BP7;F!OM=[)-9Y(HQF'7)RK/,D35?R5Y09P9-):P%N/6F?*'>JU:K
M$"C%O UL/5QL>+245FF5UF*&ZW!6199$T6ZT#$N(? R<?1F_E99O!G'/Z3?;
MC>:A =!28#C#H^WT^_OP_VIWL0*+3.ILJK;3.=QO'+96G8IW%TS4;LLYZ!=$
MCE7  -X^E/<.9!-W8.+>&FM4$_=;?6<_]UIIC59>3A!VY<(K0)+WWXWLPU;3
MZ72;CMTY. 0T-NGA7J<'@![R90Y[%.)4[6ZHRV4:@<B,Q1(/O6JK0YZ!I41!
M0AH+U#B-<E;P:YA".>\.4C)V]U8?!'FITCBE]J19GSWEH@B#%6@\WQP4M.TO
M'M_[A&YZ*B%):!2N8WFG2F)&CFQ+'Y,P('=:,+?NV-[8ICM@0,[RXF :=G45
M]HN!4K<6(F+4ZM!"$MPW&P%U[-UYIG!$8AI>"XN[T^N\+-(=T_Q6T@54!02_
MZJ&"14J65]#:^*H/D>_*N!(GL7CE^67K*7.W&IC!,/9"=FMIN06+XNS(8K"K
M5R)J3#",[:[3/CQH'!05^>5*D_T1Z95DLJTS\F5B"$YLJSFMS!SIP33[:TU3
MG9>H3QZP%9;%\FQI6XB=>,J/E7>Y%1;R(@G@12[J ]M9A0MMC-0?W6"1V)G6
M$%7"7I3=OM=J@@;2XR2D5KOC=.&=)?:O=#1G'N9FHYW/:<.!RHD[) "PL?:U
M83<ML#*I<:3J6BTK*5&FY;(&'VU'E]>[/W B?J%+\R-FW#_ULD[1A'[T5=4\
MY>&ZMNF[LEQI#.2"LS+)J7!YK>G^D,S%+641JVBGF6W9R;.'BK03RP7EU0W4
MVS$V#I5#\.VC\@[!#""5<$NO46(,QX]SJ:>M?8ZM<]HQ/8JI,30DW8EHN\"&
M?(^52^L<WTSLAZYDX-D#E>>L[J;#Q>8393'KTPLLS*>L]<TM6-1]);.^W$%>
M_$"G2%W*E^75C/DJZ7 TQ!)*&=VF=^))>".ELT'"5!JDO)&_N\-)/. [P'4)
M8A@5SG'#_AV/[#"-.-F:BPP"O-J6/:F!4!T7%BPQEX='Z[1XG:8 1_\,WV6?
M>>>-VL2Z[?P&+..$^DS0=1Y'1MEH+=&W8U%8@\1*-XC6B3>+<PR#BL/S!>99
M#3"FQ" 7XAORE$M,W0 L-%WDKY33-\B5R[+)+# *M]<N/);9T4M+C'D790-"
M_H"Q\5$FK?5]L1EI&VZ]ND3YZY:Q3N9&KUEG;I0S-_IUYL:W=F@><AF?@$=.
M TZ*0U],QMIJF;T=BSI-(^O'N>_>Q/H"-PKED-HM%76CU8G1]2N+%5'7$;I*
M#6P ==$4)2@,8#%9 F8N=R'23XU2:@R!AH'QO!MY,=WREB8J2\+%&VLX.P(M
M%0K@&I>LF^!E;CQN A.A73X0 /*X (EYZ17J$S"?E=UVY<A)P2 15P <<4<&
M@8T)<CKHGPH!/9RF"KDW0F+/D^>'^ZR@J6Y/W&B*^3<696(P;E4FDQ?9^*]8
MML,SKA&+Z=YW'E1FVG \D'(W]%W7?-5M9HA%&>[RVT,A,32DW"O7"V(>2^4Q
M#WW7FP)-_2<=76695KCW>)\N)JKHDB'RF*BV-(IBAB' I')1\"Y$X<;Z>EI<
M(Z<$(]1)B)(%:2-;@VPV=/<JZ-[$W/B2BLC&]7UQQ:8@M<C)9K-SLR7N%T&!
MN9#N%1Y9Z@6^M)I^S5*%)HQC6G8%@([<29,&0/&=#M(H%IQ[8V",3P@\ I"Z
M9D\=61<;6[PR.'/SS(+. ^.5L\ H28=N+,9]S+817U&;F#L6?&_WC8CXUN<Q
M15Z-C;686I#T4D\>42(1NF/;O DQJ]R>Z?LS5:SHPT_'/YL1Y0G,>(THD_RH
MFI;T$?*$)E;>=Y%AEB9WV)1@U&7H6H @6D .(T6.A);#+F/Y-24_85[A./6M
M*18F$X<JL(/<3=JDVG&.@Y>7HIG[Q;!P\MT6LTO,*0@^U:Q:&T*QA>T=B5!5
MJE=Q&IGIJ):E]\:+<@97 9@T)H<-V$B>N,[2PF+T9@*G,S<6^<>2M:$Q!G@'
M7H?.733U$F!F0^5F(IBS!IIJXRD(686+VEVY!8M"%T$F79%JC?-%E4AY<C&H
M29:"2'E*U^%2!P#J!&=>$<_":X!^4;HOT\87@#'92I9AXE)&0]3B)R+>JR70
MV(/C2S$'5D[(?3ZG25T_QM B_,ZY*+[W!8[").2+:_&>^6N*.MHH"J\4T>N)
M\\1K9>U4\?9+O#,>H_CH41TRS_"H'!8/"; 6QY[2]?"<V9E@'HMNAFL@H&$?
MF9]UEJT78.(FG6K9^Q65#19I?*-?0L7 5"$N+Y>/6?O)+MJE&4?N%+&N+MJ3
MRUO HPII3;%8LLNU&W8#EG$6^MX057+<QK,H' *U8WP>3\JEZ;\C@:#;N#&#
MK@V_[5C4[]0F3"HCU%H;..5-A#INH/9TC_<TO^E$'7.IQ'ID;ZAJ/584F7AD
M+%(3#U>HZJN%<5F: 3@65E:(&Z<0E"4V0NW)D.L!&Y+>6.E2WI-JLNE35BY5
M&PQ;^PCTUP2M 5+=*6-_""P/U7Z=;XPQ(IR4A9!%EX\C+ "I([N*DQ11H A!
M'TEQ7P@%9?N"INP%V;7J%R?'QFWO)%*\N#"]NH3<TCBEI'QTG3M* *ZP-UPK
MFB^CI(32 CZ. 1D)!H=_4I>A.^P1ITV<6P3-$)?-MJ31LU7W2;T1W')(]1L=
MB/S5\4YE%UAN^1IG'5_)MH0Y\CLLM3ZYI];$'3FYQJ;.BIU-%0*,%3345.=5
M4^GVN,9%\8YLNFKA+N@4]$SHA55Q"+-2/@ 3,A"2D:KW'+,T/*?&H$6?U7#X
M5)>2M9"UN(6LM%5B[6"Y#A/*1\VJ1C@Y^EI.(5O(<H?9N-!*5EM7)N48V?:<
M9&@ [ Z .AY/:.?\P0\\\GK1@U8=/2A'#_;KZ$$583V5XC'*-YOO/$RS^3NN
MNWGT%O2GEW\_.;<^??YX>OX+]:#?>GWZA9@%'X0[\D& 62B^+M(!YMQ)(_XB
MDUMH,,S"&,QD$CR?0]4FG-H9Y*SNSP"R_8=P,POU* BP(\,O0J 0VW*,Y5-M
MMW@9QNY:V>ZJ6W#:S7:_M'%/O>+:!KS/HOX(4W(3QWB8$[36C+TMF&*)+"TS
M/4N@1=)^Q]P3U,W]ID:3Y<]J.!D)(/TZEI8$.N1FE(2C-/=8W]U005X%CL/-
M?K+YIH"]3&D=8,:/#RIYQ,&>E&N6W41>=)#/DNP72@GIP@C9L@AM/C (P3*B
M("?9<ZDO5):3MNS,T G>DR?S@+ONWD&Q[EY6QF"DX BT<+T!%M:/ZSI%JJSQ
MT*!D!JP-+2S1GF(!G"HYUYUUI:U(R"M@MO:3/]JBCGS <>"JA-/LTCIV6CN%
M$T).V(A]U&KK+5G_MS+IRYBU07.YPR )H4 #Y%?.55$73BY==&;164ED[6IN
MV('LLJR[8,KNJ?W"76JM)G_M%%HYY 8#U@"F,L9V$$)Y,+6/&A\3D3^W# Y"
MW@*Z)"V=,7,B)P.C2C(E2B0<#L',HJ;4.I(F PC<EBR:A=02]0J=' $]J!Q8
M?"0YZ*@@!6Q8=Q]+ ]#<":7?\9CFGY$UM2OL=B/WR<( FCNZ]F3#5O9;Y>B-
M7328K. ::97%FPJ*7=!@3,)$MO=5?!V@01\;1?T8EEDZ -3A8J]=SR<F*?TN
MJ@,8L,R/'C9?T=WAU*4NTGO!(0JJ%Y/<]$WE)MV(0>PEE.4 "LHD269OW[SQ
MH@8R^C 0#>#;\'%O$DX%*B.-FMEM\**T3FG%P,JP-AKI>@04R93]]HG6^_#F
M[)-NU\.#_S.<IM- .-:G8-CX?A"]>6^U^X?V!<B;B?TC9F? 8?\0>>B(O4CQ
M/+:ZO28_J'[^.S ]F.+XB'%QV&RWVOS$$88:\(R_E35-($T"]PJK^+;86'HA
M-E]FMULEN[VV^K9Z4<KJ8T$NS%0Z&:&HMO]PVP-TV13T+"FZ<[$+T(W8=%)I
ME15JB50S+:XQD\H&:WYW67!29<I*'8N!EUP(0UV?AYH)QBO0 !1NY'O*!,3V
M0H?-[^-T]CZ9P&[#?V5PA]"$G8AA7EV@:A](77<WNX,$<((0QD:=*A6C+5?H
M7FO+C0Q22T%CM]K/ HX9K5+;PWFJ=+LPIXV19H9V1BB;L12(A[;0,SI#L ,
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MH,@$'2DRBJSA#I%A5;-"1]U)Y1KB@R\6)Y&B!(F3W4N4XY(!H$1R2'LE#KD
M#EOB:N#&'E?C2O:+$U0R51*P)3FP8/0%.'%U&A&HVW!F[9'<@ECV*Z!)^$HI
M6O72:YS&$3=@QPO*E\D=O-N)X5'[:ZDKV'F6AGU"%V89O<DPCS#K_W"CFDEA
M2E7BR_3-$@#<A@$ 27V^4RZ;0H)"Z9>44NGRK4D6"21*1R2!Y7LB56HTFAX
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MLAQS,%HS@=&GME09X15;VZ<$UZ1:8S"7(Q1>[>!UK +L?H4=5'I#&"Q0,Q6
MFJD!U\J&,(2QM Y D-)(NP[4%P/</7+ZS((M1CA95L.&PAUMY*B[G @C:Z3\
MX='(H?<[N3(_">KEEJQ]42L5D.']TCGG_:H>**$+@_L\#^+M%IR;-04[NH=<
MY",CXUAG(D?MY4ZWCD=JH/VL 6_B,M1/KU!X!FSPKB'D&J@-92G=LQ*4I8"9
M(XG*KZ>\:U[E/.>*LKX_%BY3'Z[/D ,EI1*=KH:=+UE@0]:7@$SDT&NYH]2
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MAQ#T/;=^T#75,BB+L&DL2.P)X2IT'QPOH)MLVW&2X$ H&[(%^J&KA3_9$-[
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MT.Z<"I,U[+2&K8B);5_\-%/&3A>/%T#4B87YPQF>)SW5/?=G!+IU!5?1&#F
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M;^B<UM04P8>%\5Y-_,!)<@M,W9ZP.^Z$#?D7XNP7?[DO_0M02P,$%     @
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MB7I@$_>V0 9T,.X?2=)H--I1"8VEZ@A:Y@"IT*(/0"9#&#HL"PA2AD>@UAF
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M,C R-3 Y,#@N>'-D4$L! A0#%     @ $8CC6M$*':R7!   HA,  !0
M         ( !2XL! &QV;RTR,#(U,#DP.%]D968N>&UL4$L! A0#%     @
M$8CC6J$3J5\9"@  IFD  !0              ( !%) ! &QV;RTR,#(U,#DP
M.%]L86(N>&UL4$L! A0#%     @ $8CC6N'O?Y.>!   Z1T  !0
M     ( !7YH! &QV;RTR,#(U,#DP.%]P<F4N>&UL4$L%!@     &  8 B0$
' "^? 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>ea0248124-pre14a_liveone_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:lvo="http://www.liveone.com/20250908"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lvo-20250908.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:ValueOfEquityAwardsDeductedFromSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lvo:PEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:ValueOfEquityAwardsDeductedFromSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lvo:PEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lvo:PEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lvo:AverageNonPEONEOsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:ValueOfEquityAwardsDeductedFromSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lvo:AverageNonPEONEOsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:ValueOfEquityAwardsDeductedFromSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lvo:AverageNonPEONEOsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:ValueOfEquityAwardsDeductedFromSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:FairValueOfEquityAwardsCompensationGrantedInCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">lvo:YearOverYearChangeInFairValueOfEquityAwardsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-154">LIVEONE, INC.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c0" id="ixv-8498">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgPredtrmndFlag contextRef="c0" id="ixv-8499">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="c0" id="ixv-8500">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="c0" id="ixv-8501">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:PvpTableTextBlock contextRef="c0" id="ixv-7025">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PAY
VERSUS PERFORMANCE&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Introduction&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a disclosure pursuant to the SEC&#x2019;s new pay versus performance (&#x201c;PVP&#x201d;) rules. The PVP rules create a new
definition of pay, referred to as Compensation Actually Paid (&#x201c;CAP&#x201d;), which is compared to certain performance measures as
defined by the SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary
Compensation Table Versus Compensation Actually Paid&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
2025 Summary Compensation Table (&#x201c;SCT&#x201d;) set forth above discloses a mix of compensation earned during the year, e.g., base
salary and annual cash incentive, and the full grant date fair value of equity awards granted during the year. The new CAP definition
of pay adjusts compensation reported for a particular year to reflect an annualized value of compensation by removing the values mandated
by the SCT for equity awards granted during the year and instead including the value of equity awards vesting during the year and the
potential change in value of unvested equity awards granted in prior&#160;years. It is important to note that the executive did not actually
earn or receive the amount defined as CAP in the applicable year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Pay
Versus Performance Table&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the SCT compensation and CAP for our principal executive officer (&#x201c;PEO&#x201d;) and the average for our
non-PEO Named Executive Officers (&#x201c;NEOs&#x201d;) for our 2025, 2024 and 2023 fiscal&#160;years. In accordance with the PVP rules,
the table also includes certain prescribed performance related measures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary &lt;br/&gt; Compensation &lt;br/&gt; Table Total &lt;br/&gt; Compensation &lt;br/&gt; for PEO&lt;sup&gt;(4)&lt;/sup&gt;&#160;&lt;br/&gt; ($)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average &lt;br/&gt; Summary &lt;br/&gt; Compensation &lt;br/&gt; Table Total &lt;br/&gt; Compensation &lt;br/&gt; for Non-PEO &lt;br/&gt; NEOs&lt;sup&gt;(4)&lt;/sup&gt; &lt;br/&gt; ($)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation &lt;br/&gt; Actually&#160;Paid&#160;to &lt;br/&gt; PEO&lt;sup&gt;(5)&lt;/sup&gt; &lt;br/&gt; ($)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average &lt;br/&gt; Compensation &lt;br/&gt; Actually &lt;br/&gt; Paid to &lt;br/&gt; Non-PEO &lt;br/&gt; NEOs&lt;sup&gt;(5)&lt;/sup&gt; &lt;br/&gt; ($)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Value of &lt;br/&gt; Initial &lt;br/&gt; Fixed $100 &lt;br/&gt; Investment &lt;br/&gt; Based on &lt;br/&gt; Total &lt;br/&gt; Shareholder &lt;br/&gt; Return &lt;br/&gt; ($)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;GAAP &lt;br/&gt; Net Loss &lt;br/&gt; (in&#160;thousands) &lt;br/&gt; ($)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 28%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;558,584&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;618,855&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;558,584&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;166,169&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17.48&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(20,370&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;547,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;809,237&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;547,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;438,236&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44.93&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,966&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;552,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;247,314&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;182,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;230,395&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26.57&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,019&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the 2025 fiscal year, Robert S.&#160;Ellin was our Chief Executive Officer and our remaining NEOs consisted of Ryan Carhart, our Chief
Financial Officer, and Aaron Sullivan, our former Chief Financial Officer. We did not have any other NEOs for such fiscal year.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the 2024 fiscal year, Robert S.&#160;Ellin was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer. We did not have any other NEOs for such fiscal year.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the 2023 fiscal year, Robert S. Ellin was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer and Dermot McCormack, our former President.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amounts
in this column represent the &#x201c;Total&#x201d; column set forth in the 2025 Summary Compensation Table on page 34. See the footnotes
to the 2025 Summary Compensation Table for further detail regarding the amounts in these columns.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
dollar amounts reported in these columns represent the amounts of &#x201c;compensation actually paid.&#x201d; The amounts are computed
in accordance with Item&#160;402(v)&#160;of Regulation&#160;S-K by deducting and adding the following amounts from the &#x201c;Total&#x201d;
column of the 2025 Summary Compensation Table (pursuant to SEC rules, fair value at each measurement date is computed in a manner consistent
with the fair value methodology used to account for share-based payments in our financial statements under GAAP):&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table provides additional information on how CAP for each reporting year was determined, starting with SCT compensation, and
applying each of the required adjustments, as applicable, in accordance with the PVP rules.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"&gt;Fiscal Year&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Summary &lt;br/&gt; Compensation &lt;br/&gt; Table&#160;Total &lt;br/&gt; Compensation &lt;br/&gt; ($)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Value&#160;of &lt;br/&gt; Equity &lt;br/&gt; Awards &lt;br/&gt; Deducted &lt;br/&gt; from&#160;SCT &lt;br/&gt; ($)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair&#160;Value&#160;of &lt;br/&gt; Equity&#160;Awards &lt;br/&gt; Compensation &lt;br/&gt; Granted&#160;in &lt;br/&gt; Current&#160;Year &lt;br/&gt; ($)&lt;sup&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year-Over-Year &lt;br/&gt; Change&#160;in &lt;br/&gt; Fair&#160;Value&#160;of &lt;br/&gt; Unvested&lt;br/&gt; Equity&#160;Awards &lt;br/&gt; ($)&lt;sup&gt;(2)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year-Over-Year &lt;br/&gt; Change&#160;in &lt;br/&gt; Fair&#160;Value&#160;of &lt;br/&gt; Equity&#160;Awards &lt;br/&gt; that&#160;Vested &lt;br/&gt; During&#160;the&#160;Year &lt;br/&gt; ($)&lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Compensation &lt;br/&gt; Actually&#160;Paid &lt;br/&gt; ($)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; font-weight: bold"&gt;PEO&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 28%; font-weight: bold; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;558,584&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-1"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-3"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-4"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;558,584&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;547,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-5"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-6"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-7"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-8"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;547,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold; text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;552,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;552,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; font-weight: bold"&gt;Average&#160;Non-PEO&#160;NEOs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold; text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;618,855&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;335,230&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;218,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(336,206&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;166,123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold; text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;809,237&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;530,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;152,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,999&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;438,236&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold; text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;285,654&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,838&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;85,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,191&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,666&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;230,395&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
amounts represent the fair value as of the indicated fiscal year-end of the outstanding and unvested equity awards granted during such
fiscal year, calculated in accordance with the methodology used for financial reporting purposes. The fair value differs from the value
in the SCT because for&#160;purposes of CAP the fair value for equity awards granted in the current year is determined as of the last&#160;day
of the applicable year. Fair values in the SCT are determined as of the grant date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
amounts represent the change in fair value during the indicated fiscal year of each equity award that was granted in a prior fiscal year
and that remained outstanding and unvested as of the last&#160;day of the indicated fiscal year, calculated in accordance with the methodology
used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on an estimate of the probable
outcome of such performance-based vesting conditions as of the last&#160;day of the fiscal year.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
amounts represent the change in fair value, measured from the prior fiscal year-end to the vesting date, of each equity award that was
granted in a prior fiscal year and which vested during the indicated fiscal year, calculated in accordance with the methodology used
for financial reporting purposes.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c0" decimals="0" id="ix_4_fact" unitRef="usd">558584</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c0" decimals="0" id="ix_5_fact" unitRef="usd">618855</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c0" decimals="0" id="ix_6_fact" unitRef="usd">558584</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c0" decimals="0" id="ix_7_fact" unitRef="usd">166169</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c0" decimals="2" id="ix_19_fact" unitRef="usd">17.48</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ix_1_fact" unitRef="usd">-20370000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c1" decimals="0" id="ix_8_fact" unitRef="usd">547032</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c1" decimals="0" id="ix_9_fact" unitRef="usd">809237</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c1" decimals="0" id="ix_10_fact" unitRef="usd">547032</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c1" decimals="0" id="ix_11_fact" unitRef="usd">438236</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c1" decimals="2" id="ix_20_fact" unitRef="usd">44.93</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c1" decimals="-3" id="ix_2_fact" unitRef="usd">-11966000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c2" decimals="0" id="ix_12_fact" unitRef="usd">552360</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c2" decimals="0" id="ix_13_fact" unitRef="usd">247314</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c2" decimals="0" id="ix_14_fact" unitRef="usd">182680</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c2" decimals="0" id="ix_15_fact" unitRef="usd">230395</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c2" decimals="2" id="ix_21_fact" unitRef="usd">26.57</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c2" decimals="-3" id="ix_3_fact" unitRef="usd">-10019000</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c0" id="ixv-7227">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the 2025 fiscal year, Robert S.&#160;Ellin was our Chief Executive Officer and our remaining NEOs consisted of Ryan Carhart, our Chief
Financial Officer, and Aaron Sullivan, our former Chief Financial Officer. We did not have any other NEOs for such fiscal year.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the 2024 fiscal year, Robert S.&#160;Ellin was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer. We did not have any other NEOs for such fiscal year.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the 2023 fiscal year, Robert S. Ellin was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer and Dermot McCormack, our former President.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c0" id="ixv-8520">Robert S.&#160;Ellin</ecd:PeoName>
    <ecd:PeoName contextRef="c1" id="ixv-8521">Robert S.&#160;Ellin</ecd:PeoName>
    <ecd:PeoName contextRef="c2" id="ixv-8522">Robert S. Ellin</ecd:PeoName>
    <ecd:PeoTotalCompAmt contextRef="c0" decimals="0" id="ixv-8523" unitRef="usd">558584</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c7" decimals="0" id="ixv-8524" unitRef="usd">558584</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c1" decimals="0" id="ixv-8525" unitRef="usd">547032</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c12" decimals="0" id="ixv-8526" unitRef="usd">547032</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c2" decimals="0" id="ixv-8527" unitRef="usd">552360</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c13" decimals="0" id="ixv-8528" unitRef="usd">552360</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c14" decimals="0" id="ixv-8529" unitRef="usd">618855</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c15" decimals="0" id="ixv-8530" unitRef="usd">335230</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c16" decimals="0" id="ix_16_fact" unitRef="usd">218750</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c17" decimals="0" id="ix_25_fact" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c18" decimals="0" id="ix_0_fact" unitRef="usd">-336206</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c14" decimals="0" id="ixv-8534" unitRef="usd">166123</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c19" decimals="0" id="ixv-8535" unitRef="usd">809237</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c20" decimals="0" id="ixv-8536" unitRef="usd">530250</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c21" decimals="0" id="ix_17_fact" unitRef="usd">152250</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c22" decimals="0" id="ix_26_fact" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c23" decimals="0" id="ix_22_fact" unitRef="usd">6999</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c19" decimals="0" id="ixv-8540" unitRef="usd">438236</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c24" decimals="0" id="ixv-8541" unitRef="usd">285654</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c25" decimals="0" id="ixv-8542" unitRef="usd">33838</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c26" decimals="0" id="ix_18_fact" unitRef="usd">85500</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c27" decimals="0" id="ix_23_fact" unitRef="usd">3191</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c28" decimals="0" id="ix_24_fact" unitRef="usd">4666</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c24" decimals="0" id="ixv-8546" unitRef="usd">230395</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <dei:DocumentType contextRef="c0" id="hidden-fact-0">PRE 14A</dei:DocumentType>
    <ecd:AdjToCompAmt
      contextRef="c3"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c4"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c5"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c6"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c8"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c9"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c10"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c11"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-8558">0001491419</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-8559">false</dei:AmendmentFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-8"
          xlink:label="hidden-fact-8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-4"
          xlink:label="hidden-fact-4"
          xlink:type="locator"/>
        <link:footnote id="ix_7_footnote" xlink:label="ix_7_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the change in fair value, measured from the prior fiscal year-end to the vesting date, of each equity award that was
granted in a prior fiscal year and which vested during the indicated fiscal year, calculated in accordance with the methodology used
for financial reporting purposes.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-8"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-4"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2025 fiscal year, Robert S.&#160;Ellin was our Chief Executive Officer and our remaining NEOs consisted of Ryan Carhart, our Chief
Financial Officer, and Aaron Sullivan, our former Chief Financial Officer. We did not have any other NEOs for such fiscal year.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2024 fiscal year, Robert S.&#160;Ellin was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer. We did not have any other NEOs for such fiscal year.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the 2023 fiscal year, Robert S. Ellin was our Chief Executive Officer and our remaining NEOs consisted of Aaron Sullivan, our former
Chief Financial Officer and Dermot McCormack, our former President.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-2"
          xlink:label="hidden-fact-2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-6"
          xlink:label="hidden-fact-6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the fair value as of the indicated fiscal year-end of the outstanding and unvested equity awards granted during such
fiscal year, calculated in accordance with the methodology used for financial reporting purposes. The fair value differs from the value
in the SCT because for&#160;purposes of CAP the fair value for equity awards granted in the current year is determined as of the last&#160;day
of the applicable year. Fair values in the SCT are determined as of the grant date.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-2"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-6"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-3"
          xlink:label="hidden-fact-3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-7"
          xlink:label="hidden-fact-7"
          xlink:type="locator"/>
        <link:footnote id="ix_6_footnote" xlink:label="ix_6_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the change in fair value during the indicated fiscal year of each equity award that was granted in a prior fiscal year
and that remained outstanding and unvested as of the last&#160;day of the indicated fiscal year, calculated in accordance with the methodology
used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on an estimate of the probable
outcome of such performance-based vesting conditions as of the last&#160;day of the fiscal year.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-3"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-7"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
in this column represent the &#x201c;Total&#x201d; column set forth in the 2025 Summary Compensation Table on page 34. See the footnotes
to the 2025 Summary Compensation Table for further detail regarding the amounts in these columns.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
dollar amounts reported in these columns represent the amounts of &#x201c;compensation actually paid.&#x201d; The amounts are computed
in accordance with Item&#160;402(v)&#160;of Regulation&#160;S-K by deducting and adding the following amounts from the &#x201c;Total&#x201d;
column of the 2025 Summary Compensation Table (pursuant to SEC rules, fair value at each measurement date is computed in a manner consistent
with the fair value methodology used to account for share-based payments in our financial statements under GAAP):</xhtml:span><xhtml:p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides additional information on how CAP for each reporting year was determined, starting with SCT compensation, and
applying each of the required adjustments, as applicable, in accordance with the PVP rules.</xhtml:span></xhtml:p><xhtml:table
  cellpadding="0"
  style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"><xhtml:tr style="vertical-align: bottom"><xhtml:td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Fiscal Year</xhtml:td><xhtml:td style="font-weight: bold">&#160;</xhtml:td><xhtml:td
          colspan="2"
          style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Summary <xhtml:br/> Compensation <xhtml:br/> Table&#160;Total <xhtml:br/> Compensation <xhtml:br/> ($)</xhtml:td><xhtml:td style="font-weight: bold">&#160;</xhtml:td><xhtml:td style="font-weight: bold">&#160;</xhtml:td><xhtml:td
          colspan="2"
          style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value&#160;of <xhtml:br/> Equity <xhtml:br/> Awards <xhtml:br/> Deducted <xhtml:br/> from&#160;SCT <xhtml:br/> ($)</xhtml:td><xhtml:td style="font-weight: bold">&#160;</xhtml:td><xhtml:td style="font-weight: bold">&#160;</xhtml:td><xhtml:td
          colspan="2"
          style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><xhtml:b>Fair&#160;Value&#160;of <xhtml:br/> Equity&#160;Awards <xhtml:br/> Compensation <xhtml:br/> Granted&#160;in <xhtml:br/> Current&#160;Year <xhtml:br/> ($)<xhtml:sup>(1)</xhtml:sup></xhtml:b></xhtml:span></xhtml:td><xhtml:td style="font-weight: bold">&#160;</xhtml:td><xhtml:td style="font-weight: bold">&#160;</xhtml:td><xhtml:td
          colspan="2"
          style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><xhtml:b>Year-Over-Year <xhtml:br/> Change&#160;in <xhtml:br/> Fair&#160;Value&#160;of <xhtml:br/> Unvested<xhtml:br/> Equity&#160;Awards <xhtml:br/> ($)<xhtml:sup>(2)</xhtml:sup></xhtml:b></xhtml:span></xhtml:td><xhtml:td style="font-weight: bold">&#160;</xhtml:td><xhtml:td style="font-weight: bold">&#160;</xhtml:td><xhtml:td
          colspan="2"
          style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><xhtml:b>Year-Over-Year <xhtml:br/> Change&#160;in <xhtml:br/> Fair&#160;Value&#160;of <xhtml:br/> Equity&#160;Awards <xhtml:br/> that&#160;Vested <xhtml:br/> During&#160;the&#160;Year <xhtml:br/> ($)<xhtml:sup>(3)</xhtml:sup></xhtml:b></xhtml:span></xhtml:td><xhtml:td style="font-weight: bold">&#160;</xhtml:td><xhtml:td style="font-weight: bold">&#160;</xhtml:td><xhtml:td
          colspan="2"
          style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Compensation <xhtml:br/> Actually&#160;Paid <xhtml:br/> ($)</xhtml:td><xhtml:td style="font-weight: bold">&#160;</xhtml:td></xhtml:tr><xhtml:tr style="vertical-align: bottom"><xhtml:td style="text-align: left; font-weight: bold">PEO</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td colspan="2">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td colspan="2">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td colspan="2">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td colspan="2">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td colspan="2">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td colspan="2">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td></xhtml:tr><xhtml:tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><xhtml:td style="width: 28%; font-weight: bold; text-align: left">2025</xhtml:td><xhtml:td style="width: 1%">&#160;</xhtml:td><xhtml:td style="width: 1%; text-align: left">&#160;</xhtml:td><xhtml:td style="width: 9%; text-align: right">558,584</xhtml:td><xhtml:td style="width: 1%; text-align: left">&#160;</xhtml:td><xhtml:td style="width: 1%">&#160;</xhtml:td><xhtml:td style="width: 1%; text-align: left">&#160;</xhtml:td><xhtml:td style="width: 9%; text-align: right"><xhtml:span style="-sec-ix-hidden: hidden-fact-1">&#x2014;</xhtml:span></xhtml:td><xhtml:td style="width: 1%; text-align: left">&#160;</xhtml:td><xhtml:td style="width: 1%">&#160;</xhtml:td><xhtml:td style="width: 1%; text-align: left">&#160;</xhtml:td><xhtml:td style="width: 9%; text-align: right"><xhtml:span style="-sec-ix-hidden: hidden-fact-2">&#x2014;</xhtml:span></xhtml:td><xhtml:td style="width: 1%; text-align: left">&#160;</xhtml:td><xhtml:td style="width: 1%">&#160;</xhtml:td><xhtml:td style="width: 1%; text-align: left">&#160;</xhtml:td><xhtml:td style="width: 9%; text-align: right"><xhtml:span style="-sec-ix-hidden: hidden-fact-3">&#x2014;</xhtml:span></xhtml:td><xhtml:td style="width: 1%; text-align: left">&#160;</xhtml:td><xhtml:td style="width: 1%">&#160;</xhtml:td><xhtml:td style="width: 1%; text-align: left">&#160;</xhtml:td><xhtml:td style="width: 9%; text-align: right"><xhtml:span style="-sec-ix-hidden: hidden-fact-4">&#x2014;</xhtml:span></xhtml:td><xhtml:td style="width: 1%; text-align: left">&#160;</xhtml:td><xhtml:td style="width: 1%">&#160;</xhtml:td><xhtml:td style="width: 1%; text-align: left">&#160;</xhtml:td><xhtml:td style="width: 9%; text-align: right">558,584</xhtml:td><xhtml:td style="width: 1%; text-align: left">&#160;</xhtml:td></xhtml:tr><xhtml:tr style="vertical-align: bottom; "><xhtml:td style="font-weight: bold; text-align: left">2024</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">547,032</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right"><xhtml:span style="-sec-ix-hidden: hidden-fact-5">&#x2014;</xhtml:span></xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right"><xhtml:span style="-sec-ix-hidden: hidden-fact-6">&#x2014;</xhtml:span></xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right"><xhtml:span style="-sec-ix-hidden: hidden-fact-7">&#x2014;</xhtml:span></xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right"><xhtml:span style="-sec-ix-hidden: hidden-fact-8">&#x2014;</xhtml:span></xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">547,032</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td></xhtml:tr><xhtml:tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><xhtml:td style="font-weight: bold; text-align: left">2023</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">552,360</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">552,360</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td></xhtml:tr><xhtml:tr style="vertical-align: bottom; "><xhtml:td style="text-align: left; font-weight: bold">Average&#160;Non-PEO&#160;NEOs</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td></xhtml:tr><xhtml:tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><xhtml:td style="font-weight: bold; text-align: left">2025</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">618,855</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">335,230</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">218,750</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">0</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">(336,206</xhtml:td><xhtml:td style="text-align: left">)</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">166,123</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td></xhtml:tr><xhtml:tr style="vertical-align: bottom; "><xhtml:td style="font-weight: bold; text-align: left">2024</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">809,237</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">530,250</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">152,250</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">0</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">6,999</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">438,236</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td></xhtml:tr><xhtml:tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><xhtml:td style="font-weight: bold; text-align: left">2023</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">285,654</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">33,838</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">85,500</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">3,191</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">4,666</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td>&#160;</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td><xhtml:td style="text-align: right">230,395</xhtml:td><xhtml:td style="text-align: left">&#160;</xhtml:td></xhtml:tr></xhtml:table><xhtml:table
  cellpadding="0"
  style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><xhtml:tr style="vertical-align: top; text-align: justify"><xhtml:td style="width: 0.35in; text-align: left"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</xhtml:span></xhtml:td><xhtml:td style="text-align: justify"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the fair value as of the indicated fiscal year-end of the outstanding and unvested equity awards granted during such
fiscal year, calculated in accordance with the methodology used for financial reporting purposes. The fair value differs from the value
in the SCT because for&#160;purposes of CAP the fair value for equity awards granted in the current year is determined as of the last&#160;day
of the applicable year. Fair values in the SCT are determined as of the grant date.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table><xhtml:table
  cellpadding="0"
  style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><xhtml:tr style="vertical-align: top; text-align: justify"><xhtml:td style="width: 0.35in; text-align: left"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</xhtml:span></xhtml:td><xhtml:td style="text-align: justify"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the change in fair value during the indicated fiscal year of each equity award that was granted in a prior fiscal year
and that remained outstanding and unvested as of the last&#160;day of the indicated fiscal year, calculated in accordance with the methodology
used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on an estimate of the probable
outcome of such performance-based vesting conditions as of the last&#160;day of the fiscal year.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table><xhtml:table
  cellpadding="0"
  style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><xhtml:tr style="vertical-align: top; text-align: justify"><xhtml:td style="width: 0.35in; text-align: left"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</xhtml:span></xhtml:td><xhtml:td style="text-align: justify"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent the change in fair value, measured from the prior fiscal year-end to the vesting date, of each equity award that was
granted in a prior fiscal year and which vested during the indicated fiscal year, calculated in accordance with the methodology used
for financial reporting purposes.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
